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Nutrition is both a maker and a marker of development.  
Improved nutrition is the platform for progress in health, education, employment, 
empowerment of women and the reduction of poverty and inequality, and can lay the 
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RESUMO 
 
Introdução: À semelhança de outros países de baixo-médio rendimento, em Angola, a 
malnutrição e a doença diarreica estão entre as principais causas de mortes em crianças 
menores de cinco anos, nomeadamente na província do Bengo. 
Objectivos: i) identificar a etiologia da diarreia e fatores associados em crianças menores 
de cinco anos atendidas no Hospital Geral do Bengo (HGB); ii) fornecer informações 
sobre a caracterização molecular de rotavírus, antes da introdução da vacina; iii) fornecer 
uma caracterização molecular de Giardia lamblia; e iv) investigar se o tratamento de 
parasitas intestinais (com ou sem diagnóstico prévio) em dois níveis diferentes (individual 
ou a nível do agregado familiar) tem impacto sobre o estado nutricional de crianças de 2-
5 anos, após seguimento de dois anos no Bengo. 
Métodos: Um estudo transversal (ET) foi implementado para investigar a presença de 
vírus, bactérias e parasitas nas fezes diarreicas de 344 crianças atendidas no HGB (2012-
2013), recolhendo dados sociodemográficos, nutricionais e clínicos, explorados por 
modelos de regressão logística simples e múltipla. Posteriormente, realizaram-se métodos 
moleculares para identificação dos genótipos circulantes de rotavírus e genótipos e 
subgenótipos de G. lamblia. Entre 2013 e 2017, um estudo longitudinal e experimental 
(RCT) com quatro braços em paralelo foi realizado em crianças infetadas com pelo menos 
um parasita intestinal patogénico (ISRCTN-72928001). As 121 crianças com critérios de 
inclusão foram distribuídas aleatoriamente (1:1:1:1) - Braço1: albendazol anual a nível 
individual; Braço2: albendazol anual ao agregado familiar; Braço3: diagnóstico e 
tratamento quadrimestral de parasitas intestinais a nível individual; Braço4: diagnóstico 
e tratamento quadrimestral de parasitas intestinais ao nível do agregado familiar. No 
início do estudo, aos 4, 8, 12, 16, 20 e 24 meses de acompanhamento avaliou-se: a altura, 
o peso, estatura-para-idade, peso-para-altura e peso-para-idade em Z-score. A análise por 
intenção-de-tratar foi realizada seguindo as diretrizes CONSORT, após a análise de 
valores omissos (IBM SPSS). Dada a falha dos pressupostos da análise paramétrica de 
medidas repetidas, uma abordagem não paramétrica (nparLD) e os modelos LMM e GEE 
foram explorados no programa R. 
Resultados: Nos dois estudos, as crianças viviam principalmente em áreas urbanas 
(>90%) e mais de 20% não tinha latrina. A água mais usada para beber provinha do rio, 
da torneira no quintal e de tanques. A desnutrição crónica ocorreu em 38% (ET) e 31% 
(RCT) das crianças. No ET, 67% das crianças estavam infetadas por um agente 
enteropatogénico, principalmente por Cryptosporidium spp. (30%), rotavírus (25%) e G. 
lamblia (22%). Cryptosporidium spp. e rotavírus foram mais frequentes em menores de 
12 meses. Os principais genótipos circulantes de rotavírus foram: G1P [8] (47%), G1P 
[6] (29%) e G2P [4] (13%). O genótipo B de G. lamblia foi predominante em relação ao 
genótipo A. No RCT, no início do estudo, as crianças estavam infetadas principalmente 
com G. lamblia (57%) e Ascaris lumbricoides (26%). Diferentes modelos não forneceram 
nenhuma evidência ou fraca evidência do efeito das intervenções nas medições 
antropométricas, embora tenha ocorrido uma evolução temporal significativa. Contudo, 
nota-se uma redução da desnutrição ligeira ao longo do estudo, apesar de, em média, as 
crianças permaneceram com valores padronizados (z-scores) negativos para os índices 
antropométricos.  
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Conclusão: Várias infeções entéricas foram identificados nos dois estudos. No RCT, 
nenhuma das estratégias de tratamento de parasitoses intestinais se destacou com efeito 
significativo nos indicadores antropométricos estudados. A duração do RCT e o tamanho 
da amostra podem não ter sido suficientes para observar diferenças significativas. Por 
outro lado, realça-se a importância de uma abordagem multifatorial integrada com vista 
à melhoria do estado nutricional (e.g., WASH, educação, alimentação adequada e acesso 
a cuidados de saúde).  
 
Palavras-chave: desnutrição, diarreia, desparasitação, crescimento, longitudinal
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ABSTRACT  
 
Background: Similar to other low- and middle-income countries, in Angola, malnutrition 
and diarrhoeal disease are among the major causes of deaths in children under-five, 
namely in Bengo province. 
Aims: i) identify the aetiology of diarrhoea and associated factors in under-five children 
attending the Bengo General Hospital (HGB); ii) provide information on the molecular 
characterization of rotavirus, before the vaccine introduction; iii) provide a molecular 
characterization of Giardia lamblia; and iv) investigate if treatment of intestinal parasites 
(with or without previous diagnosis) in two different levels (individual or household) 
impacts on nutritional status of children 2-5 years, after a two-year follow-up in Bengo. 
Methods: A cross-sectional study (CSS) was conducted to investigate the presence of 
virus, bacteria and parasites in diarrhoeal stools of 344 children attending HGB (2012-
2013), collecting sociodemographic, nutritional and clinical data, analysed by simple and 
multiple logistic regression models. Then, molecular methods were performed for the 
identification of rotavirus circulating genotypes and G. lamblia assemblages and sub-
assemblages. Between 2013 and 2017, a four-arm randomised controlled trial (RCT, 
registration ISRCTN-72928001) was conducted longitudinally in children infected with 
at least one pathogenic intestinal parasite. 121 children meeting inclusion criteria were 
randomly assigned (1:1:1:1) - Arm1: annual albendazole at individual level; Arm2: 
annual albendazole at household level; Arm3: four-monthly screening and treatment of 
intestinal parasites at individual level; Arm4: four-monthly screening and treatment of 
intestinal parasites at household level. Height, weight, height-for-age, weight-for-height, 
and weight-for-age Z-score were assessed at baseline, 4, 8, 12, 16, 20, and 24 months of 
follow-up. Intention-to-treat analysis was performed following CONSORT guidelines, 
after a missing value analysis (IBM SPSS). Given the failure of assumptions for 
parametric repeated measurements, nonparametric rank-based method (nparLD), LMM 
and GEE models were performed in R program.  
Results: In both studies, children lived mainly in urban areas (>90%) and more than 20% 
did not have a latrine. The most commonly drinking water sources were the river, the tap 
in the yard and tank. Near 38% (CSS) and 31% (RCT) of children were stunted. In the 
CSS, 67% of children were infected with an enteropathogen, mostly with 
Cryptosporidium spp. (30%), rotavirus (25%) and G. lamblia (22%). Cryptosporidium 
spp. and rotavirus were more frequent in children under 12 months. The main rotavirus 
circulating genotypes were: G1P[8] (47%), G1P[6] (29%) and G2P[4] (13%). G. lamblia 
assemblage B was predominant compared with assemblage A. In the RCT, at baseline, 
children were mainly infected with G. lamblia (57%) and Ascaris lumbricoides (26%). 
Different models provided no evidence or weak evidence of the effect of interventions on 
anthropometric measurements, although a significant temporal effect occurred. A 
reduction in mild malnutrition occurred throughout the study, although, on average, 
children remained with negative z-scores for anthropometric indices. 
Conclusion: Several enteric infections were identified in both studies. In the RCT, none 
of the treatment strategies targeting intestinal parasites stood out with significant effect 
on the anthropometric indices studied. The duration of the RCT and the sample size may 
xiv 
 
not have been sufficient to observe significant differences. On the other hand, it highlights 
the importance of an integrated multifactorial approach to improving nutritional status 
(eg, WASH, education, adequate food and access to health care). 
 
Keywords: malnutrition, diarrhoea, deworming, growth, longitudinal.
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INTRODUCTION
 
 
In the last decades, the international community has joined efforts to struggle 
malnutrition, an important public health problem with social and economic impact 
worldwide (1-9). Special attention has been given to vulnerable groups, including 
children (2, 5, 10). The normal development of children should be guaranteed, regardless 
of race, nationality or religion (11). 
In 1943, during the United Nations Conference on Food and Agriculture, and two years 
before the end of the Second World War (1939-1945), it was established the need to 
secure and adequate food for all (12). There was a scenario of under consumption in the 
global population, with important impact on several countries, mainly on the child´s 
health with evident loss in weight and height compared with the pre-war years (13). The 
goal of freedom from hunger (especially in armed conflict regions), and the need to 
increase the food production and distribution were important issues to improve (12). 
Poverty was recognized as the first cause of hunger and malnutrition, which was the 
leading cause of disease and child mortality (12). Nutrition was a primary concern of 
governments since it was essential to promote the global economic expansion, to raise the 
levels of nutrition of people and their life conditions (12).  
Following an idea of international cooperation, the United Nations (UN) Charter was 
formally signed on 26 June 1945 and came into force on 24 October 1945 (14). This was 
an era marked by the creation of organizations with public health relevance to the present 
day. The Food and Agriculture Organization (FAO) was founded on 16 October 1945 as 
a UN specialized agency in order to help countries to find solutions for their food, 
agriculture and nutrition problems (15). The United Nations Children´s Fund (UNICEF1), 
was created a year later (1946) to help and protect children affected by the war, famine, 
disease or other type of emergency (16). Two years later, on 7 April 1948, the World 
Health Organization (WHO) was formally created as an international public health 
specialized agency of the UN (17), in the same year that the Universal Declaration of 
                                                 
1 At the time known as The United Nations International Children´s Emergency Fund. 
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Human Rights was proclaimed and adopted by the UN General Assembly, enhancing the 
rights and freedoms to which every person is entitled (18).  
The 1950s were known as the era of the mass anti-disease campaign through the 
implementation of water, sanitation and hygiene projects, technical training and nutrition 
education programmes (16). This decade ended with the UN Declaration of the Rights of 
the Child (A/RES/14/1386) proclaiming the right to protection, education, healthcare, 
shelter and good nutrition (19).  
In the early 1960s, the World Food Programme (WFP) was established as an initial 
experimental programme for three years on a voluntary basis to be undertaken jointly by 
the UN and the FAO (A/RES/1714) (20). The aim of this programme was to establish 
adequate procedures to respond emergency food needs and emergency in chronic 
malnutrition, assisting pre-school and school feeding, and promoting the economic and 
social development through food aid (20). 
In the 1970s, there was a recognition that food or protein crisis was afflicting especially 
those living in developing countries (21), leading to the Universal Declaration of the 
eradication of hunger and malnutrition (A/RES/3348), adopted on 16 November 1974 by 
the First World Food Conference, proclaiming that every man, woman and child has the 
inalienable right to be free from hunger and malnutrition in order to develop fully and 
maintain their physical and mental faculties (22). This declaration guided governments 
to work together to achieve a common goal, through food and nutrition policies, 
emphasizing the need to attack on chronic malnutrition and deficiency diseases among 
the vulnerable and lower income countries (22). In 1979, the Alma-Ata Conference on 
Health for All promoted the primary healthcare, which should include, at least, health 
education, promotion of adequate nutrition, access to safe water and basic sanitation, 
maternal and child care, immunization, appropriate treatment and control of endemic 
diseases (23).  
During the 1980s, to reduce the under-five deaths, the international community was 
mobilized to adopt four low-cost techniques, also known as GOBI campaign: Growth 
monitoring for undernutrition, Oral rehydration to prevent deaths from diarrhoeal disease 
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Breastfeeding and Immunization2, which became a priority of the primary health care 
movement (16). The objective was also to address the control and prevention of infectious 
diseases in order to improve the nutritional status. During this decade, child nutrition 
improved globally, although only slightly in sub-Saharan Africa (SSA) (16).  
In 1992, commitment to eliminate hunger and reduce all forms of malnutrition was a 
priority affirmed in Rome, during the First International Conference on Nutrition (24). 
Poverty and the lack of education continued to be recognized as the main causes of 
malnutrition and, therefore, the need to improve the access to food, safe water, sanitation, 
health, education and social services of the most vulnerable was reinforced (24, 25). 
Concerns were focused on Africa, Asia and Latin America, where the number of 
malnourished children was increasing and the infectious, parasitic and communicable 
diseases needed to be reduced through adequate health care services and national 
programs (25, 26). The Rome declaration, adopted in 1996 during the World Food 
Summit (WFS), also listed commitment points for achieving food security at the 
individual, household, national, regional and global level (27). International cooperation 
continued, but each country was requested to participate by formulating its own goals and 
strategies. 
In 2000, the UN Millennium Declaration was the basis of the eight international 
Millennium Development Goals (MDGs) established to be achieved by 2015 (28). The 
first goal (MDG 1) aimed to eradicate extreme poverty and hunger, which included the 
target 1c of reducing by 50% the proportion of undernourished people who suffer from 
hunger between 1990 and 2015 (29). Two main indicators were used to assess the 
progress of MDG nutrition targets: the proportion of undernourished people and the 
prevalence of underweight in children under-five years of age (29, 30). The nutrition 
targets were integrated in many international initiatives to inspire and to promote a global 
movement towards nutrition challenges (2, 3, 5, 24, 30-32).  
                                                 
2 Immunization against the six vaccine-preventable childhood killers: tuberculosis, diphtheria, whooping 
cough, tetanus, polio and measles 
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After the MDGs era (33), the list of the 17 Sustainable Development Goals (SDGs)3 
represents now a new call to reducing health inequalities and leaving no one behind until 
2030 through a multisector approach set by the UN (6, 34-36). The second SDG aims to 
end all forms of malnutrition by 2030 (Zero Hunger), by achieving also the six global 
nutrition targets4 by 2025, set by the World Health Assembly in 2012, and integrated in 
a comprehensive implementation plan on maternal, infant and young child nutrition (34, 
35). Reducing by 40% the number of stunted children under-five years of age, and 
wasting to less than 5% are one of the targets to be achieved (34, 35). 
Recent data indicates that in 2017 approximately 151 million (22.2%) children under-five 
years of age were stunted, 50.5 million (7.5%) were suffering from wasting, and 38.3 
million (5.6%) were overweight, worldwide (37). Malnutrition contributes as an 
underlying cause with 45% of total deaths in this age group (38) and, simultaneously, 
infectious diseases are the major, although preventable, causes of death in developing 
regions (1). 
Malnutrition and infectious diseases are a serious health problem in Angola, a sub-
Saharan country that faced a 40-year period of civil war until 2002 (39). According to the 
most recent Multiple Indicator Cluster Survey (MICS) conducted in 2015-2016, 37.6% 
of Angolan children are suffering from stunting and 4.9% from wasting (40). There is a 
national commitment included in the National Health Development Plan to struggle 
malnutrition and, consequently, to prevent and treat its associated diseases (41). Some of 
the strategies include the promotion of adequate breastfeeding practices, micronutrient 
supplementation, vaccination (mainly by introducing rotavirus vaccine in the national 
immunization plan), and deworming with albendazole in under-five children (41, 42). 
Bengo province is one of the eighteenth provinces of Angola, where malnutrition and 
infectious diseases are also a major problem in children (40, 43). This thesis seeks to 
contribute to literature on malnutrition and enteric infections with data collected from a 
                                                 
3 Annexe I  List of the 17 Sustainable Development Goals 
4 Annexe II  Goal 2 - Zero Hunger: Targets and indicators 
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cross-sectional hospital-based study and a longitudinal study conducted in Bengo. The 
first study provides a global characterization of enteric infections (virus, parasites, 
bacteria) in under-five children with diarrhoea and its association with malnutrition, by 
answering the following questions: i) what are the most frequent agents of diarrhoea in 
children attending the referral hospital for the province?; ii) what is detection rate of 
rotavirus and circulating genotypes before the introduction of rotarix vaccine?, and iii) 
what is the detection rate and molecular profile of Giardia lamblia? Then, restricting our 
focus on undernutrition and intestinal parasitic infections, a four-arm parallel trial was 
implemented to investigate: iv) if the treatment of intestinal parasites (with or without 
previous diagnosis) in two different levels (individual or household) impacts on 
nutritional status of children between two and five years old, after a two-year follow-up 
period. 
This work is divided in three main sections: Introduction, Results and Discussion.  
The first section begins with a brief definition of malnutrition (1.1) and global prevalence 
rates (1.2). Then, based on the UNICEF conceptual framework, the main factors affecting 
the nutritional status are described and contextualized within the Sustainable 
Development Goals (1.3), as well as international strategies to improve child nutrition 
(1.4). After, the profile of Angola is presented considering important historical facts, the 
health system, its main indicators and nutrition targets to be achieved in the context of the 
SDGs (1.5). The introduction closes with the main objectives of this thesis (1.6), as well 
as the methodology applied in the different studies performed (1.7), and all references 
used in this first section (1.8). 
The second section is the Results section, which is composed by four papers of which 
three are already published and one was submitted to be published: paper I (2.1), paper II 
(2.2); paper III (2.3) and paper IV (2.4). 
The third section is the Discussion, where the main findings are discussed from a public 
health perspective, with an overview of the research limitations, strengthens, conclusions, 
and recommendations for future research in this field. 
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1.1. Defining Malnutrition 
Malnutrition encompasses two groups of conditions: undernutrition and overnutrition (2). 
Undernutrition is related to undernourishment, poor absorption or deficit of nutrients 
intake (44). It includes stunting, wasting, underweight and deficiency of micronutrients 
(vitamins and minerals), which can appear isolated or in combination. Overnutrition, in 
turn, is a consequence of over-consumption of nutrients and can lead to overweight and 
obesity (5, 44). The co-existence of undernutrition and overnutrition across the life course 
is known as double burden of malnutrition (45). In this thesis, undernutrition is our main 
focus. 
1.1.1. Anthropometric indices to assess growth in children  
Child malnutrition can be identified through different methods such as anthropometric 
measurements, biochemical markers, clinical assessment (identification of bilateral 
oedema and gastrointestinal symptoms) and dietary methods (46, 47). Since it is a non-
invasive and a less expensive method, anthropometric assessment has been largely used 
to assess growth in children under-five, especially in developing countries (47-49). 
Growth reflects the welfare, quality of life of the individuals and, therefore, can be used 
to predict health and survival of populations (44, 50, 51). To compare measurements 
obtained from surveys conducted in different regions, or in the same region but at 
different moments, it is essential the use of an international reference5 (52). Thus, in 1977, 
the WHO recommended the use of the National Center for Health and Statistics (NCHS) 
growth curve of the Centers for Disease Control and Prevention (CDC), also known as 
NCHS/WHO international reference population (50, 52). Over the years, the 
NCHS/WHO growth reference played as an important guide for screening and monitoring 
malnutrition worldwide (50, 52). However, several technical and scientific limitations
                                                 
5 The WHO Expert Committee defined reference as a toll for grouping and analysing data through a 
common basis for comparing populations, but not for making inferences about the meaning of observed 
differences.  
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were pointed out to these curves (48, 53-56): 1) they were developed on data collected in 
only one country (the USA), and for that reason it was not representative of children´s 
growth patterns from different regions of the world (56); 2) the distribution of weight in 
the reference population was positively skewed, with a high prevalence of overweight, 
resulting in a non-healthy sample (56); 3) the growth curves were a result of two distinct 
data sets collected in different moments (1929-1975 for children under 24 months of age, 
and 1960-1975 in the children with 2-18 years), while a single sample would be the ideal 
(50, 56); 4) and the dataset reflected the growth of formula-fed infants, rather than 
breastfed infants (56).  
Therefore, in 1993 the WHO concluded that it was necessary to create new curves which 
could represent more adequately the growth of children (54, 55). Under this perspective, 
between 1997 and 2003, the Multicentre Growth Reference Study (MGRS) was 
conducted and data from approximately 8.500 healthy children from different regions of 
the world (Brazil, Ghana, India, Norway, Oman and the USA) was collected, combining 
a longitudinal follow-up (0-24 months) and a cross-sectional survey (18-71 months) (54). 
The MGRS provided standards describing how children should grow under optimal 
conditions (54), including adequate feeding practices (breastfeeding established as the 
standard for measuring healthy growth), good healthcare and environmental conditions 
(infants with morbidity and infants whose mothers did not follow the recommended 
exclusive breastfeeding and non-smoking guidelines were excluded) (54, 57). This study 
confirmed that the effect of ethnic differences on the growth of children is small compared 
with the effects of environment, including infectious diseases, inadequate diet, and 
poverty (46, 58). 
Thus, in April 2006 the MGRS led to the launch of the WHO Child Growth Standards, 
also known as WHO standards (54). Since then, many countries adopted and implemented 
the Z-score system of WHO standards in their nutrition and public health sectors (54, 59). 
Switching from NCHS/WHO curves to WHO standards brought some differences 
described elsewhere (54, 60). 
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There are three basic measurements in anthropometry: age, weight and height (or length 
in children under two) 6  (48). Anthropometric indices result from a combination of 
measurements and enables its interpretation (48). They can be expressed in Z-scores, 
percentiles7, or percent of median (51). Z-scores can be used as continuous variables with 
a normal distribution (Gaussin distribution) with mean equal to zero and standard 
deviation (SD) equal to 1 (Figure 1), and it represents the deviation of the value for an 
individual from the median or mean value of the reference, divided by the standard 
deviation for the reference population (61, 62), Figure 1. Z-scores are more useful for 
research, whereas percentiles are easier for use in clinical settings (62).   
 
Figure 1. Cumulative probability and percentile of Z-score 
For normal distribution (Gaussian distribution), Z-scores and percentiles are mathematically related (57). 
A Z-score of 0 divides the total area into equal halves. Z-scores of 1, 2 and 3 are found to the right, and -1, 
-2 and -3 to the left. Each point of Z-score corresponds to a percentile. The commonly used -3, -2 and -1 
are, respectively, 0.13th, 2.28th, and 15.8th percentiles. The Z-score of 1 corresponds to the 84th percentile 
(0.5+0.34), i.e., 84% of the population are measured lower than Z-score of 1, and a Z-score of 2 corresponds 
97.7th percentile. A Z-score is calculated as dividing the difference between value measured (x) and the 
mean (µ) by standard deviation ( ). Adapted from (63). 
 
The most common anthropometric indices are height-for-age (HAZ), weight-for-
length/height (WHZ) and weight-for-age Z-score (WAZ) (49, 51, 54)8.
                                                 
6 For more detail on the assessment of weight and length/height in children see Annexe III. 
7 A percentile is the value below which a certain percentage of observation falls. The most common 
percentiles include the 3rd, 5th, 50th (median), 85th, 95th, 97th and 99th.  
8 For simplification, the term height is used throughout the thesis. However, the reader should be aware that 
in children below two years (or less than 85 cm), the term length is used instead of height: length-for-age 
(LAZ) or weight-for-length. Length refers to the measurement in recumbent position, whereas stature refers 
to standing height measurement. For more detail see Annexe III. 
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The use of Z-score is widely recommended since, as standardized measures, they are 
comparable across different groups (e.g., sex and age groups). Thus, calculating a Z-score 
is useful for comparing a child with a reference population. As an example, in Figure 2, 
Z-score lines are numbered positively (1, 2, 3) or negatively (-1, -2, -3), and according to 
the point plotted in the graphical representation, it is possible to see that the girl is 4 years 
and 6 months of age and measures 106 cm of height. Her height-for-age is plotted in the 
median, with a Z-score between -1 and 1, which means that she is in the normal range 
(51, 57).  
 
Figure 2. Graphical representation of height-for-age of a girl 
The horizontal reference line (x-axis) represents the age (in years and months) and the vertical reference 
line (y-axis) shows the height (cm). Source: (64) 
 
Therefore, depending on the Z-score obtained and by using some cut-offs, different levels 
of malnutrition can be identified in each one of the anthropometric indices: mild, 
moderate and severe, Table 1 (44, 54).  
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Table 1. Anthropometric indices to assess growth in children 
 
Anthropometric 
indices Indicator Interpretation 
Degree of 
malnutrition 
Cut-off  
value 
HAZ Stunting 
Poor nutrition  
and recurrent infections 
Mild -2  Z-score < -1 
Moderate -3  Z-score < -2 
Severe Z-score < -3 
WHZ Wasting 
Weight loss due to recent 
episode of infection or 
inadequate nutrient intake 
Mild -2  Z-score < -1 
Moderate -3  Z-score < -2 
Severe Z-score < -3 
WAZ Underweight 
Can be a result of acute or 
chronic malnutrition 
Mild -2  Z-score < -1 
Moderate -3  Z-score < -2 
Severe Z-score < -3 
HAZ: height-for-age Z-score; WHZ: weight-for-height Z-score; WAZ: weight-for-age Z-score. Adapted from (54) 
 
According to 2006 WHO Child Growth Standards, a child is considered stunted, wasted 
or underweight when the Z-score is below -2 (including the moderate and severe forms) 
for HAZ, WHZ and WAZ, respectively (49, 54)  Table 1. When the Z-score of a child 
is located between -1 and 1, it means that she or he is growing and developing normally 
for the indicator assessed, as demonstrated previously in Figure 2. 
Underweight (assessed by WAZ, Table 1) was the most used indicator to assess the 
progress of nutrition targets during the MDG era (29, 30). Despite being easy to assess 
weight, interpretation of underweight is difficult, as it can be a result of acute or chronic 
malnutrition (4, 44, 54). Therefore, to assess malnutrition it is more useful to consider 
wasting and stunting instead of underweight (65). 
A new emphasis have emerged on stunting in recent years, especially after being endorsed 
as a key indicator for monitoring infant and young child nutrition during the Sixty-sixth 
World Health Assembly in 2012 (9, 34, 35, 66, 67). Stunting, or chronic malnutrition 
(assessed by HAZ, Table 1), is a result of a long term process, often beginning in utero 
(as a consequence of the mother´s malnutrition) and is usually associated to recurrent 
nutrition deprivation and infections during the childhood (6, 44). It is an indicator of linear 
growth retardation and a barrier to improvements on child health, educational 
performance and economic development (44, 68).
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Wasting (thinness, assessed by WHZ, Table 1) is a symptom of acute malnutrition and 
results from immediate and inadequate nutrient intake or infection associated, mainly 
diarrhoea, leading to a rapid weight loss (54, 68). Severe acute malnutrition (SAM) can 
be assessed by WHZ status (Z-score<-3) or by using mid-upper-arm circumference 
(MUAC) criteria for children between 6 and 59 months of age (MUAC<115mm, with or 
without oedema) (46, 69). MUAC was introduced for the assessment and management of 
SAM in the community (70) to identify high-risk malnourished children (71). 
Kwashiorkor and marasmus are forms of SAM, which can be identified through clinical 
assessment (46). Kwashiorkor (oedematous malnutrition) is characterized by the presence 
of oedema, the muscles are wasted, and the hair is usually thin, sparse and discoloured 
(72, 73). In Marasmus (non-oedematous malnutrition) the child does not present oedema 
and there is a loss of muscle and fatty tissue (74). Some children can have signs of both 
kwashiorkor and marasmus, which is known as marasmic-kwashiorkor (74). Children 
who are severely malnourished have a high risk of death exceeding 9-fold that of children 
with a Z-score > -1 (2, 46).  
1.1.2. Micronutrient deficiencies  
Poor quality diets can contribute micronutrient deficiencies, also known as hidden 
hunger. Deficiency of micronutrients, such as vitamin A, iron, zinc and iodine, among 
others, can lead to important health consequences, since they are essential to the physical 
and mental development (5, 75).  
Iron deficiency (ID) is the major cause of anaemia and results from inadequate intake or 
absorption of iron (76). Anaemia is a condition in which the oxygen-carrying capacity of 
red blood cells is compromised and develops especially in periods of life in which iron 
requirements are higher, such as during pregnancy and infancy (77). Malaria and helminth 
infections can also lead to anaemia, especially in children living in endemic regions (78, 
79). During the childhood, iron deficiency can result in fatigue, reduced physical capacity, 
and contributes to impaired growth since it is required for development and cell growth 
of the immune and neural systems, metabolism and exercise (78).  
Anaemia can be classified through the assessment of blood haemoglobin concentration, 
as presented in Table 2. The diagnosis of anaemia can be also performed through serum 
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ferritin and/or transferrin receptor, but in poor-resource settings the diagnosis based on 
clinical signs (palmar pallor in children) and medical history is commonly used (77). 
Table 2. Classification of anaemia according to haemoglobin concentration 
Diagnosis of anaemia 
 (6-59 months of age) 
Haemoglobin  
concentration (g/L) 
No anaemia  110 
Mild anaemia 100-109 
Moderate anaemia 70-99 
Severe anaemia < 70 
Adapted from (77) 
 
Vitamin A deficiency (VAD) has been associated to increasing number of deaths from 
measles and diarrhoea, as well as higher severity of respiratory illness and susceptibility 
to malaria (2, 75, 80). Children are the age group at higher risk of enteric infections, which 
can contribute to reducing the vitamin A absorption (81). This micronutrient is essential 
to the normal functioning of the visual and immunity systems, epithelial integrity, red 
blood cell production, reproduction and growth (80). VAD is defined as a serum retinol 
concentration < 0·70 mol/L, and can lead to several ocular manifestations known as 
xerophthalmia (including Bitot spots), which can progress to blindness (5, 80, 81).  
Another important micronutrient is iodine, especially for the synthesis of thyroid 
hormone, which is essential for neuronal migration and myelination of the fetal brain (44, 
82, 83). In some regions, the soils have a poor iodine concentration and, consequently, 
the food grown in these soils are also deficient in iodine. Thus, when there is a deficit 
consume of iodine, the thyroid is not able to synthesize sufficient amount of thyroid 
hormone, which can contribute to iodine-deficiency disorders (84, 85). One of the most 
important consequences of this disorder is the brain damage (which can occur even before 
birth), and impaired cognitive development in children (82, 84).  
Since more than 90% of dietary iodine appears in the urine, the urinary iodine 
concentration is used as biomarker of recent iodine intake (86). According to WHO, 
school-aged children should intake 90 µg of iodine daily, and severity of iodine deficiency 
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in children can be defined as a median urinary iodine concentration of under 100 µg/l, as 
presented in Table 3 (85).  
Table 3. Classification of iodine deficiency level in children  
Iodine deficiency 
 
Median urinary 
iodine concentration (µg/l) 
No  100 
Mild 50-99 
Moderate 20-49 
Severe < 20 
Adapted from (44) 
 
Zinc is essential for the immune system, cell division, and growth from in utero until 
puberty (75). Its deficiency can result from deficient diet in zinc or morphological and 
functional changes in the small intestine (excessive intestinal loss of zinc and impairment 
in small intestine absorptive function), and has been associated to poor health, increased 
risk of diarrhoea and pneumonia, and impaired growth (5, 87-89). However, zinc 
supplementation has been only recommended in the clinical management of acute 
diarrhoea (along with other strategies) by giving 20 mg per day of zinc supplementation 
for 10-14 days (10 mg per day in infants under six months) (44, 90, 91).  
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1.2. Global prevalence of malnutrition 
1.2.1. Stunting, wasting and overweight 
There are well-defined prevalence thresholds for stunting, wasting and overweight (Table 
4), which are important for identifying priority countries for action and for monitoring 
progress towards nutrition targets to be achieved by 2025 (92). 
Table 4. Prevalence thresholds for stunting, wasting and overweight in children under-five 
Labels 
Prevalence thresholds (%) 
Stunting Wasting Overweight 
Very low < 2.5 < 2.5 < 2.5 
Low 2.5  < 10 2.5  < 5 2.5  < 5 
Medium 10  < 20 5  < 10 5  < 10 
High 20  10  10  
Very high  30  15  15 
Adapted from (92) 
  
The global proportion and the number of children under-five estimated to suffer from 
stunting, wasting and overweight in 2000 and 2017 are presented in Figure 3 (37).  
 
Figure 3. Global prevalence and number of children with stunting, wasting and overweight 
in 2000 and 2017 
Source: (93)
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The graph shows that the global prevalence of stunting reduced from 32.6% (very high 
level in 2000) to 22.2% (high level in 2017); while overweight prevalence increased from 
4.9% (in 2000) to 5.6% (in 2017); and 7.5% of children were suffering from wasting in 
2017. The global number of children affected by stunting also decreased in the same 
period (from 198 million to 151 million), while those with overweight increased (from 
30.1 to 38.3 million). The same data are also described in the Table 5, but by regions and 
sub-regions of the world (94). 
Table 5. Progress of stunting, wasting and overweight in under-five children by regions and 
sub-regions of the world 
 Stunting1 Wasting1,2 Overweight1 
 2000 2017 2017 2000 2017 
 n (%) n (%) n % n (%) n (%) 
World 198.4 (32.6) 150.8 (22.2) 50.5 (7.5) 30.1 (4.9) 38.3 (5.6) 
Africa 50.6 (38.3) 58.7 (30.3) 13.8 (7.1) 6.6 (5.0) 9.7 (5.0) 
Eastern Africa 21.5 (45.7) 23.9 (35.6) 4.0 (6.0) 2.2 (4.7) 3.0 (4.4) 
Middle Africa 7.1 (40.2) 9.3 (32.1) 2.1 (7.1) 0.8 (4.4) 1.4 (4.7) 
Northern Africa 4.9 (23.8) 5.0 (17.3) 2.3 (8.1) 1.7 (8.2) 3.0 (10.3) 
Southern Africa 2.0 (33.1) 2.0 (29.1) 0.3 (4.0) 0.6 (10.3) 0.9 (13.7) 
Western Africa 15.1 (36.9) 18.6 (29.9) 5.1 (8.1) 1.3 (3.2) 1.5 (2.4) 
Asia* 134.6 (38.1) 83.6 (23.2) 35.0 (9.7) 13.9 (3.9) 17.5 (4.8) 
Central Asia 1.6 (28.0) 0.9 (11.8) 0.3 (3.7) 0.5 (8.9) 0.8 (10.7) 
Eastern Asia 17.1 (19.2) 4.8 (5.3) 1.7 (1.8) 5.5 (6.2) 4.8 (5.2) 
Southern Asia 89.5 (49.6) 58.7 (33.3) 26.9 (15.3) 4.6 (2.5) 5.4 (3.1) 
South-eastern Asia 21.0 (38.4) 14.9 (25.7) 5.1 (8.7) 1.7 (3.2) 4.2 (7.3) 
Western Asia 5.4 (23.3) 4.2 (15.2) 1.1 (3.9) 1.5 (6.7) 2.3 (8.2) 
Latin America and 
the  Caribbean 9.7 (16.9) 5.1 (9.6) 0.7 (1.3) 3.9 (6.8) 3.9 (7.3) 
Caribbean 0.6 (15.0) 0.3 (8.0) 0.1 (3.2) 0.2 (5.3) 0.3 (7.2) 
Central America 4.1 (23.9) 2.3 (14.1) 0.1 (0.9) 1.0 (5.7) 1.0 (6.4) 
South America 5.0 (13.8) 2.5 (7.5) 0.4 (1.3) 2.7 (7.5) 2.6 (7.7) 
Oceania** 0.4 (36.8) 0.5 (38.1) 0.1 (9.2) 0.1 (4.7) 0.1 (7.9) 
1 Includes moderate and severe forms (Z-score<-2); 2 Only recent trends are presented for wasting due to rapid change that this 
acute condition can suffer over the course of a year period. *Asia and Eastern Asia excluding Japan; **Oceania excluding 
Australia and New Zealand. Adapted from (94) 
 
Stunting rates dropped in all regions: Africa from 38.3% to 30.3%, Asia from 38.1% to 
23.2%, the Latin America and the Caribbean from 16.9% to 9.6%, with the exception of 
Oceania, increasing from 36.8 to 38.1% (94), Table 5. The number of stunted children 
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declined in most regions, but in Africa it rose, probably due to the population increase (5, 
35). Despite the improvements, stunting continues to be an important public health 
problem, especially in Africa and Asia (37), with considerable variation within sub-
regions, Table 5.   
The great number of stunted children was in Asia (almost 70.0%) and Africa (slightly 
more than 27%), Table 5. The proportion of wasted children was higher in Asia (9.7%), 
compared to other regions such as Africa (7.1%), Latin America and the Caribbean 
(1.3%) and Oceania (9.2%) (94).  
Unlike wasting and stunting, the global proportion of overweight increased over the years, 
as it was previously mentioned. This trend was noted in all regions as a whole (with the 
highest increase registered in Oceania), with the exception of Africa, where the 
prevalence remained constant (5.0%), Table 5. 
1.2.2. Micronutrient deficiencies 
Over two billion people are suffering from micronutrient deficiencies (95). Iron 
deficiency is the one affecting the highest percentage of children under-five years of age 
worldwide, accounting for 42% (77). The proportion of anaemia attributable to iron 
deficiency for preschool children is 28% for Sub-Saharan countries and 24% for South-
East Asia. The magnitude of anaemia at country-level can be classified as a public health 
problem according to its prevalence, as describe in Table 6 (77).  
 
Table 6. Classification of anaemia as a problem of public health significance 
Prevalence of 
anaemia (%) 
Category of 
public health significance 
< 4.9 No public health problem 
5.0  19.9 Mild public health problem 
20.0  39.9 Moderate public health problem 
40 Severe public health problem 
Adapted from (77) 
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Trends and mortality effects of vitamin A deficiency in children was provided by a pooled 
analysis of population-based surveys from 138 low-income and middle-income countries 
(96). The analysis showed that between 1991 and 2013 the prevalence of VAD fell from 
39% to 29%, respectively. Despite the global progress, there has been no evidence of 
decreasing in the prevalence of vitamin in SSA and South Asia. Indeed, these were the 
regions with the highest prevalence of VAD in 2013: 48.0% for SSA (ranging from 25 
and 75%) and 44.0% for South Asia (13-79%). Nearly 1.7% of all deaths in under-five 
children were attributable to VAD in 2013, of which more than 95% occurred in SSA and 
South Asia (96).  
Estimates from 2011 indicate that the iodine intake was insufficient for (<100 µg/l) 29.8% 
of school-aged children worldwide (5.2% with severe, 8.1% with moderate, and 15.9% 
with mild iodine deficiency) (86). Off the total children with insufficient iodine intake 
(240.9 million), 31.5% and 24.1% in southeast Asia and Africa, respectively. Iodine 
intake was estimated to be insufficient in 32 countries, where Angola was included and 
categorized as moderately deficient, as shown in Figure 4. 
 
 
 
Figure 4. Degree of public health importance of iodine deficiency based on urinary iodine 
concentration in school-age children in 2011. 
Source: (86) 
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According to global estimates, 17.3% of the world´s population were at risk of inadequate 
zinc intake during 2003-2007, especially in SSA and south Asia and in regions, as shown 
in Figure 5 (97).  The estimates found that the higher the percentage of dietary zinc 
obtained from foods of animal origin, the lower the prevalence of inadequate zinc intake 
(97).  
 
 
Figure 5. Prevalence of inadequate zinc intake (2003-2007)  
Source: (97) 
  
INTRODUCTIONININTRODUCTIONINTRODUCTION
21 
 
1.3. Conceptual framework on malnutrition and the Sustainable Development 
Goals  
The UNICEF conceptual framework on nutrition, originally created in 1990, has been 
used to emphasized the complexity of malnutrition, and to identify priority areas for 
action in this sector during the last decades (2, 25). Currently, the international 
community is joining efforts to reducing health inequalities and leaving no one behind 
until 2030 through the SDGs (36) 9 . Considering the multifactorial causality of 
malnutrition, it is understandable that achieving all SDGs is a way to improve nutrition 
and, at the same time, achieving nutrition targets is a key to the success of SDGs. Thus, 
in Figure 6 it is represented not only the potential causes of malnutrition and its associated 
short- and long-term consequences (Figure 6-A), as well as some of the SDGs targets and 
indicators that play an important role in this field (Figure 6-B) (2, 25). 
Children suffering from chronic malnutrition in the early stages of life, especially during 
the first 1000 days after conception, can fail to achieve their potential growth (2, 5, 98, 
99) and, consequently, they have an increased risk of chronic diseases in adulthood and 
reduced productivity, with impact not only at the individual level, but also at the 
household and national levels (2, 3, 6, 9, 100). Specifically, the framework identifies three 
main groups of causes of undernutrition: immediate, underlying and basic causes (Figure 
6-A). The immediate causes are linked with individual factors such as the inadequate 
dietary intake and disease, and in most cases it is a combined result of both (2, 5, 25, 101). 
The underlying causes are those that can influence the bidirectional cycle between 
nutrition and disease at the community level, such as the household food insecurity, the 
inadequate care and feeding practices, unhealthy household and environment (poor 
drinking water, sanitation and hygiene), as well as poor access to health services (98, 
102). The basic causes represent the global context of certain region or country, including 
the social cultural and political factors, policies and programs adopted that can influence 
the access to essential services and resources (102, 103). All these factors together can 
influence the economic growth and health outcomes and, consequently, are strictly related 
to poverty (2, 3).
                                                 
9 Annexe I - List of the 17 Sustainable Development Goals 
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1.3.1. Malnutrition and infection 
 
The inadequate intake of nutrients (deficiency, excess or imbalance of nutrients) and 
disease (affecting the digestion, absorption, transport and utilization of nutrients) are 
factors (Figure 6-A) with impact on the body structure (such as weight and height) and 
functions, on the psychosocial well-being, and on the individual clinical outcome (2, 5, 
25). For this reason the inadequate dietary intake and disease are identified as the 
immediate causes of malnutrition (2, 5, 25, 101).  
The vicious cycle between malnutrition and infection was emphasized by Scrimshaw in 
the monograph entitled Interactions of Nutrition and Infection (1968), based on two basic 
patterns: malnutrition generally alters resistance of the host to infection, and infectious 
diseases exaggerates existing malnutrition (104). This means that infection can be, at the 
same time, the cause and the consequence of malnutrition (104). Meanwhile, an 
additional key concept was recently added to this cycle: the environmental enteric 
dysfunction (EED) as an important mediator between the child and the acquisition of 
nutrients necessary for growth (71, 105), as shown in  Figure 7. 
 
Figure 7. Malnutrition, infection and intestinal dysfunction 
Malnourished children can be more susceptibility to infection, which, in turn, may lead to reduced nutrient 
absorption and nutrient losses ( ), diversion of nutrients to inflammatory responses 
( ) and tissue repair (104-106). The circulating levels of vitamin A, 
zinc suffer a decrease, and iron remains in the liver, restricting its availability to other tissues of the body 
) and, consequently, the nutritional status deteriorates via anorexia ( ) (96). 
EED affects mostly children who are repeatedly exposed to faecal contaminated environments 
(environmental exposures) that induces morphological changes in the small intestine (altered microbiome) 
(105, 106). It is characterized by an asymptomatic syndrome (subclinical infection) of poor absorption, 
local intestinal inflammation (inflammation) and systemic immune activation (immune exhaustion & 
dysregulation). Source: (71).  
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EED syndrome has been associated to stunting and linked with the reduced efficacy of 
oral vaccines in developing countries, although the exact mechanisms are not clearly 
understood and further research is needed (106, 107).  
The vicious cycle between malnutrition and infection have relevant impact on the 
morbidity and mortality of vulnerable groups (100, 104, 105, 108-111). Children severely 
malnourished are at higher risk of infectious diseases, with higher incidence and severity 
(71, 112). Acute diarrhoeal disease and respiratory infections are the most frequent 
infections during the childhood in low- and middle-income countries (112, 113), but only 
the former will be addressed in this thesis. 
1.3.1.1. The magnitude of diarrhoeal disease 
According to the WHO definition, diarrhoea is the passage of three or more loose or liquid 
stools per day (or more frequent passage than is normal for the individual) (114). Acute 
watery diarrhoea can last for several hours or days, while persistent diarrhoea lasts 14 
days or more. The presence of blood in diarrhoeal stool (acute bloody diarrhoea) is also 
known as dysentery (114).  
Diarrhoeal disease can lead to rapid fluid loss, poor absorption of nutrients and marked 
loss of proteins, vitamin A, zinc and other micronutrients. In a healthy child, an episode 
of diarrhoea is usually self-limiting with no long-term consequences. However, in 
children living in poor settings, if the fluids are not replaced, chronic diarrhoea can lead 
to severe dehydration, malnutrition and death (113).  
The most common mode of transmission of the pathogenic agents causing diarrhoea 
(virus, parasites and bacteria) is faecal-oral transmission: by ingesting water or food 
contaminated with the stool of a person infected (114). The leading risk factors for 
diarrhoea deaths described in the Global Burden of Disease Study 2016, a systematic 
analysis including 195 countries, were childhood wasting (80.4%), unsafe water (72.1%) 
and unsafe sanitation (56.4%) (112). Chronic diarrhoea is also a common symptom 
among the clinical syndrome of acquired immune deficiency syndrome (113).  
Diarrhoea is the fifth leading cause of death in children younger than five years (8.9% of 
all deaths in this age group) (112). Between 2000 and 2016, there were important 
improvements: a decrease in the incidence of the disease (from 2.0 to 1.75 per child year), 
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in the number of diarrhoeal deaths (from 1204 538 to 445 600), and in the global mortality 
rate (from 173.3 to 70.6 per 100.000). In 2016, the highest rates of under-five diarrhoeal 
deaths were mainly in the SSA, Figure 8.   
 
 
Figure 8. Diarrhoea mortality rate in children under-five years of age (2016) 
Source: (112)  
 
To address information related to the burden, factors, aetiology and risk factors of 
diarrhoea, a three-year prospective, age-stratified, matched controlled study of moderate-
to-severe diarrhoea was conducted between December 2007 and March 2011 (10). The 
study, also known as Global Enteric Multicenter Study (GEMS), was conducted in seven 
sites located in Africa (Kenya, Mali, Mozambique, and Gambia) and Asia (Bangladesh, 
India, and Pakistan), and included 9.439 children with moderate-to-severe diarrhoea 
(cases), and 13.129 children without diarrhoea (control group) (10).  
GEMS found that Rotavirus, Cryptosporidium spp. enterotoxigenic Escherichia coli 
producing heat-stable toxin (ST-ETEC), and Shigella were the major pathogens 
contributing to moderate-to-severe diarrhoea (10). Rotavirus had the highest moderate-
to-severe diarrhoea attributable-fraction of any pathogen in all sites in infants (0-11 
months) and in four sites in toddlers (12-23 months). The risk of dying during the follow-
up was 8.5-fold higher in cases than in controls. The pathogens ST-ETEC and typical 
enteropathogenic Escherichia coli (in children 0-11 months), and Cryptosporidium spp. 
(12-23 months) were associated with increased risk of death (10). After enrolment, the 
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mean HAZ became significantly lower in children with moderate-to-severe diarrhoea 
than in controls, confirming the impact diarrhoeal disease in the nutritional status of 
children (10). Giardia lamblia was significantly more frequent in controls than in cases, 
which demonstrates that, even in the absence of diarrhoea, children are exposed to 
enteropathogens with important long-term consequences on their health and development 
(10, 115).  
Another important study was a community birth cohort conducted between 2009 and 
2014 in eight sites in Africa (South Africa, Tanzania), Asia (Bangladesh, India, Nepal, 
Pakistan) and South America (Brazil and Peru), also known as a MAL-ED: The Etiology, 
Risk Factors, and Interactions of Enteric Infections and the Consequences for Child 
Health and Development Project (116). MAL-ED birth cohort included 2145 children 
under two years and enteropathogens were detected in both diarrhoeal (76.9%) and non-
diarrhoeal samples (64.9%) (116). In the first year of a child´s life, the study found that 
five pathogens, mainly norovirus GII (5.2%), rotavirus (4.8%), Campylobacter spp. 
(3.5%), astrovirus (2.7%) and Cryptosporidium spp. (2.0%) were the major pathogens 
associated with diarrhoea; while Campylobacter spp (7.9%), norovirus GII (5.4%), 
rotavirus (4.9%), astrovirus (4.2%) and Shigella (4.0%) were the most frequent in the 
second year of life (116). Giardia lamblia was not associated with diarrhoea in any site 
or age group (116).  
Meanwhile, the stool samples from MAL-ED were reanalysed using molecular methods 
to reassess estimates of diarrhoea (117). According to the results, viral diarrhoea (36.4%) 
was more common than bacterial (25.0%) and parasitic diarrhoea (3.5%) (117), with only 
ten pathogens accounting for almost 96.0% of attributable episodes per 100 child-years, 
namely Shigella (26.1), sapovirus (22.8%), rotavirus (20.7%), adenovirus 40/41 (19.0%), 
enterotoxigenic Escherichia coli (18.8%), norovirus (15.4%), astrovirus (15%), 
Campylobacter jejuni or C. coli (12.1%), Cryptosporidium spp. (5.8%) and typical 
enteropathogenic Escherichia coli (5.4%) (117).  
The effect of enteric infections on linear growth in children less than two years, based on 
a longitudinal analysis of MAL-ED, was recently reported by Rogawski and colleagues 
(118). The mean episodes per child caused by any enteropathogens was 2.1 during the 
first two years of a child´s life: viral (1.4), bacterial (0.9), and parasitic agents (0.1 
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episodes per child). Bacterial and parasitic diarrhoeal infections were more negatively 
associated with reduced linear growth after three months than viral agents (118). 
However, asymptomatic infections (Escherichia coli, Giardia lamblia, Campylobacter, 
Shigella, and E. bieneusi) were more commonly associated with reductions of LAZ than 
diarrhoeal infections in children with two years of age (118). High prevalences of 
asymptomatic infections were associated with a LAZ reduction of -0.41 (-0.61 to -0.21) 
compared with low prevalence of asymptomatic infections, enhancing the need to prevent 
asymptomatic or subclinical infections to improve stunting, Figure 9. 
 
Figure 9. Site-specific effects of enteropathogen infections in non-diarrhoeal stools on height 
at age 2 years 
Difference in LAZ at age 2 years between site-specific high and low combined pathogen prevalence in non-
diarrhoeal stools among 1469 children in the MAL-ED. Bacteria (Campylobacter, Shigella, 
enteroaggregative Escherichia coli, typical enteropathogenic E coli, atypical enteropathogenic E coli, and 
enterotoxigenic E coli); viruses (norovirus, adenovirus 40/41, astrovirus, and sapovirus) and protozoa 
(Giardia, Cryptosporidium, and Enterocytozoon bieneusi - intracellular parasitic fungus). Estimates were 
adjusted for site, enrolment LAZ, sex, socioeconomic status, exclusive breastfeeding in the first 6 months, 
and maternal height. LAZ=length-for-age Z-scores. Source: (118) 
 
1.3.2. Household food insecurity, inadequate care and feeding practices 
Household food insecurity, inadequate care and feeding practices can influence the 
relation between nutrition and infection, and are identified as underlying causes of 
malnutrition, according to the UNICEF framework presented in Figure 6-A.  
Household food insecurity 
Food security exists when all people, at all times, have physical and economic access to 
sufficient, safe and nutritious food to meet their dietary needs and food preferences for 
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an active and healthy life (27). The prevalence of undernourishment (PoU) is an indicator 
that measures the probability that a randomly selected individual from the reference 
population is found to consume insufficient food to meet dietary energy required to 
maintain a normal, active and healthy food (119).  
The PoU has been included in international nutrition goals. The WFS goal, established in 
1996, aimed to eradicate hunger in all countries, with an immediate view to reducing the 
number of undernourished people to half no later than 2015 (27). Additionally, the first 
Millennium Development Goal (MDG1) aimed to reduce by 50% the proportion of 
undernourished people who suffer from hunger between 1990 and 2015 (29). At the 
present, the PoU is an indicator for monitoring the first target of SDG 2 (indicator 2.1.1, 
Figure 6-B) (36).  
The PoU is presented in Table 7 considering three different periods (1990-1992, 2000-
2002 and 2014-2016) and achievements towards WFS and MDG. As shown, in 1990-92, 
18.6% of total population was undernourished, of which 98.0% lived in developing 
regions: 74.9% in Asia and 18.3% in Africa (119). Between 1990-92 and 2014-16, the 
PoU fell from 18.6% to 10.9%. This was a decline of 216 million people, while the world 
population increased by 2 billion. Despite the progress, undernourished people remained 
highly concentrated in developing regions (98.2%) and the WFS was not globally 
achieved (119). 
Several factors could have contributed to these results, such as the increase of food prices, 
droughts, weak agricultural growth, and political instability (119). Wars are also an 
important factor, since people living in countries affected by conflict are usually more 
vulnerable to food insecure and malnutrition, although these factors can also be founded 
in peaceful countries (68). 
In 2014-16, Africa presented the highest proportion of undernourished people (20.0%) 
(68, 119). However, substantial differences are noted across sub-regions (119): SSA is 
the region with the highest proportion of undernourished people (23.2%), while Northern 
Africa attained a prevalence below five (<5%). SSA is also the second region with the 
highest burden in absolute numbers, which have increased from 175.7 to 220 million 
people (from 1990-92 to 2014-16, respectively), Table 7.  
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Table 7. Prevalence of undernourishment and achievements towards World Food Security 
and Millennium Development Goal 
         
 Prevalence of undernourishment (PoU) Change* 
Region 1990-1992 2000-2002 2014-2016 
Towards 
WFS 
 Target#  
Towards 
MDG 
target¶ 
Sub-region  No. millions % 
No. 
millions % 
No. 
millions % % % 
World 1 010.6 18.6 929.6 14.9 794.6 10.9 -21.4 -41.6 
Developed regions  20.0 <5.0 21.2 <5.0 14.7 <5.0 -26.3 na 
Developing regions  990.7 23.3 908.4 18.2 779.9 12.9 -21.3 -44.5 
Africa 181.7 27.6 210.2 25.4 232.5 20.0 27.9 -27.7 
Northern Africa 6.0 < 5.0 6.6 < 5.0 4.3 < 5.0 -27.9 na 
Sub-Saharan Africa 175.7 33.2 203.6 30.0 220.0 23.2 25.2 -30.1 
Eastern Africa 103.9 47.2 121.6 43.1 124.2 31.5 19.6 -33.2 
Middle Africa 24.2 33.5 42.4 44.2 58.9 41.3 143.7 23.2  
Angola  6.9 63.5 7.0 48.9 3.2 14.2 -52.1 -77.6 
Southern Africa 3.1 7.2 3.7 7.1 3.2 5.2 2.3 -28.0 
Western Africa 44.6 24.2 35.9 15.0 33.7 9.6 -24.5 -60.2 
Asia 741.9 23.6 636.5 17.6 511.7 12.1 -31.0 -48.9 
Caucasus and Central Asia 9.6 14.1 10.9 15.3 5.8 7.0 -39.9 -50.8 
Eastern Asia  295.4 23.2 221.7 16.0 145.1 9.6 -50.9 -58.5 
South-Eastern Asia  137.5 30.6 117.6 22.3 60.5 9.6 -56.0 -68.5 
Southern Asia 291.2 23.9 272.3 18.5 281.4 15.7 -3.4 -34.4 
Western Asia  8.2 6.4 14.0 8.6 18.9 8.4 129.5 32.2 
Latin America and Caribbean 66.1 14.7 60.4 11.4 34.3 5.5 -48.0 -62.2 
Caribbean  8.1 27.0 8.2 24.4 7.5 19.8 -7.2 -26.6 
Latin America 58.0 13.9 52.1 10.5 26.8 <5.0 -53.3 na 
Central America 12.6 10.7 11.8 8.3 11.4 6.6 -9.6 -38.2 
South America 45.4 15.1 40.3 11.4 ns <5.0 <-50.0 na 
Oceania 1.0 15.7 1.3 16.5 1.4 14.2 51.5 -9.9 
* Change calculated considering the period from 1990-92 to 2014-16. # Achieving the WFS target means reducing the number by 
more than half (<-50%); progress, but insufficient to achieve WFS target means reducing the number by less than half (>50%); or an 
increase in the number of people undernourished (>0.0%); ¶ Millennium Development Goal 1, target 1c: halve between 1990 92 and 
2015, the proportion of people suffering from undernourishment, or reduce this proportion below 5 percent. na means not applicable. 
Source: (119) 
 
In Asia, the proportion of undernourished people almost halve from 1990-92 (23.6%) to 
2014-16 (12.1%), though with variations within sub-regions, with Southern Asia 
presenting a higher prevalence at the end of the period (15.7%) compared with the other 
Asian sub-regions, Table 7. Furthermore, Southern-Asia had the lowest reduction of 
undernourished people (-3.4%), compared with the remaining sub-regions, and is now the 
region with the highest burden of undernourishment in absolute numbers (281 million 
people, of which 194.6 million are in India) (119).  
The slow progress and increase of undernourishment in Western Asia was a result of the 
rapid population growth in the region (119). The success achieved in South-Eastern and 
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Eastern Asia (including China) in both nutrition targets was possible due to overall 
economic growth that have contributed to the improved access to food in rural areas (119). 
Latin America have achieved both nutrition targets, but with differences among countries 
(119).  
Between 1990-92 and 2014-16, Latin America and Caribbean was the region with the 
greatest reduction of undernourished people (from 66.1 to 5.5 million, -48%), especially 
in Latin America (from 58.0 to less than 5 million) and South America (from 45.4 to less 
than 5 million), In contrast, since 1990-92, Oceania have increased the number of 
undernourished people from 1.0 to 1.4 million in 2014-16, too slow to reach the WFS 
target.  
Of the total of 129 countries monitored, 72 (55.8%) have reached the MDG 1c target, of 
which a list of 29 countries achieved also the WFS goal, where Angola is included (119). 
At the end of the MDG period, the global reduction of the proportion of undernourished 
people estimated was 41.6%, Table 7. Despite being slightly lower than the reduction rate 
required for MDG1 target, from a development perspective the target was considered to 
be achieved (119).  
According to recent data, in 2016 the estimated number of undernourished increased to 
815 million, which can be related to greater numbers of violent conflict, wars, 
displacement of populations, drop of economies (68). These figures suggest that 
achieving the nutrition goal of the Sustainable Agenda for 2030 will be challenging. 
Inadequate care and feeding practices 
Of the 17 SDGs, feeding practices are more directly related to SDG 2 - End hunger, 
achieve food security and improved nutrition and promote sustainable agriculture; and 
SDG 3 - Ensure healthy lives and promote well-being for all at all ages (36).  
WHO and UNICEF recommend (120):  
 Early initiation of breastfeeding (within the first hour of birth); 
 Exclusive breastfeeding in children under 6 months (continue with exclusive 
breastfeeding with no other foods or liquids during the first six months of a 
child´s life, and providing counselling to mothers); 
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 Continued breastfeeding in children 6-24 months, with appropriate 
complementary solid food (continued breastfeeding at one year includes the 
proportion of children aged 12-15 months who are fed breastmilk, and at two 
years those with 20-23 months). 
Globally, it is estimated that 44% of infants are breastfed within the first hour of birth, 
40% aged 0-5 months are fed exclusively by breastmilk, and 60% of those aged 6-24 
months are continued breastfed, mostly those at 1 year (74%), compared with at age of 
two (45%) (120). Breastfeeding rate varies considerably depending on the region of the 
world. The prevalence of all indicators (with the exception of early initiation) are higher 
in low- and middle-income countries compared with high-income countries (121). This 
trend is also observed within countries, with poorer individuals breastfeeding for longer 
periods compared with the richest ones (121, 122).  
Considering the benefits of adequate breastfeeding practices, the 2030 agenda aim is to 
increase the global rate of early breastfeeding to 70%, exclusive breastfeeding to 60%, 
continued breastfeeding at age 1 to 80%, and continued breastfeeding at age 2 to 60% 
(120). 
Adequate care of the caregivers is extremely important, since it requires time, persistence 
and dedication to ensure that the children are well fed in frequency, quality and quantity, 
which can influence the child's development and growth. Supporting women to 
breastfeeding is a social responsibility, including governments, legislators, policy makers 
and civil society (123). Despite this, there are other several factors that can contribute to 
the delayed onset of breastfeeding, such as health (mother or new-born llness), education 
(little information on the benefits of breastfeeding), industry (access to free samples of 
breastmilk substitutes) and cultural beliefs (121). 
1.3.3. Unhealthy environment and inadequate health services   
Unhealthy environment and inadequate health services are identified as underlying causes 
of the UNICEF conceptual framework (Figure 6-A).  
Unhealthy environment 
The access to safe water, good sanitation and hygiene conditions is essential to health of 
communities, and has a great impact on nutrition (98, 102, 124). WASH is a term usually 
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related to a group of interventions, such as handwashing with soap, water quality and 
quantity, sanitation, food hygiene and environmental hygiene (124). Progress of WASH 
is monitored through the indicators described in Figure 10.  and access to safe drinking 
water, sanitation and hygiene is included in the SDGs (Goal 6) as shown in Table 8 (36, 
125). 
Drinking Water ladder  Sanitation ladder  Handwashing ladder 
Safely managed 
Drinking water from an improved 
water source which is located on 
premises available when needed 
and free from faecal and priority 
contamination 
 Safely managed 
Use of an improved sanitation 
facility which is not shared with 
other households and where 
excreta are safely disposed in situ 
or transported and treated off-site 
 
Basic 
Hand washing facility 
with soap and water 
in the household 
Basic 
Drinking water from an improved 
source provided collection time is 
not more than 30 minutes for a 
roundtrip including queuing 
 Basic 
Use of improved facilities which 
are not shared with other 
households 
 
 
Limited 
Drinking water from  an improved 
source where collection time 
exceeds 30 minutes for a 
roundtrip including queuing 
 Limited 
Use of improved facilities shared 
between two or more households  
Limited 
Handwashing facility 
without soap or water 
Unimproved 
Drinking water from an 
unprotected dug well or 
unprotected spring 
 Unimproved 
Use of pit latrines without a slab or 
platform, hanging latrines and 
bucket latrines 
 
No facility 
No handwashing 
facility 
Surface water 
Drinking water directly from a 
river, dam, lake, pond, stream, 
canal or irrigation channel 
 Open defecation 
Disposal of human faeces in fields, 
forest, bushes, open bodies of 
water, beaches or other open 
spaces or with solid waste 
 
 
 
Figure 10. Monitoring WASH for the SDGs 
For water, improved sources include piped water, boreholes or tubewells, protrected dug wells, protrected 
springs and package or delivered water; For sanitation, improved facilities include flush/pour flush to piped 
sewer system, septic tank or pit latrine; ventilated improved pit latrine composting toilet or pit latrine with 
slab. Adapted from (126, 127)
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Table 8. WASH and Sustainable Development Goals 
 
Source: (128) 
 
Untreated excreta contaminate lagoons, lakes and rivers, some of them used as drinking 
water sources, for bathing, washing clothes and other household purposes (125, 129). 
Consequently, unsafe WASH can contribute to the faecal oral transmission of several 
pathogens, and influence the health of individuals, mainly children, through illnesses such 
as diarrhoeal diseases and parasitic infections. In 2012, unsafe WASH have caused more 
than 842.000 diarrhoea deaths (129).   
Providing safe WASH is an opportunity to end cholera epidemics by 2030 and is 
important to respond to emergencies and minimize the risks of infection transmission 
(e.g., prevent the transmission of outbreaks such as Ebola Virus Disease). The SDG 3 
(target 3.3) includes the reduction of neglected tropical diseases (NTDs) and water-borne 
diseases (36), including malaria and other NTDS such as schistosomiasis, filariasis, 
Chikungunya, Zika, Japanese encephalitis and West-Nile virus (129).  
It is estimated that 71% of global population used a safely managed drinking water service 
in 2015. However, in SSA only 24% did it. In this region, 58% of people still use untreated 
surface water sources. Considering sanitation, in 2015, 39% of global population used a 
safely managed sanitation service. Open defecation is still being used for 10.892 million 
people in the world, mainly in SSA and southeast Asia. Open defecation practice has fell 
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between 2000 and 2015, except in SSA, where population growth has contributed to an 
increase from 204 to 220 million people (128).  
Health care services  
Achieve Universal Health Coverage (UHC), including financial risk protection, access to 
quality essential health-care services and access to safe, effective, quality and affordable 
essential medicines and vaccines for all is included in the SDG 3 (target 3.8) (36, 130). 
This target is assessed by two indicators: coverage of essential health services (3.8.1) and 
large household expenditure on health (3.8.2) (131).  
The UHC is based on the concept that all people receive the health service they need 
(health promotion, prevention, treatment, rehabilitation and palliative care) and with 
quality, to achieve potential health gains (130).  
A specific index (UHC coverage index) was created for assessing progress of health 
coverage in countries during SDGs (131), which is based on indicators grouped into four 
categories: i) reproductive, maternal, new-born and child health; ii) infectious diseases; 
iii) noncommunicable diseases and; iv) service capacity and access and health security 
(131). The methodological aspects can be found in greater detail in the report Tracking 
Universal Health Coverage: 2017 Global Monitoring Report (131). 
Table 9 presents the means of UHC service coverage index by regions. As it shows, the 
global value of UHC coverage index is 64, with values ranging from 22 to 86 among 
countries in 2015 (131). However, the coverage index differs across regions, with Eastern 
Asia and North America and Europe achieving all the value of 77, while the SSA 
registered the lowest value with 42 (131). 
High-income countries tend to have high values on the index, while the lowest values are 
seen among low-income countries and some countries affected by armed-
there is a growing number of people who are spending at least 10 percent of their 
household budgets on out-of-pocket health expenses (130, 131). Thus, inequalities persist 
and many children still not accessing vital healthcare services, Table 9. 
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Table 9. Means of UHC service coverage index and its component indices by regions 
 
Area 
UHC 
service 
coverage 
index 
RMNCH Infectious 
diseases 
NCDs Service 
capacity 
and 
access 
Global 64 75 54 63 71 
Africa 46 55 40 67 37 
Northern Africa 64 73 50 62 77 
Sub-Saharan Africa 42 51 37 69 27 
Asia 64 75 51 63 71 
Eastern Asia 77 86 64 64 99 
Southern Asia 53 66 41 64 47 
South-Eastern Asia 59 78 45 59 63 
Central Asia 70 81 56 58 93 
Western Asia 65 69 59 57 79 
Europe and Northern America 77 88 73 58 96 
Latin America and the Caribbean 75 81 65 68 88 
Oceania 74 83 71 62 84 
NCDs: noncommunicable diseases; RMNCH: reproductive, maternal, newborn and child health; UHC: Universal Health 
Coverage. Adapted from: (131) 
 
Improving the primary healthcare is the most cost-effective way to ensure access to 
essential health services along with good governance, supply of medicines, health 
technologies and well-functioning health information systems (130).  
Challenges in the health systems differ across countries. In developing regions, in 
addition to infectious diseases, national health systems have to join efforts to face the 
e services in some countries will have to 
deal with the co-existence of underweight and overweight in the same households (5). 
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1.4. Strategies to improve nutritional status 
 
The first series of Lancet Maternal and Child Nutrition 2013 presented a framework for 
actions to improve fetal and child nutrition, Figure 11. As shown, strategies are included 
based on three different groups: i) nutrition specific interventions; ii) nutrition sensitive 
interventions; and iii) strategies focused on the politics, resources and legislation at 
national and global levels (5). Some of these strategies are addressed to mothers, since 
the nutritional status during the pregnancy is important for fetal growth. However, in this 
thesis, only child-related strategies will be addressed.   
 
 
Figure 11. Framework for actions to improve fetal and child nutrition and development 
Source: (5) 
 
The most common interventions to improve the child´s health are the promotion of 
exclusive breastfeeding during the first six months of life; adequate complementary 
feeding in addition to breastfeeding in children between 6 and 23 months of age; 
improved WASH; immunization; deworming; and treatment of common diseases such as 
diarrhoea, pneumonia, malaria and intestinal parasites (9, 67, 132-134)
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Breastfeeding 
Breastfeeding has important short-term and long-term consequences for the child and the 
mother (121, 135, 136). A meta-analyses recently published in the Breastfeeding Lancet 
Series, described the impact of breastfeeding promotion on health, nutrition and 
developmental outcomes  (121). Regarding mortality, the results have found that children 
who were breastfed had lower risk of death compared with those not breastfed, in both 
low-middle and high-income countries. There was also benefits of breastfeeding in 
reducing hospital admissions for diarrhoea (by 72%) and respiratory infections (by 57%) 
in low-middle income countries. Moreover, longer periods of breastfeeding were 
associated with a reduction by 26% of the odds of overweight or obesity, and with higher 
performance in intelligence tests in children (increase of 3.4 intelligence quotient points) 
(121).  
WASH 
Providing safe WASH can contribute to the interruption of the transmission of faecal 
pathogens and, thus, it is important for preventing diseases transmission (129), Figure 12. 
 
Figure 12. Interrupting transmission of pathogens providing adequate access to water, 
sanitation and hygiene 
Source: (124) 
However, research results showing the effect of WASH interventions on improved 
nutritional status have been inconsistent (124). A Cochrane systematic review published 
in 2013 concluded that available data from 14 cluster-randomized trials, with an 
intervention period ranging from 9 to 12 months, is suggestive of a small benefit of 
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WASH interventions (solar disinfection of water, provision of soap, and improvement of 
water quality) on growth of children under-five years of age (137). However, the short 
time of interventions and the fact that none of studies were of high quality methodology 
were pointed as limitations in the Cochrane review (137). 
The effect of WASH and nutritional interventions on diarrhoea and child growth were 
assessed in a cluster-controlled trial conducted in a rural area of Kenya between 2012 and 
2014 (138). After two-year of follow-up period, the study concluded that none of the 
interventions reduced diarrhoea and only intervention including nutrition counselling and 
nutrient supplementation improved growth (138). In contrast, a research conducted in 
four sites (Ethiopia, India, Peru, and Vietnam), found that access to improved sanitation 
was more frequently associated with reduced stunting risk than improved water (139) 
Vitamin A supplementation 
Vitamin A supplementation is a low-cost intervention recommended by WHO (44). A 
recent Cochrane systematic review published in 2017 have assessed the effect of Vitamin 
A supplementation for preventing morbidity and mortality in children 6 months to five 
years. Findings of this review are consistent with a reduction in morbidity and mortality 
in children, the later ranging from 12-24% of reduction (140). Given the benefits, 
supplementation continues to be recommended. However, the effects on growth have 
been less studied. Results from a randomised controlled trial assessing the effect of 
vitamin A supplementation on height and weight increments among preschool children 
in Indonesia, have showed greater benefits in children with very low serum retinol 
concentrations compared with children who did not receive supplementation (141). 
Universal salt iodization 
Universal salt iodization and iodine supplementation have been included in many 
countries where iodine deficiency was identified as a public health problem. These are 
safe, cost-effective and sustainable strategies to ensure adequate intake of iodine (142). 
In 2017, 86.0% of total population used salt with iodine (93) 
Zinc supplementation 
The effect of zinc supplementation for preventing morbidity and promoting growth was 
assessed in a Cochrane systematic review published in 2014 and including 80 trials 
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(205.401 children 6 months-12 years of age) (143). It was found a decrease in diarrhoea 
morbidity and a very small improvement in height (0.0 to 0.2 HAZ better, moderate-
quality evidence) in children who received zinc supplementation compared to control 
groups. Zinc supplementation have also lead to increased vomiting (143).  
Another Cochrane systematic review published in 2017 aimed to evaluate oral zinc 
supplementation for treating children with acute or persisting diarrhoea. The review 
included 33 trials (10.841 children aged one month to five years), most of them conducted 
in Asian countries. According to the results, zinc supplementation may reduce the average 
duration of diarrhoea by near half a day and probably reduce the number of children 
whose diarrhoea persists until day seven. In malnourished children the effect was 
apparently greater, decreasing the duration of diarrhoea by around a day (144). Thus, 
these findings enhanced the benefits of zinc supplementation in areas where the 
prevalence of malnutrition is high. 
Rotavirus vaccine 
Given the burden of diarrhoea, with rotavirus being the leading cause during infancy, 
especially in low- and middle-income countries, (10, 112, 113, 145), immunization is a 
key strategy to reduce the diarrhoeal morbidity and mortality, along with promotion and 
treatment packages (solutions of low-osmolarity to prevent dehydration along with 
breastfeeding and zinc supplementation) (114). WHO recommends the introduction of 
rotavirus vaccines in all national immunization programmes worldwide, especially in 
south and south-eastern Asia and SSA (146). 
F
strain of human rotavirus G1P[8]); RotaTeq entavalent rotavirus reassortant with 
human G1, G2, G3, G4 and P[8]) -human 
-human reassortant 
with human G1, G2, G3 and G4 bovine UK G6P[5] backbone) are available 
internationally and WHO prequalified (147)  and RotaT  have been 
licensed for use since 2006, while  and  received prequalification 
almost ten years after, in 2018. All four vaccines are considered highly effective in 
preventing severe gastrointestinal disease, although the lower effectiveness reported in 
low-income countries (50%-64%) compared with upper-middle and high-income 
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countries (85-98%) (148). In August 2018, 96 countries have introduced rotavirus 
vaccines (149).  
Deworming 
Deworming, or preventive chemotherapy, is a public health strategy against soil-
transmitted helminths (STHs), which can be caused by Ascaris lumbricoides, Trichuris 
trichiura and the hookworms Necator americanus and Ancylostoma duodenale. These 
infections have been associated to impaired growth, deficit cognitive development and 
reduced education attendance (150). In areas where the prevalence of STH is 20.0% or 
higher, WHO recommends deworming using annual or biannual single-dose of 
albendazole (ALB) or mebendazole for preschool- and school-age children in order to 
reduce the worm burden and achieve a coverage of 75% of children until 2020 (150).  
Albendazole and mebendazole are safe drugs, but the efficacy diverges within STH. It is 
well established the benefits of deworming on reducing the worm burden and, 
consequently, decreases morbidity. However, it does not breaks the cycle of transmission 
(150).  
The health benefits and cost-effectiveness of deworming strategy are under discussion. 
Recently, systematic reviews have reported little or no benefits of deworming children 
living in endemic areas for STH at the community level (infected and non-infected), 
including growth and haemoglobin levels (151, 152).  Similarly, no significant effect of 
routine deworming was found on weight gain and on mortality of 2 million PSAC study 
carried out in India (153). Conversely, analysis of more than 320.000 PSAC have reported 
benefits of deworming: those who received treatment were less likely to be stunted and 
anaemic, supporting the implementation of deworming (154). Results are controversial 
and it is clear that further research with new approaches is needed (155).  
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1.5. Angola  country profile 
 
Angola is a sub-Saharan country bordered by the Atlantic Ocean (west), Namibia (south), 
the Democratic Republic of Congo (north), and Zambia (east). Portuguese is the official 
language of Angola, but there are more than 18 national languages (156).  
1.5.1. Population 
The country is divided into eighteen provinces that covers an area of 1.246,700 km2. 
According to the last census, in 2014 Angola had a total population of 25.8 million 
inhabitants (157), of which 26.9% lived in the capital Luanda and 19.4% were under-five 
years of age, Table 10 (157). According to the World Bank, in 2017 the population 
increased to 29.8 million (158). 
Table 10. Population of Angola in 2014 (by region, provinces, age and sex) 
  N (%) 
 Angola 25 789 024 (100.0) 
Region Urban 16 153 987  
 Rural 9 635 037  
Provinces Bengo 356 641  
 Cuanza Norte 443 386  
 Namibe 495 326  
 Cuando Cubango 534 002  
 Luanda Sul 537 587  
 Zaire 594 428  
 Cabinda 716 076  
 Moxico 758 568  
 Lunda Norte 862 566  
 Malanje 986 363  
 Cunene 990 087  
 Bié 1 455 255  
 Uíge 1 483 118  
 Cuanza Sul 1 881 873  
 Huambo 2 019 555  
 Benguela 2 231 385  
 Huíla 2 497 422  
 Luanda 6 945 386  
Age Under-five 4 998 148 (19.4) 
 5-14 years 7 198 348 (27.9) 
 15-64 years 12 980 098 (50.3) 
  65 years 612 430 (2.4) 
Sex Women 13 289 983 (51.5) 
 Men 12 499 041 (48.5) 
    Adapted from (157) 
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1.5.2. The war 
After 14 years of armed-conflict, Angola gained the independence from Portugal in 1975 
(156). Then, nationalist groups engaged a protracted and severe civil war between 1975-
2002. The war contributed to a massive destruction of the infrastructures, with several 
areas heavily mined, and caused numerous deaths (from fighting, diseases, starvation) 
and forced migration (156, 159-161). More than 1 million of Angolans died, 4.5 million 
were displaced to other regions of the country, and 450.000 fled the country (156). This 
led to a humanitarian crisis, with negative consequences on the economy, on the health 
systems and on the social welfare (159, 161). In fact, the armed-conflict period affected 
negatively an entire nation, although in an unevenly way (159). Children were the primary 
victims of the war through malnutrition and lacking of immunization, especially in 
fighting areas where the production and delivery of food, and the public health system 
were compromised (159). During the war, the city of Luanda was one of the safest places 
and, for that reason, attracted many people to escape the fighting zones, to search relatives 
and to look for better educational and economic conditions (162).   
1.5.3. Health System and main indicators 
Once the war was over, Angola begun an enormous challenge period of rebuilding the 
national economy and improving the living conditions of the individuals (159). There was 
an intention of the government to implement a national decentralization in order to 
transfer the decision-making from the central level to the provincial and district level 
(156, 163).  
Several problems have been reported in the Angolan health system, such as the lack of an 
effective administrative-financial system, insufficient number and inefficient distribution 
of health units, and poor quality of services (lack of equipment, drugs, electricity and 
water, poorly trained health professionals and lack of supervision in care) (156). Indeed, 
the health service coverage index registered for Angola is 36, lower than 44 for the WHO 
African region (and 64 for the global average value) (131). Meanwhile, Angola has made 
a strong investment in the collection of health information, mainly since 2005, such as 
the elaboration of provincial health maps and health surveys (156).  
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The health politics of the country are based on the long-term strategy Angola 2025: join 
efforts to reduce poverty, improve the health status of the population, especially the most 
vulnerable groups to ensure greater longevity (41). The main objectives included are: 
 Combat diseases (including those of origin transmissible and parasitic diseases, 
and chronic diseases); 
 Protect maternal health and support reproductive health; 
 Reduce under-five mortality; 
 Develop the primary health care network; 
 Expand the secondary health care as second priority (hospitals); 
 Consolidate the tertiary health care (differentiated health care); 
 Increase the human resources (in quantity and quality); 
 Develop a financial model with different participants (public sector, private sector 
and international aid). 
Progress of the Human Development Index (HDI) 10  made in the after-war period 
translates important improvements achieved across the years, mainly in expected years 
of schooling and Gross National income per capita, which more than duplicated between 
2000 and 2017. A great increase in the life expectancy at birth also occurred, from 47.1 
to 61.8 between the same period, Table 11 (164). 
 
Table 11. Progress of Human Development Index and its components in Angola 
Dimension Indicator 2000 2010 2015 2017 
 HDI 0.387 0.520 0.572 0.581 
A long and healthy life Life expectancy at birth (years) 47.1 58.2 61.2 61.8 
Access to knowledge 
Expected years of schooling 5.1 8.6 11.0 11.8 
Mean years of schooling 4.4 4.7 5.0 5.1 
Standard of living Gross National income (GNI) per capita 2.443 5.421 6.251 5.790 
Adapted from: (164)  
 
                                                 
10 The Human Development Index (HDI) is a composite index measuring average achievement in three 
basic dimensions -  a long and healthy life, access to knowledge and a decent standard of living. 
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According to the most recent statistical update of the Human Development Indices and 
Indicators, Angola is classified in the medium human development category with a HDI 
value of 0.581 (147 rank in a total of 189 countries and territories), Table 11 (164). 
Angola´s HDI value is above the average for SSA (0.537), but below the average for the 
group of countries with the same classification (0.645) (165). The great economic 
expansion observed in the country was mainly due to oil exportation (156). However, 
despite the macroeconomic growth achieved, the same level of progress was lacking in 
the health and social sectors (166).  
The main indicators of Angola are described in Table 12. These indicators are related to 
poverty, health, nutrition, education and environment. All of them are essential to 
understand the living conditions and the major challenges of the country.  
The Multidimensional Poverty Index (MPI) is an international measure of acute poverty 
based on 10 indicators of severe deprivations related to education, health and living 
standards, described in detail in Table 13 (167). Each dimension (and each indicator 
within the dimension) is equally weighted, and by applying the Alkire and Foster´s 
methodology described elsewhere (167), it results in a score ranging from 0 to 1.  
The most recent Global MPI was published in 2018 and includes 105 countries, covering 
77% of the global population. Angola is one of the countries included and analysis was 
based on data  from the  Demographic Health Survey conducted in 2015-2016 (MICS 
2015-2016) (168).  
The country obtained a multidimensional poverty score of 0.283, Table 12. According to 
the results, 51.2% of the Angolan population is multidimensionally poor, which means 
that they are deprived in more than one third (33.3%) of the weighted indicators described 
in Table 13. Moreover, the percentage of severe poverty (proportion of individuals 
deprived in 50-100% of the weighted indicators) is higher is rural areas (66.5%) compared 
with urban areas (12.9%), Table 12. 
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Table 12. Indicators of Angola related to poverty, health, nutrition, education and 
environment  
 Indicator  Total 
 
Urban 
(63.5%) 
Rural 
(36.5%) 
Year 
Po
ve
rt
y 
     
Multidimensional poverty index (0-1) 0.283 0.145 0.523 2018a 
Vulnerable to poverty (20%<deprivation<33.3%) 15.5 19.8 7.9 2018a 
Incidence of poverty (deprivation 33.3%) 51.2 29.9 88.2 2018a 
Severe poverty (50% < deprivation < 100.0%) 32.5 12.9 66.5 2018a 
Population below poverty line (PPP $1.90 a day) 30.5   2006-17b 
H
ea
lth
 
     
Infant mortality rate (per 1000 live births) 44 43 61 2016c 
Under-five mortality rate (per 1000 live births) 68 68 65 2016c 
Under-five mortality rate (per 1000 live births) 81.1 - - 2017d 
Maternal mortality rate (deaths per 100,000 live births)  477 - - 2015e 
Total fertility ratio (births per women) 6.2 5.3 8.2 2016c 
Birth attendance by skilled personnel 50 68 21 2016c 
Births delivered in a health facility (%) 46 65 17 2016c 
Physicians density 0.17   2009f 
Nurses density 1.442   2009f 
Malaria prevalence by RDT (6-59 months, %) 13.5 7.5 21.8 2016c 
Total HIV prevalence  2.0 2.1 1.5 2016c 
N
ut
ri
tio
n 
     
Stunting U5 (%) 38 32 46 2016c 
Wasting U5 (%) 4.9 4.6 5.3 2016c 
Underweight U5 (%) 19.0 15.0 24.7 2016c 
Prevalence of undernourishment (total population) 14.0   2014-16g 
Overweight U5 (%) 3.2 3.8 2.5 2016c 
Exclusive breastfeeding (<6months, %) 37.4 36.8 38.2 2016c 
Complementary feeding (6-23 monthts, %) 80.0 78.4 82.4 2016c 
Minimum acceptable diet (6-23 months, %) 13.3 15.8 9.4 2016c 
Vitamin A supplementation (6-59 months, %) 5.7 7.3 3.3 2016c 
Consumption of iodized salt (households, %) 88.5 94.3 78.4 2016c 
Prevalence of anaemia in children (6-59 months, %)     
- Mild (10.0-10.9 g/dl) 30.7 31.1 30.0 2016c 
- Moderate  (7.0-9.9 g/dl) 31.8 31.2 32.7 2016c 
- Severe (<7.0g/dl) 2.2 2.1 2.4 2016c 
Prevalence of anaemia among women (15-49 years, %) 47.7   2014-16g 
E
du
ca
tio
n      
Literacy rate adult (% ages +15) 65.6 79.4 41.1 2014h 
Expected years of schooling 11.8   2017b 
Mean years of schooling  5.1   2017b 
     
E
nv
ir
on
m
en
t 
     
Drinking water estimates      
- At least basic  41 63 23 2015i 
- Limited (>30mins) 16 19 13 2015i 
- Unimproved 19 15 22 2015i 
- Surface water 24 3 42 2015i 
Sanitation estimates     
- At least basic 39 62 21 2015i 
- Limited (shared) 15 27 5 2015i 
- Unimproved 13 7 17 2015i 
- Open defecation 33 3 56 2015i 
Hygiene estimates     
- Basic 25 37 15 2015i 
- Limited (without water or soap) 12 13 12 2015i 
- No facility 63 50 73 2015i 
aSource (168); bSource (164); cSource (40); dSource (169); eSource (170); fSource (171); gSource (172); hSource (157); iSource (128) 
RDT: rapid diagnostic test. HIV: human immunodeficiency virus 
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Table 13. Multidimensional Poverty Index 2018 (dimensions, indicators and weights) 
Dimension 
of poverty Indicator SDG Deprived if living the household where Weight 
Health 
Nutrition SDG 2 An adult under 70 years of age or a child is undernourished 1/6 
Child mortality SDG 3 Any child has died in the family in the five-period preceding the survey 1/6 
Education 
Years of schooling SDG 4 No household member aged 10 years or older has completed six years of schooling 1/6 
School attendance SDG 4 Any school-aged child is not attending school up to the age at which he or she would complete class 8 1/6 
Standard 
of living 
Cooking fuel SDG 7 The household cooks with dung, wood, charcoal or coal 1/18 
Sanitation SDG 11 
The household´s sanitation facility is not improved 
(according to SDG guidelines) or it is improved but 
shared with other households 
1/18 
Drinking water SDG 6 
The household does not have access to improved 
drinking water (according to SDG guidelines) or safe 
drinking water is at least a 30-minute walk from home, 
round trip 
1/18 
Electricity SDG 7 The household has no electricity 1/18 
Housing SDG 11 
Housing materials for at least one of roof, walls and 
floor are inadequate: the floor is of natural materials 
and/or the roof and/or walls are of natural rudimentary 
materials 
1/18 
Assets SDG 1 
The household does not own more than one of these 
assets: radio, TV, telephone, computer, animal cart, 
bicycle, motorbike or refrigerator, and does not own a 
car or truck 
1/18 
Adapted from (173) 
 
Currently, of the three dimensions considered to elaborate the index, in Angola the 
standards of living are the major contributor of deprivation in overall poverty (46.8%), 
followed by education (32.0%) and health (21.2%), Figure 13.  
 
Figure 13. Indicator contributing to overall poverty by area, in Angola 
Source: (168)
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Among the 10 indicators, the largest contributors to poverty in Angola are deprivations 
in years of schooling (18.5%) and nutrition (17.3%), as shown in Figure 14. Considering 
the MPI by age group, the highest score is among children less than nine years (0.343) 
compared with older individuals. In this age group (0-9 years), nutrition is the indicator 
that most contributes to overall poverty with 19.8% (167).  
Undernutrition has improved since the nineties, though it remains a public health 
problem. As Table 14 presents, during the first MICS (1996-1997), the prevalence of 
stunting in under-five Angolan children was 53.1% and it decreased across the years until 
2007 achieving a percentage of 29.2%. However, in 2015-2016, the prevalence of 
stunting increased to 37.6%, which could be related with economic crisis faced in 2014 
(174).  
As shown in Table 14, wasting has maintained stable until 2002 (6.3%), increased to 8.2% 
in 2007, and decreased to 4.9% in 2016. Regarding underweight, it decreased 
progressively in the first decade (41.6% in 1996-1997; 30.5% in 2001-2002; and 15.6% 
in 2007). However, in 2015-2016, it has increased to 19.0%. 
 
Table 14. Progress of stunting, wasting and underweight in Angola and targets to achieve 
by 2021 
 1996-1997a 2001-2002b 2007c 2015-2016d 
Target 
2021e 
 (%) (%) (%) (%) (%) 
Stunting (HAZ<-2 ), % 53.1 45.2 29.2 37.6 < 5 
Wasting (WHZ<-2), % 6.4 6.3 8.2 4.9 <5 
Underweight (WAZ<-2), % 41.6 30.5 15.6 19.0 <10 
a Source: (175); b Source:(176); c Source:(177); d Source:(40); e Source: (41)  
 
 
In 2012, through the National Plan for Health Development 2012-2025 (41), Angola has 
made a commitment to achieve nutrition targets until 2021, including: 
 Reducing chronic malnutrition in under-five children to less than 5%  
 Reducing acute malnutrition in under-five children to less than 5% 
 Reducing underweight in under-five children to less than 10% 
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Between 1990 and 2010, Angola achieved one of the fastest average annual reduction rate 
of stunting with 6.6% (after Saudi Arabia with 7.3% and before China and Brazil with 
6.0% and 5.7%, respectively) (178). However, as presented in Figure 14, stunting 
reduction decelerated considerably, and adjusted projections considering the number of 
children in 2016 (1.82 million) indicate that national (2021) and international nutrition 
targets (2025) will remain to be achieved.  
 
 
Figure 14. Progress of stunting prevalence and average annual rate of reduction  
Source: (179) 
 
It is important to understand the distribution of malnutrition within the country. 
Malnutrition differs across areas, with a higher proportion of children suffering from 
undernutrition in rural areas than urban areas, whereas overweight is more prevalent in 
urban areas, as showed previously in Table 12.  Indeed, there are considerable differences 
in several indicators comparing rural to urban areas, which can influence the distribution 
of malnutrition: access to at least basic drinking water (23% vs 63%); open defecation 
practices (3% vs 56%); basic hygiene conditions (15% vs 37%); literacy rate adult (41.1% 
vs 79.4%); total fertility ratio (8.2% vs 5.3%); birth attendance by skilled personnel (21% 
vs 68%); and malaria (21.8 vs 7.5).  
All these factors seem to contribute to a higher proportion of people living in a situation 
of severe poverty in rural areas compared with urban areas (66.5% vs 12.9%), Table 12
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The national prevalence of exclusive breastfeeding in 2015/2016 was 37.4%, and the 
Angolan Government has the target of increasing exclusive breastfeeding to 85% until 
2021 (180). Breastfeeding is more frequent in rural than urban areas (38.2% vs 36.8%, 
Table 12). 
Differences of stunting prevalence are presented in Figure 15 for two different periods: 
2006-07 and 2015-16 (39).  
 
Figure 15. Prevalence of stunting in Angola in 2006-2007 and 2015-2016 
Source: (174) 
 
According to MICS 2015-2016, the provinces of Bié, Cuanza Sul and Cuanza Norte are 
in the three leading positions of moderate to severe stunting (50.8%, 48.8% and 44.5%, 
respectively), while Luanda, Zaire and Cabinda are those with the lowest prevalence 
registered (29.7%, 24.9% and 21.6%, respectively). The overall mean HAZ of under-five 
children was -1.5 Z-score, ranging from -2.0 to -1.0 Z-score across provinces, Table 15. 
Regarding wasting, Cunene, Malanje and Huambo are the provinces with the highest 
prevalence levels (10.5%, 7.6%, and 6%, respectively); while Luanda, Cuanza Sul and 
Zaire registered the lowest prevalence of moderate-to-severe wasting (3.9%, 3.3% and 
3.2%, respectively). The overall mean WHZ was -0.1 Z-score, ranging from -0.3 to 0.1 
Z-score, Table 15.   
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INTRODUCTION
National data indicates an infant mortality rate (probability of dying between birth and 
age of 1 year per 1000 live births) of 44 per 1000 live births, and when considering 
children under-five years it increases to 68.0 deaths per 1,000 live births (40), as shown 
previously in Table 12. However, the international data estimates a higher under-five 
mortality rate than the national data: 81.1 deaths per 1,000 live births, the equivalent to 1 
child in 12 dying before completing his or her fifth anniversary. 
 
Infectious diseases have been a serious public health problem in children under-five years 
for many years in Angola. According to data extracted from Global Burden Disease 
(Institute for Health Metrics and Evaluation), enteric infections were the major cause of 
death in this age group in 1990. Though there has been a slight improvement, enteric 
infections remain among the three leading causes of death of under-five children, after 
maternal and neonatal factors, and before respiratory infections, as shown in Figure 16.  
 
Figure 16. Cause of deaths in children under-five years in Angola in 1990 and 2017. 
Source: (181) 
 
Adequate nutrition is recognised as the key to sustainable social and economic 
development of the country, and the Prevention and treatment of nutrition diseases are 
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goals also included in the National Health Development Plan 2012-2025. Thus, several 
strategies are identified at national-level, and recognized as essential to reducing 
morbidity and mortality caused by malnutrition in children under five years (41). 
 Inclusion of nutrition services in primary health care as an absolute priority; 
 Reinforcement of micronutrient distribution and deworming with albendazole in 
children under five years of age;  
 Establishment of a disease surveillance system due to food institutional and 
community-based micronutrients; 
 Strengthening epidemiological surveillance of malnutrition; 
 Promotion of breastfeeding soon after birth, exclusive up to 6 months and 
appropriate feeding practices after 6 months of age; 
 Promotion of healthy eating habits and lifestyles; 
 Iron fortification of staple food for the general population; 
 Capacity-building efforts and nutrition-education and training opportunities; 
 Strengthening community participation and family empowerment through skills 
family members; 
 Mobilizing strategic partnerships for a multisectoral response. 
 
Considering results from MICS 2015-16, only 13% of children aged 12-23 months and 
9% of children 24-35 months received all-age appropriate vaccines, and it was reported 
that coverage increased with mother´s level of education (40). Of those who reported 
diarrhoea in the previous two weeks, 53% received oral-rehydration treatment, though 
almost 30% did not receive any treatment.  
The strategy of deworming is also included in the NTD national program through the 
distribution of albendazole to school-age children. Soil-transmitted helminths are 
endemic and considered a public health problem in Angola (42, 43).  
According to MICS 2015-16, 48% of infants was breastfed within the first hour. The 
median duration in months of exclusive breastfeeding was 3.1 months, and 
complementary breastfeeding was 18.7 months (40). Exclusive breastfeeding in the first 
6 months was reported for 38% of children. 
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Considering other strategies such as the use of iodized salt, the survey registered a 
household coverage higher in urban than rural areas (95% vs 80%). Consumption of 
vitamin A supplement was reported in only 6% of under-five children, though 75% of 
those aged 6-23 months ate foods rich in this micronutrient in the 24 hours before the 
study. Moreover, only 6% (6-59 months) have received iron supplementation in the week 
before  (40).  
In 2013, Angola was the country with the highest mortality rate due to rotavirus (240 per 
100,000 children under-five years of age) (182). To reduce severe diarrhoeal disease, 
Angola requested assistance from The Global Alliance for Vaccines and Immunizations 
(GAVI) to introduce Rotarix vaccine in the national immunization program in 2014. The 
existing data on child malnutrition and the enteric infections in Angola are scarce and are 
mainly transversal studies and focused on intestinal parasites infections (43, 183-185). 
As will be explained further, in the Methodology section, this thesis intends not only to 
contribute with data on the etiological agents of diarrhoea (Results section  papers I, II 
and III), as well as to investigate longitudinally different treatment strategies of intestinal 
parasites on nutritional status of children (paper IV).  
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1.6. Objectives of this thesis 
 
This thesis aims to: 
1) identify the most frequent pathogenic agents (viral, bacteria and parasites) of 
diarrhoea and associated factors in children under-five years of age attending the 
referral hospital of Bengo province between September 2012 and December 2013; 
 
2) provide baseline information on the detection rate, associated risks and molecular 
characterization of rotavirus infection, before the vaccine introduction in Angola, 
in children under-five years of age attending the referral hospital of Bengo 
province between September 2012 and December 2013 
 
3) provide a molecular characterization of Giardia lamblia infection in children 
under-five years of age attending the Bengo General Hospital between September 
2012 and December 2013 
 
4) investigate if treatment of intestinal parasites (with or without previous diagnosis) 
in two different levels (individual or household) impacts on nutritional status of 
children between 2 and 5 years old, after a two-year follow-up period in Bengo 
province, Angola. 
 
The general and specific objectives of this thesis and the corresponding articles are 
described in detail in Table 16. Furthermore, a conceptual framework, including questions 
addressed through these research studies, is presented in Figure 17.
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1.7. Methodology 
To answer the four research questions previously described in Figure 17, two main studies 
were performed: a cross-sectional and a longitudinal study. Both studies were conducted 
in the Dande Health and Demographic Surveillance System (Dande HDSS) area, 
implemented by the Health Research of Angola (CISA) in Bengo province, northern 
Angola. The main activity is agriculture and maize and cassava are the main crops grown 
in the region. Other activities include also fishing, charcoal exploitation and stone and 
sand extraction (39). STHs, schistosomiasis and malaria are endemic in the region, as 
reported in a community-based study conducted in 2010. (43). The main causes of death 
in under-five children between 2009 and 2012 in the verbal autopsy were intestinal 
infectious diseases, malnutrition and acute respiratory infections (186). 
The cross-sectional study was conducted to identify the most frequent pathogenic agents 
of diarrhoea in children under-five attending the Bengo General Hospital (research 
question 1, paper I, published). Then, additional methodological techniques were 
performed to address the molecular characterization of rotavirus before the national 
vaccine introduction (research question 2, paper II, published); and the molecular 
characterization of Giardia lamblia (research question 3, paper III, published). 
Methodology of the cross-sectional study is described in Figure 18. 
Finally, to investigate if giving albendazole or treating intestinal parasites after diagnosis 
at two different levels (individual and household) contributes to changing nutritional 
outcomes of children between 2 and 5 years (research question 4, paper IV, submitted), a 
longitudinal study was performed during two years, through a four-arm randomised 
controlled trial (trial registration ISRCTN-72928001).  
1.7.1. Paper I 
A cross-sectional hospital-based study was conducted between September 2012 and 
December 2013 in the Bengo General Hospital (BGH), the referral hospital for the Bengo 
province, in Caxito, Bengo province. Children under five years, with diarrhoea (114), 
attending the paediatric emergency unit or the hospital outpatient unit, were invited to 
participate in the study (Figure 18). Those with history of antibiotic and antiparasitic drug 
in the previous ten days were excluded to avoid false negatives. Informed consent was 
obtained from caregivers.  
INTRODUTION
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A survey to collect sociodemographic and clinical data was performed. Anthropometric 
measurements were assessed to calculate anthropometric indices (HAZ, WAZ, WHZ) 
using ANTHRO software, and according to WHO Child Growth Standards. Malnutrition 
was classified as mild, moderate and severe. Children with oedema were included in the 
severe level of acute malnutrition. One stool sample per child was requested to identify 
enteric viruses, bacteria and parasites, according to the laboratory methods described in 
the methodology section of paper I (please, see results section of this thesis, 2.1). 
Laboratory results were provided to the clinical staff of the hospital no more than a day 
after examination, Figure 19. 
Data were analysed using IBM SPSS software. 2 test was used for comparison of 
the categorical variable proportions. For tables with expected cell frequencies of less than 
5, the Fisher exact test was applied. A P value of less than 0.05 was deemed statistically 
significant. The independent variables that were significantly associated with each 
response at a significance level of 0.1 were included in a multiple logistic regression 
model. The goodness of fit was based on Hosmer and Lemeshow test, considering a P 
value greater than 0.05. Adjusted associations were expressed in odds ratio (OR) and 
respective 95% confidence intervals (CIs).  
The study was approved by the Ethics Committee of the Angolan Ministry of Health and 
the Ethics Committee of the Institute of the Hygiene and Tropical Medicine. 
1.7.2. Paper II 
In this study, only children who tested positive for rotavirus (immunochromatographic 
rapid test) in the previous study (paper I) investigating the most frequent agents of 
diarrhoea were included  Figure 18. 
In Angola, stool samples were preserved in guanidine thiocyanate solution until RNA 
extraction. Then, stools were transported to the Institute of the Hygiene and Tropical 
Medicine for viral RNA extraction, reverse transcription, VP6 sub-grouping, G and P-
genotyping, molecular characterization of rotavirus strains by phylogenetic analysis. 
Methodological aspects of these procedures are described in detail in the material and 
methods section of paper I (point 2.2). 
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For statistical analysis, absolute (n) and relative frequency (%) were used for descriptive 
statistics of categorical and ordinal variables, and the mean and standard deviation (SD) 
were presented in the case of continuous variables. The chi- 2) test or Fisher's 
exact test (for tables with expected cell frequencies less than 5) were used to compare 
categorical variable proportions (gender, group age, province of residence, settlement 
type, maternal literacy and education level, drinking water source and treatment method, 
sanitation facilities, breastfeeding, malnutrition and clinical symptoms) between RVA-
positive and RVA-negative children. A p-value less than 0.05 was considered to be 
significant and associations were expressed in odds ratio (OR) and respective 95% 
confidence intervals (95% CI). Student t-test was applied to compare the mean age (in 
months) between RVA-positive and RVA-negative children. When the p-value was less 
than 0.05, the mean age between the two groups were considered significantly different. 
1.7.3. Paper III 
In this study, only children with stool samples positive for Giardia lamblia (through 
microscopy or using the antigen rapid test) in the previous study (aiming to identify the 
most frequent agents of diarrhoea, paper I) were included. Positive stool samples were 
preserved at -20ºC for DNA extraction, DNA amplification, and DNA sequence analysis 
 Figure 18. Laboratory methods are described in detail in the Material and Methods 
section of Paper III (point 2.3). 
1.7.4. Paper IV 
This is a four-arm randomised controlled trial conducted between December 2013 and 
January 2017 in the Health and Demographic Surveillance System (HDSS) (187) . This 
area includes Caxito, Mabubas, Úcua and a small part of Kicabo communes, located in 
Dande Municipality, Bengo, Angola (187).  
In a first stage, between December 2013 and December 2014, children were recruited in 
three outpatient health units, namely: Hospital Geral do Bengo (outpatient unit), Hospital 
Municipal do Dande (outpatient unit) and Posto Médico o Bom Samaritano.  
Children aged 20-36 months, living in the Dande Health and Demographic Surveillance 
System study area, with no history of antibiotic/antiparasitic drugs in the previous ten 
days, were invited to participate in the study. A sociodemographic survey was applied 
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and anthropometric assessment was performed. A single stool sample was requested for 
the microscopic detection of intestinal parasites. Then, after delivering the stool sample, 
those who were infected with at least one pathogenic intestinal parasite were invited to 
be included in the study for a two year of follow-up period.  
As shown in Figure 19, 121 children were included and randomly allocated to one of the 
four arms (1:1:1:1): Arm 1 (A1) - to receive a single dose of ALB 400 mg once a year at 
individual level; Arm 2 (A2) - to receive a single dose of ALB 400 mg once a year at 
household level; Arm 3 (A3) - screening of pathogenic intestinal parasites every four 
months and treatment of positive results at individual level; in Arm 4 (A4) - screening of 
pathogenic intestinal parasites every four months and treatment of positive results at 
household level. Participants and clinical trial staff were aware of the group to which 
children were assigned. 
Community follow-up (Fu) was performed at 4th (Fu1), 8th (Fu2), 12th (Fu3), 16th (Fu4), 
20th (Fu5) and 24th months (Fu6) after inclusion of each child. The primary outcomes 
were growth assessed by height, HAZ, WHZ and WAZ at baseline, 4, 8 12, 16, 20 and 
24 months of follow-up. 
Sample size calculation was explored using GLIMMPSE software and 152 participants 
with intestinal parasitic infections was required (38 per arm). For more details, please see 
the appendix of Paper IV (point 2.4).  
Intention-to-treat (ITT) analysis is widely recommended as the preferred analysis, as it 
avoid bias associated with non-random loss, in order to fully preserve the huge benefit of 
randomization (188). Thus, all randomised participants were included, after a missing 
values treatment (189). Analyses to primary outcomes started describing the proportion 
of subjects with missing by arms and choosing different methods to handle missing data. 
A special attention was given to height due to facility in terms of interpretation. In cases 
where the missing value was flanked by valid observations, interpolation was used to 
height, since there is a monotonic increasing in their values. For the remaining values, we 
performed multiple imputation using the Expectation Maximization, identifying the most 
plausible mechanism underlying our data. Missing Completely at Random (MCAR) was 
tested using Little´s test (188, 190). 
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Initially, nonparametric rank-based methods were explored in the nparLD (R software 
package) (191) to provide a response to the followed key questions for each primary 
outcome: i) do the arms/treatments have the same effect?; ii) Is the time profile flat or 
there is a trend over the follow-up period?; iii) Are the effects of the treatments similar 
over time? This first rank-based approach is robust to outliers and present a competitive 
performance for small sample sizes (191). However, other strategies are advantageous 
(189, 192). Thus, linear mixed effect models (LMM) and generalized estimating 
equations (GEE) for longitudinal data were explored to reinforce our findings, using 
packages (lme, nlme and geepack) (189, 192). Different correlation structures were also 
considered in several LMM and GEE models. Plots were explored using gglopt2 package. 
Initial data analysis was done using IBM SPSS Software, version 24 (IBM Corp, Armonk, 
NY, USA), and a more advanced modelling was performed using R Program.   
Data statistical analysis are described in detail in methods section of Paper IV (point 2.4). 
 
 
64 
 
INTRODUCTION
 
Figure 19. Consort flow-chart of the four-arm randomised controlled trial 
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Background: Diarrheal disease is among the leading causes of death in 
children younger than 5 years, especially in developing countries. The aim 
of this study was to investigate the most frequent etiological agents of diar-
rhea and its associated factors in children younger than 5 years attending the 
Bengo General Hospital in Angola.
Methods: From September 2012 through December 2013, stool samples 
were collected from 344 children presenting with diarrhea to investigate the 
presence of viral, bacterial and parasitic agents. Relevant sociodemographic 
and clinical data were obtained from parents and caregivers.
Results: An enteric pathogen was detected in 66.6% of stool samples: 
Cryptosporidium spp. (30.0%), rotavirus (25.1%), Giardia lamblia 
(21.6%), diarrheagenic Escherichia coli (6.3%), Ascaris lumbricoides 
(4.1%), adenovirus (3.8%), Strongyloides stercoralis (3.5%), astrovirus 
(2.6%), Hymenolepis nana (1.7%), Entamoeba histolytica/dispar (0.9%), 
Taenia spp. (0.6%), Trichuris trichiura (0.3%) and Entamoeba histolytica 
(0.3%). Children younger than 12 months were more frequently infected 
with Cryptosporidium spp. compared with older children (age: 12–59 
months), independently of sex, season, lethargy and wasting [odds ratio 
(OR): 3.5, 95% confidence interval (95% CI): 2.0–6.2]. Age (OR: 5.0, 95% 
CI: 2.6–9.3), vomiting (OR: 2.7, 95% CI: 1.5–4.8) and type of admission 
(inpatients, OR: 0.5, 95% CI: 0.3–0.9) were significantly associated with 
rotavirus infection.
Conclusions: This study demonstrates high rates of infection with an 
enteric pathogen, particularly in children younger than 12 months, empha-
sizing the need to address diarrheal disease in this age group.
Key Words: diarrhea, etiology, Angola
(Pediatr Infect Dis J 2016;35:e28–e34)
Diarrhea is among the leading causes of death in children younger than 5 years, especially in developing countries 
where it is often associated with malnutrition, either as a cause or 
a consequence.1,2 Diarrhea represents a symptom of gastrointesti-
nal infections caused by bacteria, viruses, protozoa and helminths, 
and the route of transmission is usually fecal-oral or from person 
to person.3 In some cases, infection results from skin penetration 
by infective larvae in contaminated soil. Poor hygiene conditions, 
lack of access to treated drinking water and inadequate sanitation 
foster high rates of transmission.4 Several studies have shown that 
rotavirus (RV), norovirus, adenovirus and astrovirus; the protozoa 
Giardia lamblia and Entamoeba histolytica; the bacteria Escheri-
chia coli, Shigella spp. and Campylobacter spp. are the most fre-
quent diarrhea-associated agents.3,5–8
Angola has the highest under 5 mortality rate (167 deaths 
per thousand live births).9 After malaria, diarrheal disease is con-
sidered the second most frequent disease in the country,10 with one 
of the highest annual rates of child deaths being attributable to diar-
rhea (19.700 deaths).3 Furthermore, the prevalence of chronic and 
acute malnutrition (29.0% and 8.0%, respectively) represents also 
a national concern.11,12
A community survey conducted in the Bengo province, 
Angola, identified high-prevalence estimates for geohelminths 
(22.6%), malaria (18.4%) and schistosomiasis (10.0%) in preschool 
children.13 According to data from the Bengo General Hospital 
(BGH), the province’s referral hospital, 14.9% of admissions of chil-
dren younger than 5 years was because of diarrhea, the third cause of 
death in the hospital during 2009, after malaria and lower respiratory 
infections (unpublished data). Given the paucity of relevant data, this 
study aims to identify the most frequent etiological agents of diarrhea 
in children younger than five years attending the BGH.
MATERIALS AND METHODS
Study Design
A cross-sectional study was conducted between September 
2012 and December 2013 in the BGH, located in Caxito, Dande 
Municipality, capital of Bengo province, 60 km northeast of Luanda. 
The climate is characterized by 2 seasons: a rainy (from October to 
April) and a dry season (from May to September).14 The majority 
of patients attending the hospital live in the province, whereas some 
patients come from Luanda province given its proximity.
All the children younger than 5 years with diarrhea (3 or 
more loose or liquid stools per day),3 attending the pediatric emer-
gency service (inpatients and outpatients) or the hospital outpatient 
pediatric unit, were invited to participate in the study. Those receiv-
ing an antibiotic or antiparasitic drug within the preceding 10 days 
were excluded to avoid false-negative results.3
Parents or legal guardians of children meeting the inclu-
sion criteria were interviewed by clinical staff. The survey included 
sociodemographic information (age in months, sex, province of 
residence, maternal age in years and maternal education); data on 
breastfeeding practices (exclusive breastfeeding was considered 
when the infant received only breast milk without addition of other 
liquids or solids, with the exception of oral rehydration solution, or 
drops/syrups of vitamins, minerals or medicines)15; water source 
and method of treatment; sanitation conditions (access to a private 
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
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or shared latrine with or without water). Parents or legal guard-
ians were asked about the duration of diarrhea (in days) and the 
presence of symptoms in the previous 10 days (vomiting, fever and 
bloody diarrhea). Physical examination of children was conducted 
to assess signs of dehydration (fontanelle, eyes, skin elasticity and 
lethargy). Weight and length/height were measured according to 
the standard procedures and used to calculate anthropometric indi-
ces expressed as Z score for each child with ANTHRO software: 
weight-for-age (underweight), weight-for-height (wasting) and 
height-for-age (stunting). Malnutrition was classified as mild (−2 
≤ Z score <−1), moderate (−3 ≤ Z score <−2) and severe (Z score 
<−3).16 Children with symptoms of bilateral pitting edema were 
diagnosed as suffering from severe acute malnourishment.17
Sample Collection
A blood sample collected by finger prick was used for 
malaria diagnosis. A single stool sample per child was collected in 
a sterile container provided by clinical staff.
Laboratory Methods
Figure 1 shows the different laboratory diagnostic meth-
ods used for enteric pathogens detection (virus, parasites and 
bacteria) and the number of samples processed and those not pro-
cessed because of insufficient stool amount. Once delivered at the 
laboratory, stool samples were immediately processed for patho-
gen detection with the adequate amount, in accordance with each 
manufacturer´s instructions.
RV and adenovirus were detected using rapid qualitative 
immunochromatographic assay (RV/adenovirus CerTest, Biotec 
S.L., Spain). Astrovirus was detected by a commercial enzyme-
linked immunosorbent assay (ELISA; Oxoid, United Kingdom).
Microscopic detection of intestinal parasites was performed 
through direct examination with saline and iodine and a concentra-
tion method using the Kit Parasitrap-System (Biosepar, Germany). 
Immunochromatographic rapid tests were used to detect Entamoeba 
spp. (RIDAQUICK Entamoeba, R-Biopharm, Darmstadt, Germany), 
G. lamblia and Cryptosporidium parvum. (RIDAQUICK Crypto-
sporidium/Giardia Combi, R-Biopharm) antigens in stools. Positive 
stool samples for Entamoeba (by rapid test and/or microscopy) were 
then subjected to ELISA (Thermo Fisher Scientific) for the detection 
of E. histolytica (Wampole® ELISA II Test Kits, Alere™, Waltham, 
MA). The presence of malaria parasites was carried out by rapid 
immunochromatographic test (Standard Diagnostics Bioline Malaria 
Ag P.f/P.v, Standard Diagnostics Inc., Republic of Korea).18
Bacterial agents were studied by conventional solid selective 
culture for Salmonella spp. and Shigella spp. (Salmonella–Shigella 
Agar, Liofilchem, Roseto degli Abruzzi, Italy),19 Campylobacter 
jejuni (Campylobacter Agar Base, product CM0983, Oxoid Ltd, Bas-
ingstoke, UK)20 and E. coli (Chromogenic Agar for E. coli O157:H7, 
Biolife, Italy). After 12 hours of incubation, suspicious colonies for 
Salmonella spp., Shigella spp. and E. coli were confirmed using 
API20E (Biomerieux, Marcy-l'Etoile, France). An agglutination test 
on chromogenic agar was performed for E. coli O157:H7 serologi-
cal confirmation of suspected colonies. Further differentiation of the 
diarrheagenic strains of E. coli was performed by polymerase chain 
reaction (PCR): enteropathogenic, enterotoxigenic (ETEC), entero-
aggregative (EAEC), verotoxigenic and enterohemorrhagic.21
Ethical Considerations
The study protocol was approved by the Ethics Committee 
of the Angolan Ministry of Health and the Ethics Committee of 
the Instituto de Higiene e Medicina Tropical, Portugal. Informed 
and voluntary consent was obtained from parents or legal guard-
ians before the inclusion of each child. Parasitological (microscopy 
and rapid tests) and viral (rapid tests) test results were provided to 
the hospital clinical staff no more than a day after examination to 
ensure appropriate patient clinical management.
Statistical Analysis
Data were analyzed using IBM SPSS software, version 22 
(IBM Corp, Armonk, NY). The χ2 test was used for comparison of 
the categorical variable proportions. For tables with expected cell 
frequencies of less than 5, the Fisher exact test was applied. A P 
value of less than 0.05 was deemed statistically significant. The 
independent variables that were significantly associated with each 
response at a significance level of 0.1 were included in a multivariate 
logistic regression model. The goodness of fit was based on Hos-
mer and Lemeshow test, considering a P value greater than 0.05. 
Adjusted associations were expressed in odds ratio (OR) and respec-
tive 95% confidence intervals (CIs).
RESULTS
Three hundred forty-four children were included in the 
study: 53.0% male and 47.0% female (Table 1), with a mean age 
of 15.5 months ± 12.4 standard deviation (SD). The prevalence 
of exclusive breastfeeding in the first 6 months of life was 50.9% 
(28/55), and the mean age of weaning was 4.93 months ± 2.07 
SD in children younger than 6 months and 15.05 months ± 6.57 
SD in children aged between 6 and 24 months. The most frequent 
drinking water source was the river (27.0%), and bleach was the 
most commonly used method of water treatment. In terms of 
sanitation, 20.3% of households did not have a latrine (Table 1).
Among the children included, 52.3% were inpatients (Table 2). 
The mean duration of reported diarrheal episodes was 3.10 days ± 
1.9 SD. Fever was the most frequent symptom reported (74.7%), 
followed by vomiting (51.5%) and bloody diarrhea (7.0%; Table 2). 
Sixty-one percent of children were underweight, 54% were stunted 
and 51% were wasted (Table 2). Nine children (9/289) were posi-
tive for Plasmodium falciparum.
An enteric pathogenic agent was identified in 66.6% of the 
total stool samples: in 41.9% of the samples, a single agent was 
detected, whereas in 24.7%, 2 or more pathogenic agents were iden-
tified. Cryptosporidium spp. (30.0%), RV (25.1%) and G. lamblia 
(21.6%) were the most frequent pathogenic agents. Salmonella 
spp., Shigella spp. and Campylobacter spp. were not isolated in any 
of the analyzed samples (Table 3).
In the univariate analysis, infection with RV was more fre-
quent in children younger than 12 months than in older children 
aged 12–59 months (P < 0.001) and in inpatients compared with 
outpatients (P = 0.002; Table 4). Furthermore, RV infection was 
associated with vomiting (P < 0.001) and with wasting (Table 4). 
Conversely, RV was less frequent in children with stunting than in 
children without stunting (P = 0.002; Table 4). The multivariate 
analysis confirmed that RV infection was more frequent in younger 
children aged 0–12 months compared with older children aged 12–
59 months (OR: 5.0, 95% CI: 2.6–9.3). Moreover, type of admis-
sion (OR: 0.5, 95% CI: 0.3–0.9) and vomiting (OR: 2.7, 95% CI: 
1.5–4.8) continued to be associated with RV infection (Table 5).
Infection with Cryptosporidium spp. was more frequent in 
boys (P = 0.047), in children younger than 12 months compared 
with older children (P < 0.001) and more prevalent in the rainy sea-
son compared with dry season (P = 0.037; Table 4). Only age (OR: 
3.5, 95% CI: 2.0–6.2) was significantly associated with Crypto-
sporidium spp. in the multivariate model fitted (Table 5).
Ten children (2.9%) were positive for E. histolytica/
dispar by antigen rapid test (5 were also positive by micros-
copy). ELISA was performed on stool samples of 7 children of 
which 1 sample was confirmed as E. histolytica (0.3%; Fig. 1). 
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ELISA was not performed in the remaining 3 stool samples because 
of their insufficient quantity and were therefore classified as E. his-
tolytica/dispar (Table 3).
Hymenolepis nana was identified in 6 children, and all of them 
were stunted (Table 4). Maternal education and the presence of vomit-
ing were significantly associated with Strongyloides stercoralis infec-
tion (Tables 4 and 5) independently of the considered confounders (OR: 
0.2, 95% CI: 0.1–0.7; Table 5). No age differences were observed for 
Ascaris lumbricoides, S. stercoralis, H. nana, Taenia spp. and Trichuris 
trichiura infections. However, considering helminth infections col-
lectively (N = 34), older children (age: 12–59 months) were more fre-
quently infected than younger children (age: 0–12 months; P = 0.019).
The presence of E. coli was confirmed in 140 of 344 stool 
cultures. Among these, PCR was not performed on 43 samples 
because of an insufficient amount of stool (Fig. 1). The PCR con-
firmed 19 of 97 (19.6%) to be pathogenic: 12 of 97 (12.4%) EAEC 
and 7 of 97 (7.2%) ETEC (Table 3).
Among children younger than 6 months, there was no signifi-
cant difference in the proportion of infection by any pathogenic agent 
between those who were and were not exclusively breastfed. Also, 
no significant difference was found between children using treated 
or untreated water and between the groups with or without a latrine.
DISCUSSION
At least 1 pathogenic agent was isolated in 66.6% of the 
study samples, supporting the importance of infectious causes of 
diarrheal disease in children younger than 5 years in this region of 
Angola. This percentage was higher compared with that obtained in 
a Mozambican hospital-based study (42.2%) but similar to a study 
conducted in Tanzania (67.1%).6,22 Our study confirmed a high rate 
of infection caused especially by parasitic and viral agents, whereas 
bacterial agents were the less common.
The prevalence of RV (25.1%) was similar to estimates 
obtained in studies conducted in the Republic of Ivory Coast 
(28.6%),23 but lower compared with a study from Huambo prov-
ince, Angola (37.0%).24 Some studies demonstrated an increase in 
childhood diarrhea hospitalizations worldwide because of RV: from 
22% (between 1986 and 1999) to 39% (2000 and 2004).25 Like-
wise, recent data from The African Rotavirus Surveillance Network 
TABLE 1. Sociodemographic Data of Children Younger 
Than 5 Years Included in the Study and Data on 
Breastfeeding, Maternal Age, Maternal Education, Drinking 
Water Source, Water Treatment Method and Sanitation
N n (%)
Age (mo) 344
  0–6 55 (16.0)
  6–12 132 (38.4)
  12–24 94 (27.3)
  24–59 63 (18.3)
Sex 344
  Male 184 (53.0)
  Female 160 (47.0)
Province 344
  Bengo 257 (83.4)
  Luanda 57 (16.6)
Breastfeeding
  0–6 mo 55
   Exclusive 28 (50.9)
   Complementary 25 (45.5)
   Already weaned 1 (1.8)
   Never 1 (1.8)
  6–24 mo 226
   Exclusive 9 (4.0)
   Complementary 172 (76.1)
   Already weaned 44 (19.5)
   Never 1 (0.4)
Maternal age 299
  13–20 55 (18.4)
  20–30 163 (54.5)
  30–49 81 (27.1)
Maternal education 339
  Without 65 (18.9)
  Basic education 221 (64.2)
  High school 48 (14.0)
  Superior 5 (1.5)
Drinking water source 344
  River 93 (27.0)
  Tap in the yard 84 (24.4)
  Private tank 84 (24.4)
  Public tap water 47 (13.7)
  Piped water 21 (6.1)
  Irrigation channel 5 (1.5)
  Mineral water 4 (1.2)
  Borehole 3 (0.9)
  Tubewell 3 (0.9)
Water treatment method 344
  No 137 (39.8)
  Yes 207 (60.2)
   Bleach 170 (82.1)
   Boiling 30 (14.5)
   Alum stone 6 (2.9)
   Filter 1 (0.5)
Sanitation 344
  Without latrine 70 (20.3)
  With latrine 274 (79.7)
   Private with water 100 (36.5)
   Private without water 47 (17.2)
   Shared with water 60 (21.9)
   Shared without water 67 (24.5)
TABLE 2. Clinical Information of Children Younger 
Than 5 Years With Diarrhea Attending the Bengo 
General Hospital: Type of Admission, Reported 
Symptoms, Signs of Dehydration and Malnutrition 
(Underweight, Wasting and Stunting)
N n (%)
Type of admission 344
  Inpatient 180 (52.3)
  Outpatient 164 (47.7)
Reported symptoms 344
  Fever 257 (74.7)
  Vomiting 177 (51.5)
  Diarrhea with blood 24 (7.0)
Signs of dehydration
  Reduced skin elasticity 320 14 (4.4)
  Sunken fontanelle 322 49 (15.2)
  Sunken eyes 331 77 (23.3)
  Lethargy 327 95 (27.6)
Malnutrition
  Underweight 334
   Eutrophic 130 (38.9)
   Mild 89 (26.6)
   Moderate 65 (19.5)
   Severe 50 (15.0)
  Wasting 334
   Eutrophic 164 (49.1)
   Mild 65 (19.5)
   Moderate 37 (11.1)
   Severe 68 (20.4)
  Stunting 334
   Eutrophic 152 (45.5)
   Mild 74 (22.2)
   Moderate 53 (15.9)
   Severe 55 (16.5)
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in children younger than 5 years hospitalized with acute diarrhea 
revealed a prevalence of 35% in a year round studies from Cam-
eroon, Ethiopia and Zimbabwe and 41% in children recruited over 
a 2-year period in Ghana, Kenya, Uganda and Zambia.26 In contrast 
to the aforementioned studies, we included inpatients and outpa-
tients in our study, and RV infections were significantly lower in 
outpatients (22.6%) than in inpatients (29.6%) (OR: 0.5; 95% CI: 
0.3–0.9). This could explain the lower RV prevalence in our study 
compared with studies recruiting patients requiring hospitalization.
Our results also demonstrate that RV infection was signifi-
cantly more frequent in children younger than 12 months (OR: 4.7, 
95% CI: 2.7–9.3) compared with older children. This is in line 
with the literature, reporting that 80% of primary RV infections in 
developing countries occur among infants younger than 12 months, 
as opposed to estimates from developed countries where the median 
age of primary infection ranges from 9 to 15 months.26,27
A higher number of RV cases were registered in children 
with wasting (30.4%) when compared with well-nourished children 
(20.7%). Acute malnutrition indicates recent weight loss and may 
typically be associated with insufficient food intake or a higher 
incidence of infectious diseases such as diarrhea.1 In fact, some 
studies suggest that malnutrition may result from infection but also 
is itself a cause.2 Also, the presence of vomiting was strongly asso-
ciated with RV infection. This was previously reported in Africa 
and specifically in Angola suggesting that RV is an important cause 
of dehydration.24,28,29 Among the viral agents, adenovirus and astro-
virus were the least frequent viral agents (3.8% and 2.6%, respec-
tively), which is in line with previous findings.30,31
Cryptosporidium spp. (30.0%) and G. lamblia (21.0%) were 
the most frequent protozoa agents detected in stool samples. However, 
the prevalence of Cryptosporidium spp. in our results contrasts with 
those from at least 2 recently hospital-based studies: one conducted in 
Kenya (4%) and another study conducted in Mozambique (0.6%).6,32 A 
higher prevalence was reported in the Democratic Republic of Congo, 
in both community and health center (14.8% and 22.2%, respectively) 
using modified acid-fast stain method.33 A study comparing modified 
acid-fast stain and antigen rapid test methods reported a slightly higher 
positivity among the second method (11.3% vs. 15.3%).34 For diagnos-
ing Cryptosporidium spp., conventional microscopy requires an expert 
technician and depends on the number of oocysts per gram of stool.35 
In this study, the use of an immunochromatographic test for detecting 
Cryptosporidium antigen could explain the higher prevalence of infec-
tion compared with those using conventional microscopy.
Children younger than 12 months were 3.7 times more likely 
to be infected with Cryptosporidium spp. (P < 0.01) compared with 
older children. This follows the findings of a study carried out in 
Kenya where children younger than 12 months were 2.4 times more 
likely to be infected by Cryptosporidium spp.36 However, higher 
prevalence estimates have also been reported among children aged 
12–24 months.32,37 The introduction of complementary food above 
6 months of age and the increased contact with contaminated water 
may contribute to a higher prevalence of infection.38
TABLE 3. Frequency of Pathogenic Agents Isolated 
From Stool Samples of Children Younger Than 5 Years 
With Diarrhea Attending the Bengo General Hospital
N n (%)
Virus
  Rotavirus 342 86 (25.1)
  Adenovirus 342 13 (3.8)
  Astrovirus 274 7 (2.6)
Parasites
  Cryptosporidium spp. 337 101 (30.0)
  Giardia lamblia 338 73 (21.6)
  Ascaris lumbricoides 344 14 (4.1)
  Strongyloides stercoralis 344 12 (3.5)
  Hymenolepis nana 344 6 (1.7)
  Entamoeba histolytica /dispar 344 3 (0.9)
  Entamoeba histolytica 341 1 (0.3)
  Taenia spp. 344 2 (0.6)
  Trichuris trichiura 344 1 (0.3)
Bacteria
  Diarrheagenic Escherichia coli 301 19 (6.3)
   EAEC 301 12 (4.0)
   ETEC 301 7 (2.3)
  Salmonella spp. 343 0 (0.0)
  Shigella spp. 343 0 (0.0)
  Campylobacter jejuni 257 0 (0.0)
TABLE 4. Proportions of Enteric Pathogenic Agents According to Clinical Information: Type of Admission, Vomiting, 
Lethargy, Wasting and Stunting
Admission, n (%) Vomiting, n (%) Lethargy, n (%) Wasting, n (%) Stunting, n (%)
Outpatient Inpatient Yes No Yes No Yes No Yes No
Rotavirus 29 (17.7) 57 (32.0)* 62 (35.4) 24 (14.4)* 29 (31.2) 57 (24.6) 51 (30.4) 34 (20.7) 34 (18.9) 51 (33.6)*
Adenovirus 5 (3.0) 8 (4.5) 7 (4.0) 6 (3.6) 3 (3.2) 10 (4.3) 7 (4.2) 5 (3.0) 6 (3.3) 6 (3.9)
Astrovirus 1 (0.8) 6 (4.0) 2 (1.5) 5 (3.7) 0 (0.0) 6 (3.4) 4 (3.1) 3 (2.2) 3 (2.0) 4 (3.5)
Cryptosporidium spp. 47 (29.0) 54 (30.8) 46 (26.9) 55 (33.1) 34 (37.4) 61 (26.6)† 56 (34.1) 42 (25.8)† 47 (26.7) 51 (33.8)
Giardia lamblia 41 (25.3) 32 (18.2) 33 (19.2) 40 (24.1) 26 (28.3) 45 (19.7)† 29 (17.6) 42 (25.8)† 37 (20.9) 34 (22.5)
Entamoeba histolytica/ 
dispar
1 (0.6) 2 (1.1) 0 (0.0) 3 (1.8) 0 (0.0) 3 (1.3) 0 (0.0) 3 (1.8) 2 (1.1) 1 (0.7)
Entamoeba histolytica 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.6) 0 (0.0) 1 (0.4) 1 (0.6) 0 (0.0) 1 (0.6) 0 (0.0)
Ascaris lumbricoides 5 (3.0) 9 (5.0) 8 (4.5) 6 (3.6) 5 (5.3) 9 (3.9) 9 (5.3) 5 (3.0) 7 (3.8) 7 (4.6)
Strongyloides stercoralis 3 (1.8) 9 (5.0) 10 (5.6) 2 (1.2)* 1 (1.1) 8 (3.4) 8 (4.7) 3 (1.8) 5 (2.7) 6 (3.9)
Hymenolepis nana 2 (1.2) 4 (2.2) 3 (1.7) 3 (1.8) 0 (0.0) 6 (2.6) 4 (2.4) 2 (1.2) 6 (3.3) 0 (0.0)*
Taenia spp. 1 (0.6) 1 (0.6) 1 (0.6) 1 (0.6) 1 (1.1) 0 (0.0) 0 (0.0) 1 (0.6) 0 (0.0) 1 (0.7)
Trichuris trichiura 0 (0.0) 1 (0.6) 1 (0.6) 0 (0.0) 1 (1.1) 0 (0.0) 1 (0.6) 0 (0.0) 1 (0.5) 0 (0.0)
Helminths 11 (6.7) 23 (12.8) 22 (12.4) 12 (7.2) 7 (7.4) 23 (9.9) 21 (12.4) 11 (6.7) 18 (9.9) 14 (9.2)
Diarrheagenic  
 Escherichia coli
8 (5.8) 11 (6.8) 7 (4.4) 12 (8.5) 6 (7.1) 13 (6.5) 11 (7.6) 8 (5.5) 12 (7.5) 7 (5.4)
  EAEC 6 (4.3) 6 (3.7) 4 (2.5) 8 (5.7) 5 (5.9) 7 (3.5) 8 (5.5) 4 (2.7) 9 (5.6) 3 (2.3)
  ETEC 2 (1.4) 5 (3.1) 3 (1.9) 4 (2.8) 1 (1.2) 6 (3.0) 3 (2.1) 4 (2.7) 3 (1.9) 4 (3.1)
*P value < 0.05.
†0.05 < P value < 0.1.
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Cryptosporidium spp. infection was more prevalent dur-
ing rainy season, which is similar to the previous findings from 
Brazil and a meta-analysis that included 13 studies undertaken 
in Sub-Saharan Africa.39,40 Rainfall in regions with low access to 
basic sanitation can increase the risk of water contamination with 
human or animal excreta.39,40
G. lamblia prevalence in our study was higher  compared 
with studies conducted in Mozambique (2.5%), Cameroon 
(13.2%), Tanzania (14.0%) and Kenya (16%).6,22,37,41 All the 
aforementioned studies applied microscopy for diagnosing 
G. lamblia. In our study, we identified G. lamblia by both methods 
(microscopy and the antigen rapid test) and found that more than 
half of the positive cases were detected only by the antigen rapid 
test. These differences could be explained by the fact that G. lam-
blia trophozoites are usually found in diarrheal stools, less resistant 
than cysts to environmental conditions and not detected if the micro-
scopic analysis is not immediately conducted.42 Moreover, the rapid 
diagnostic test are reported to be more sensitive than microscopy.35
Some studies identify Cryptosporidium spp. and G. lamblia 
as factors predisposing to significant growth impairment.43 How-
ever, no significant differences were found between these protozoa 
agents and malnutrition. Longitudinal approaches are needed to 
investigate the relationship between infection and childhood growth.
Protozoa were more prevalent than helminths infections, 
probably because more than 80.0% of the sample was younger than 
24 months. Furthermore, diarrhea is a common symptom of infec-
tion by protozoa.35 Children whose mother had higher education lev-
els presented lower odds of S. stercoralis infection (OR: 0.2, 95% 
CI: 0.1–0.7). This association between the mother’s education and 
risk of intestinal parasites was previously reported in Mexico and is 
probably related to an adequate knowledge of hygiene practices.44
Despite the fact that several other African studies detected C. 
jejuni in prevalences ranging from 1.7% to 21.0%, we did not isolated 
this pathogen.6,22,41,45 Shigella spp. and Salmonella spp. were also not 
isolated and are important bacterial agents usually linked to outbreaks.6
E. coli was the only potentially pathogenic bacterial agent iso-
lated by our methodology. The importance of E. coli is well documented 
in diarrheal disease with EAEC and ETEC strains being more frequent 
than verotoxigenic or enterohemorrhagic among children in develop-
ing countries.46 Suspicious colonies were isolated in 140 samples, but 
only 19 (6.3%) were confirmed as pathogenic: 12 EAEC (4.0%) and 
7 ETEC (2.3%), with a higher prevalence in children younger than 6 
months. A study conducted in Tanzania detected a higher prevalence 
of E. coli (22.9%) with EAEC predominating (14.6%) and also more 
prevalent in children younger than 6 months (P < 0.05).47
According to the literature, improvements in access to clean 
water and sanitation contribute to reduce diarrhea in African coun-
tries.4 However, no significant association was observed between infec-
tious agents and water sources, water treatment or latrine usage. When 
the interviews were performed, the water treatment procedures were 
not explored in detail to the parents, and for this reason, there may be 
insufficient data in these exposures to be associated with infection risk.
This study contain limitations: other diarrhea-associated 
pathogenic agents, such as norovirus and Cyclospora spp., fell 
beyond the scope of this research project. Collecting 3 instead of only 
1 stool specimen would increase the microscopy detection rate of G. 
lamblia, as for other parasites, but parental collaboration would be 
much harder.35 A further limitation of this study is that we included only 
children with diarrhea, but a case-control design comparing children 
with and without diarrhea would allow to explore potential associations 
between these exposures and the actual occurrence of the disease.
In conclusion, this study identified Cryptosporidium spp., RV 
and G. lamblia as the most frequent pathogens present in children 
younger than 5 years with diarrhea attending the BHG. Moreover, 
children younger than 12 months were more frequently infected with 
Cryptosporidium spp. and RV than older children. This reinforces the 
TABLE 5. Sociodemographic and Clinical Characteristics Independently Associated With Infection 
by Rotavirus, Cryptosporidium spp. and Strongyloides stercoralis and Helminths Among Children With 
Diarrhea
Dependent Variable Independent Variables Unadjusted OR 95% CI Adjusted OR 95% CI
Rotavirus* Age† 4.747 2.645–8.519 4.969 2.650–9.319
Vomiting‡ 3.269 1.921–5.564 2.677 1.503–4.771
Admission§ 0.456 0.274–0.759 0.508 0.289–0.895
Wasting‡ 1.667 1.010–2.750 1.362 0.782–2.371
Stunting‡ 0.461 0.279–0.762 0.659 0.379–1.148
Cryptosporidium spp.¶ Sex║ 1.617 1.006–2.600 1.305 0.774–2.201
Age† 3.868 2.288–6.539 3.531 2.022–6.166
Season** 1.658 1.029–2.670 1.337 0.777–2.298
Lethargy‡ 1.643 0.981–2.752 1.620 0.909–2.887
Wasting‡ 1.494 0.927–2.407 1.489 0.886–2.500
Giardia lamblia†† Lethargy‡ 1.611 0.921–2.816 1.770 0.991–3.161
Wasting‡ 0.072 0.361–1.047 0.734 0.421–1.279
Strongyloides stercoralis‡‡ Vomiting‡ 4.940 1.066–22.891 3.198 0.656–15.590
Maternal Education‡ 0.153 0.043–0.540 0.188 0.052–0.678
Helminths§§ Age† 0.421 0.201–0.880 0.499 0.229–1.087
Maternal Education‡ 0.462 0.207–1.029 0.552 0.239–1.274
Admission§ 0.491 0.231–1.041 0.554 0.236–1.300
*Adjusted for age, vomiting, wasting and stunting.
†Reference class = 12–59 mo.
‡Reference class = no.
§Reference class = inpatient.
¶Adjusted for sex, age, season, lethargy and wasting.
║Reference class = female.
**Reference class = dry season.
††Adjusted for lethargy and wasting.
‡‡Adjusted for vomiting and maternal education.
§§Adjusted for age, maternal education and admission.
OR indicates odds ratio.
The unadjusted OR and P values were calculated from univariate analysis and the adjusted OR from the fit of multivariate logistic regression.
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importance of interventions for diarrhea control in the earlier months 
of life. In 2014, Angola included RV vaccine in the national immuni-
zation plan.48 Surveillance of the RV disease in the next few years is 
going to be crucial for a better understanding of diarrhea-associated 
morbidity and mortality, but other diarrhea-associated agents need to 
be addressed. This study presents relevant information for health pol-
icy makers and emphasizes the importance of diagnosing the agents 
of diarrhea in young children as a part of them can be easily treated.
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Abstract
Background
Rotavirus group A (RVA) is considered the leading cause of pediatric diarrhea, responsible
for the high burden of diarrheal diseases in sub-Saharan Africa. Despite recent studies, the
existent data are scarce for some African countries like Angola, a country with one of the
highest RVA-related death estimates. The aim of this study was to determine the RVA
detection rate and circulating genotypes in children less than five years of age with acute
gastroenteritis attended at the Bengo General Hospital in Caxito, Bengo province, Angola,
before vaccine introduction.
Methods
Between September 2012 and December 2013, 342 fecal specimens were collected from
children enrolled. Positive samples for RVA by immunochromatographic rapid test were G
and P-typed by hemi-nested type-specific multiplex PCR, and subgrouped for the VP6
gene. VP4 and VP7 genes from a subset of samples were sequenced for phylogenetic
analysis.
Results
During the study period, a high RVA detection rate was registered (25.1%, 86/342).
The age group most affected by RVA infection includes children under 6 months of age
(p<0.01). Vomiting was highly associated with RVA infection (72.1%; p<0.001).
From the 86 RVA-positive samples, 72 (83.7%) were genotyped. The most prevalent
genotype was G1P[8] (34/72; 47.2%), followed by the uncommon G1P[6] (21/72; 29.2%),
and G2P[4] (9/72; 12.5%). Only two G-types were found: G1 (60/72; 83.3%) and G2 (11/72;
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15.3%). Among the P-genotypes, P[8] was the most prevalent (34/72; 47.2%), followed by P
[6] (22/72; 30.6%) and P[4] (9/72; 12.5%). In the phylogenetic trees, the identified G and P-
types clustered tightly together and with reference sequences in specific monophyletic
groups, with highly significant bootstrap values (92%).
Conclusion
This pre-vaccination study revealed, for the first time for Bengo province (Angola), the RVA
genotype profile, including phylogenetic relationships, and a high RVA detection rate, sup-
porting the immediate introduction of a RVA vaccine in the national immunization
programme.
Introduction
Rotavirus group A (RVA) remains the most important etiological agent of severe diarrhea in
children under five years of age [1, 2], especially in remote areas with difficult or inexistent
access to the healthcare infrastructure and inadequate domestic sanitation conditions [2, 3].
According to the global estimates from 2008, RVA was responsible for 453,000 deaths
among children under five years of age each year, with African children accounting for more
than 50% of the total [4], but a recent study showed a decline in this number, up to 215,000
deaths in 2013, the majority of them in India [5]. In the last decade, an increased research
effort on epidemiology and disease burden of RVA infection has been made. Data obtained
helped in the definition of more effective health policies, including the implementation of
RVA vaccination. Two live attenuated RVA vaccines, the monovalent Rotarix (GlaxoSmithK-
line Biologicals, Belgium) and the pentavalent human-bovine reassortant RotaTeq (Merck,
USA), were recommended by the World Health Organization (WHO) to be included in the
national immunization programmes worldwide in 2009 [6]. Recently, a third RVA vaccine,
the low-cost, live attenuated Rotavac (Bharat Biotech International, India) was licensed for use
in India but not yet pre-qualified for the Global Alliance for Vaccines and Immunization
(GAVI) market [7]. Both recommended vaccines require multiple dose administration (two
doses for Rotarix and three for RotaTeq), the first to be administered between 6 and 15 weeks
of age [8], and raise homo- and heterotypic immune response against RVA different strains
[9]. The two vaccines have been proven to be effective worldwide, but lower efficacy was
observed in low-income countries from Africa and Southern Asia [10, 11]. Among the several
hypothesis to explain the differences in the immune response and consequent efficacy of these
vaccines in low- versus high-income countries, RVA strains diversity, host genetic factors, mal-
nutrition, host co-infection, deficient micronutrient ingestion, and interfering gut flora have
been put forward [12–14].
Worldwide, there is a great genetic diversity of circulating RVA wild-type strains. Several
studies conducted in Africa identified G1P[8] as the most frequent RVA strain, while the most
common strains for high- and middle-income countries in the pre vaccination era, G2P[4],
G3P[8], G4P[8], and G9P[8] [15], have also been identified, but to a much lesser extent [16,
17]. Noteworthy, is the emergence of uncommon strains, such as G1P[6], G8P[6], G6P[6],
G8P[8], G12P[6], and mixed G and P-strains, in sub-Saharan Africa [18–21]. This picture is
still far from completed for the majority of African countries, e.g. Angola. Despite the recent
publication of an RVA epidemiology study in four provinces of Angola [22], present data on
RVA prevalence and genotype distribution remain scarce.
RVA prevalence and genotype distribution in Bengo, Angola
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Angola is a sub-Saharan African country with an estimated population of 25.8 million in
2014. The Angolan population is very young, with an average age of 20.6 years and a propor-
tion of 47.3% aged 0–14 years [23]. Angola has one of the highest RVA attributable death rate
in children under five years (5% of global total) [5]. Bengo province, situated in Northwestern
Angola and close to the capital city, Luanda, has a population of about 357.000 individuals,
with 56.3% of them living in rural settings [24]. The capital, Caxito, harbor the Bengo General
Hospital (BGH), a reference hospital for the province. To reduce severe diarrheal disease, and
preventing RVA-associated hospitalizations and mortality, Angola requested assistance from
the GAVI in 2014 to introduce RVA vaccine in the national immunization program.
This study is part of a larger investigation regarding diarrhea burden in children under five
years in the Bengo province, Angola [25], and aims to provide baseline information on RVA
infection before vaccine introduction. This hospital-based study was established to investigate
RVA prevalence and genotype distribution during a period of more than one year in children
up to five years attended with acute gastroenteritis (AGE).
Material and methods
Setting or study site
This study was conducted at the Bengo General Hospital (BGH), located in Caxito, capital of
Bengo province, 60 km northeast of the capital Luanda. Besides receiving patients from Bengo
province, the BGH also attends patients from neighboring Luanda province. The climate of
this province is subtropical, characterized by a rainy and warm season, from mid-September
to mid-May, and a dry and cold season, from mid-May to mid-September.
Study design
This study was conducted at the BGH between September 2012 and December 2013 and is part of
a cross-sectional study set up to investigate the most frequent etiological agents of diarrhea
(viruses, parasites and bacteria) in children under five years of age [25]. Surveillance data was col-
lected before rotavirus group A (RVA) vaccine introduction in the country. A total of 342 children
with acute gastroenteritis AGE (diarrhea, with or without vomiting) attending the pediatric emer-
gency room or the outpatient pediatric unit were enrolled and tested for RVA infection. During
the sampling period, all children with AGE presenting at BGH, originating from Bengo province
(n = 286) or Luanda province (n = 56), were included in this study. Diarrhea was defined as three
or more loose or liquid stools per day [26]. Children receiving antibiotic or antiparasitic treatment
within 10 days before the examination were excluded from the study. After informed consent
was given by parents or legal guardians, sociodemographic variables [i.e. date of birth (n = 342),
gender (n = 342), province of residence (n = 342), residence type (n = 250), maternal literacy
(n = 337), education level of the mother (n = 272)], and information on breastfeeding practices
(n = 240), drinking water source (n = 342), water treatment methods (n = 342) and sanitation
conditions (n = 342) were obtained, whenever possible. Nutritional status was also assessed from
anthropometric measurements (n = 332). Weight and length/height were measured according to
standard procedures established by the World Health Organization (WHO) and used to calculate
anthropometric indices expressed as individual z scores using ANTHRO software (version 3.2.2)
[27]: weight-for-age (WAZ, underweight), weight-for-height (WHZ, wasting) and height-for-age
(HAZ, stunting). Malnutrition was classified as mild (-2 z score< -1), moderate (-3 z score
< -2) or severe (z score< -3) [28]. Children with symptoms of bilateral pitting edema were diag-
nosed as suffering from severe acute malnourishment as described in WHO procedures [29].
After physical examination, the clinical variables regarding symptoms associated to AGE
were registered [e.g. duration of diarrhea in days (n = 333), vomiting (n = 342), fever
RVA prevalence and genotype distribution in Bengo, Angola
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(n = 342), lethargy (n = 325), dehydration signs, such as depressed fontanelle (n = 320), sunken
eyes (n = 329), skin elasticity (n = 318)]. Depending upon the severity of symptoms, each child
was referred for regular follow-up treatment (oral rehydration, drugs, etc.) or hospitalization.
The type of admission was registered [e.g. outpatient department (n = 164) or emergency unit
(n = 178)].
Ethical considerations
The study protocol (including detailed working plan, epidemiological survey and informed con-
sent forms) was approved by the National Ethics Committee of the Angolan Ministry of Health
in Luanda and the Ethics Committee of the Institute of Hygiene and Tropical Medicine, in Lis-
bon, Portugal (Process number:12-2012-PN). As stated before, informed and voluntary written
consent was obtained from parents or legal guardians of each child prior to inclusion in the
study.
Sample collection and RVA antigen detection
Fecal specimens were collected in sterile containers provided by clinical staff. A total of 342
samples were screened locally for the presence of RVA and adenovirus serotype 40/41 antigens
using a rapid qualitative immunochromatographic assay (Rotavirus + Adenovirus, CerTest
Biotec S.L., Zaragoza, Spain), following the manufacturer’s instructions. RVA-positive stool
samples were preserved in guanidine thiocyanate solution until RNA extraction as described
before [30].
Viral RNA extraction
Preserved stool samples were transported to the Institute of Hygiene and Tropical Medicine in
Lisbon, Portugal for RVA genotyping. Viral RNA was extracted from 10% (w/v) stool suspen-
sions using the innuPREP Virus RNA Kit (Analytik Jena AG, Jena, Germany), according to
the manufacturer’s instructions. The RNA was eluted in RNase-free water (60 μl) and stored at
-80˚C until further use.
Reverse transcription, VP6 subgrouping, G and P-genotyping
Reverse transcription (RT) with random hexamers, to produce cDNA to be used as template
in specific PCRs for the different genes, was carried out using a commercial kit (NZY First-
strand cDNA Synthesis Kit, NZYTech, Lisbon, Portugal), according to the manufacturer’s
instructions. Briefly, 16 μl of the RNA eluate was denatured at 94˚C for 5 minutes, and quickly
chilled on ice for 2 minutes, followed by the addition of 20 μl of NZYRT 2x Master Mix and
4 μl of NZYRT Enzyme Mix, to a final volume of 40 μl. The RT reaction was carried out at
25˚C for 10 minutes, and 50˚C for 30 minutes, being the inactivation made at 85˚C for 5 min-
utes. After the final addition of 2 μl of NZY RNase H (E. coli), the product was incubated at
37˚C for 20 minutes.
VP6 subgrouping was performed using conventional PCR, previously described in 2010 by
Thongprachum et al. [31].
RVA G and P-genotyping were done using hemi-nested type specific multiplex PCRs, opti-
mized to detect eight G-types (G1, G2, G3, G4, G8, G9, G10 and G11) and six P-types (P[4],
P[6], P[8], P[9], P[10] and P[11]), as described previously [32–34]. The G- and P-genotypes
were assigned according to the amplicon size visualized under ultraviolet light after electro-
phoresis on 2% agarose gels stained with ethidium bromide.
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Molecular characterization of RVA strains by phylogenetic analysis
First-round PCR amplicons for VP7 and VP4 genes from a set of randomly selected G- and P-
typed viruses from each detected genotype, as well as from non-typable strains, were sent for
DNA sequencing (Sanger method) for further molecular characterization. DNA sequencing
was performed using the corresponding first-round PCR primers by STAB VIDA (Caparica,
Portugal).
After sequence editing using the BioEdit Sequence Alignment Editor version 7.1.3.0 [35],
multiple sequence alignments were made with Clustal Omega (available at http://www.ebi.ac.
uk/Tools/msa/clustalo/). Phylogenetic analysis was performed with the MEGA 5.1 software
[36], using a distance-based neighbour-joining method, based on the Kimura 2-parameter
model [37]. Bootstrap values were calculated from 1,000 replicates [36].
Nucleotide sequence accession numbers
The GenBank/DDBJ/EMBL accession numbers for sequences obtained in this study are
KP216531-KP216547, for VP4, and KP216548-KP216561, for VP7.
Statistical analysis
Data were analyzed using IBM SPSS software, version 22 (IBM Corp, Armonk, NY, USA).
Absolute (n) and relative frequency (%) were used for descriptive statistics of categorical and
ordinal variables, and the mean and standard deviation (SD) were presented in the case of con-
tinuous variables.
The chi-squared (χ2) test or Fisher’s exact test (for tables with expected cell frequencies less
than 5) were used to compare categorical variable proportions (gender, group age, province of
residence, settlement type, maternal literacy and education level, drinking water source and
treatment method, sanitation facilities, breastfeeding, malnutrition and clinical symptoms)
between RVA-positive and RVA-negative children. A p-value less than 0.05 was considered to
be significant and associations were expressed in odds ratio (OR) and respective 95% confi-
dence intervals (95% CI). A multiple logistic regression model was applied for stunting
(dependent variable), and included the independent variables age, gender, infection with RVA
and infection by an enteric pathogen other than RVA (data from the cross-sectional study
published before [25]). The goodness of fit was based on Hosmer and Lemeshow test, consid-
ering a p value greater than 0.05. Student´s t-test was applied to compare the mean age (in
months) between RVA-positive and RVA-negative children. When the p-value was less than
0.05, the mean age between the two groups were considered significantly different.
Results
RVA detection rate and basic socio-demographic characterization of the
studied population
From September 2012 to December 2013, 342 children under five years of age with acute gas-
troenteritis (AGE), attended at the Bengo General Hospital (BGH), were tested for rotavirus
group A (RVA) and enteric adenovirus (AdV) type 40/41 infections. RVA detection rate was
25.1% (86/342), while for AdV type 40/41 was much lower, reaching 3.8% (13/342). Two chil-
dren were shown to have mixed infection (0.6%, 2/342).
No association was found between infection by RVA and children gender (Table 1). The
mean age was significantly lower for children with RVA infection as detected by the RVA anti-
gen immunochromatographic assay (9.2±5.00 versus 17.6±13.40 months, p<0.001)—Table 1.
The age distribution is significantly different between RVA infected and non-infected children
RVA prevalence and genotype distribution in Bengo, Angola
PLOS ONE | https://doi.org/10.1371/journal.pone.0176046 April 19, 2017 5 / 19
(p<0.001, Table 1), with a positive association between infection and younger ages (<12
months).
Although BGH is a reference hospital for the province, 16.4% (56/342) of the attended chil-
dren were residents of the neighbor Luanda province (Table 2). The vast majority of the
enrolled children were living in an urban area (92.4%, 231/250), with only 7.6% (19/250) living
in rural settlements (Table 2). When asked about maternal education, the majority of the
respondents (65.0%, 219/337) declared as graduating basic education, only 14.2% (48/337) fre-
quented the high school, and 1.5% (5/337) had a university degree. 19.3% (65/337) of the
mothers never attended school. No significant association was found between level of maternal
literacy or education and RVA infection or the age of children enrolled. Apart from age and
age distribution, there was no statistically significant association between RVA infection and
any other socio-demographic variable analyzed.
Drinking water source and treatment method
The majority of the households with children participating in the study (69.6%, 238/342) used
water supplied by the Central Water Treatment Plant (CWTP) (Table 2). However, in 58.8%
(140/238) of these households an additional treatment, including the use of bleach and alum
stone, boiling and/or filtration, was applied before drinking. The consumption of water only
treated at home or without any type of treatment was reported, respectively, for 19.0% (65/
342) and 11.4% (39/342) of the households.
Among all the RVA positive cases, 43.0% (37/86) of children were drinking water from the
CWTP with a further household treatment, 31.4% (27/86) were using water from CWTP with-
out any additional treatment. In 16.3% (14/86) of the cases, it was applied only a household
treatment and a minority of the children (9.3%, 8/86) drank untreated water. This distribution
was not significantly different for RVA negative children. Comparing RVA-positive and -neg-
ative children of different age groups, no significant association was found concerning the
drinking water source and the treatment method applied (Table 2).
Sanitation facilities
Regarding sanitation facilities, 79.5% (272/342) of the children had access to latrines, either
private (53.7%, 146/272) or public (46.3%, 126/272). In a significant proportion of these
latrines (41.9%, 114/272), there was no running water. So, for a high proportion of children,
i.e. 20.5% (70/342), without access to any type of latrines, the most probable option could
mean open defecation close to the households. The use of a public latrine with running water
determined the highest RVA infection rate in children (35.6%, 21/59). On the other hand, the
Table 1. Characteristics of the study sample.
RV (+) RV (-) p-value Total
n (%) n (%) n (%)
Study sample 86 (25.1) 256 (74.9) 342 (100)
Gender Male 49 (57.0) 134 (52.3) 0.456 183 (53.5)
Female 37 (43.0) 122 (47.7) 159 (46.5)
Mean age (months) 9.2±5.00 17.6±13.4 <0.001 15.5±12.39
Group age (months) [0–6[ 21 (24.4) 34 (13.3) <0.001 55 (16.1)
[6–12[ 48 (55.8) 84 (32.8) 132 (38.6)
[12–24[ 16 (18.6) 76 (29.7) 92 (26.9)
[24–59] 1 (1.2) 62 (24.2) 63 (18.4)
https://doi.org/10.1371/journal.pone.0176046.t001
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Table 2. Sociodemographic profile of children with diarrhea attended at the Bengo General Hospital.
Variable [0–12 [months [12–24 [months [24–59] months [0–59] months
RV(+) RV(-) RV(+) RV(-) RV(+) RV(-) RV(+) RV(-)
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Child gender (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
Male (N = 183) 39 (56.5) 72 (61.0) 9 (56.3) 34 (44.7) 1 (100.0) 28 (45.2) 49 (57.0) 134 (52.3)
Female (N = 159) 30 (43.5) 46 (39.0) 7 (43.8) 42 (55.3) 0 (0.0) 34 (54.8) 37 (43.0) 122 (47.7)
Province of residence (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
Bengo (N = 286) 54 (78.3) 100 (84.7) 14 (87.5) 64 (84.2) 1 (100) 53 (85.5) 69 (80.2) 217 (84.8)
Luanda (N = 56) 15 (21.7) 18 (15.3) 2 (12.5) 12 (15.8) 0 (0.0) 9 (14.5) 17 (19.8) 39 (15.2)
Settlement typea (N = 250) N = 49 N = 90 N = 8 N = 57 N = 1 N = 45 N = 58 N = 192
Urban (N = 231) 44 (89.8) 81 (90.0) 8 (100.0) 54 (94.7) 1 (100.0) 43 (95.6) 53 (91.4) 178 (92.7)
Rural (N = 19) 5 (10.2) 9 (10.0) 0 (0.0) 3 (5.3) 0 (0.0) 2 (4.4) 5 (8.6) 14 (7.3)
Maternal literacy (N = 337) N = 69 N = 115 N = 16 N = 74 N = 1 N = 62 N = 86 N = 251
No (N = 65) 14 (20.3) 20 (17.4) 2 (12.5) 13 (17.6) 0 (0.0) 16 (25.8) 16 (18.6) 49 (19.5)
Yes (N = 272) 55 (79.7) 95 (82.6) 14 (87.5) 61 (82.4) 1 (100.0) 46 (74.2) 70 (81.4) 202 (80.5)
Education level of the mother (N = 272) N = 55 N = 95 N = 14 N = 61 N = 1 N = 46 N = 70 N = 202
Basic (N = 219) 46 (83.6) 78 (82.1) 11 (78.6) 48 (78.7) 1 (100.0) 35 (76.1) 58 (82.9) 161 (79.7)
High school (N = 48) 6 (10.9) 16 (16.8) 3 (21.4) 13 (21.3) 0 (0.0) 10 (21.7) 9 (12.9) 39 (19.3)
University (N = 5) 3 (5.5) 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.2) 3 (4.3) 2 (1.0)
Water source from the CWTPb (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
Yes (N = 238) 51 (73.9) 80 (67.8) 12 (75.0) 50 (65.8) 1 (100.0) 44 (71.0) 64 (74.4) 174 (68.0)
No (N = 104) 18 (26.1) 38 (32.2) 4 (25.0) 26 (34.2) 0 (0.0) 18 (29.0) 22 (25.6) 82 (32.0)
Drinking water source/treatmentc (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
From CWTP and not treated at home (N = 98) 20 (29.0) 32 (27.1) 6 (37.5) 21 (27.6) 1 (100.0) 18 (29.0) 27 (31.4) 71 (27.7)
From CWTP and treated at home (N = 140) 31 (44.9) 48 (40.7) 6 (37.5) 29 (38.2) 0 (0.0) 26 (41.9) 37 (43.0) 103 (40.2)
Only treated at home (N = 65) 11 (15.9) 25 (21.2) 3 (18.8) 16 (21.1) 0 (0.0) 10 (16.1) 14 (16.3) 51 (19.9)
Not treated (N = 39) 7 (10.1) 13 (11.0) 1 (6.3) 10 (13.2) 0 (0.0) 8 (12.9) 8 (9.3) 31 (12.1)
Sanitation facilities (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
Without latrine (N = 70) 12 (17.4) 24 (20.3) 2 (12.5) 14 (18.4) 0 (0.0) 18 (29.0) 14 (16.3) 56 (21.9)
Private latrine with running water (N = 99) 18 (26.1) 39 (33.1) 4 (25.0) 20 (26.3) 1 (100.0) 17 (27.4) 23 (26.7) 76 (29.7)
Private latrine without running water (N = 47) 11 (15.9) 12 (10.2) 3 (18.8) 14 (18.4) 0 (0.0) 7 (11.3) 14 (16.3) 33 (12.9)
Public latrine with running water (N = 59) 15 (21.7) 18 (15.3) 6 (37.5) 11 (14.5) 0 (0.0) 9 (14.5) 21 (24.4) 38 (14.8)
Public latrine without running water (N = 67) 13 (18.8) 25 (21.2) 1 (6.3) 17 (22.4) 0 (0.0) 11 (17.7) 14 (16.3) 53 (20.7)
Breastfeeding (N = 342) N = 69 N = 118 N = 16 N = 76 N = 1 N = 62 N = 86 N = 256
Exclusive (N = 38) 14 (20.3) 20 (16.9) 0 (0.0) 3 (3.9) 0 (0.0) 1 (1.6) 14 (16.3) 24 (9.4)
Complementary (N = 202 54 (78.3) 85 (72.0) 14 (87.5) 45 (59.2) 0 (0.0) 4 (6.5) 68 (79.1) 134 (52.3)
Weaned (N = 98) 1 (1.4) 11 (9.3) 2 (12.5) 28 (36.8) 1 (100.0) 55 (88.7) 4 (4.7) 94 (36.7)
Never (N = 4) 0 (0.0) 2 (1.7) 0 (0.0) 0 (0.0) 0 (0.0) 2 (3.2) 0 (0.0) 4 (1.6)
Malnutrition (N = 332)
- Underweight (weight for age z score)
WAZ  -2SD (N = 113) 23 (33.8) 36 (31.3) 9 (56.3) 25 (35.2) 1 (100.0) 19 (31.1) 33 (38.8) 80 (32.4)
WAS > -2SD (N = 219) 45 (66.2) 79 (68.7) 7 (43.8) 46 (64.8) 0 (0.0) 42 (68.9) 52 (61.2) 167 (67.6)
- Wasting (weight for height z score)
WHZ -2SD (N = 103) 26 (37.7) 32 (28.3) 5 (33.3) 26 (35.1) 1 (100.0) 13 (21.7) 32 (37.6) 71 (28.7)
WHZ > -2SD (N = 229) 43 (62.3) 81 (71.7) 10 (66.7) 48 (64.9) 0 (0.0) 47 (78.3) 53 (62.4) 176 (71.3)
- Stunting (height for age z score)
HAZ -2SD (N = 107) 10 (14.5) 37 (32.7)* 4 (26.7) 33 (44.6) 0 (0.0) 23 (38.3) 14 (16.5) 93 (37.7)**
(Continued )
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lowest rate of infection is associated with the absence of latrine (20.0%, 14/70). Nonetheless,
no significant difference was observed between the type of sanitation facilities (Table 2) and
the rate of RVA infection, on the overall and when considering each age group per se.
Breastfeeding and nutritional assessment
Breastfeeding practice was reported for 240 (70.2%) children included in the study (of whom
38 were exclusively breastfed and 202 had complementary breastfeeding), while 98 children
have already been weaned (28.7%) and 4 have never been breastfed (1.2%). RV infection was
significantly more frequent among children who were being breastfed at the time of enroll-
ment (82/240, 34.2%), compared to those that had already been weaned or had never been
breastfed (4/102, 3.9%)–p-value<0.001; OR = 12.7; 95% CI [4.518;35.786]. In relation to nutri-
tional assessment, 34.0% (113/332) of the enrolled children were moderate to severe under-
weighted, 31.0% (103/332) presented moderate to severe wasting and 32.2% (107/332) were
moderate to severe stunted. Overall, the percentage of underweighted children (z score-2)
was higher in children with RVA infection as compared to the non-infected (38.8% versus
32.4%, respectively, p = 0.280; CI [0.795; 2.209]), with a higher percentage of underweighted
children among RVA infected children between 12–24 months compared to negative cases in
the same age group (56.3% and 35.2%, respectively, p = 0.119; CI [0.786;7.116]) (Table 2).
However, none of these differences proved to be significant. Similarly, the percentage of
wasted children (z score-2) was higher in children with RVA infection compared to those
with a negative result for RVA antigen detection (37.6% and 28.7%, respectively, p = 0.126; CI
[0.89;2.513]), more evident for children under twelve months (p = 0.188), although also with-
out significant difference. In contrast, the overall proportion of children stunted (z score-2)
was significantly higher in children not infected with RVA (37.7%) compared to children with
RVA positive rapid test (16.5%) (p<0.0001), mainly considering the group age under 12
months (p = 0.006) (Table 2). Stunting continued to be significantly associated with the
absence of RVA infection (OR adj = 2.7, 95% CI: 1.390–5.158), considering age, gender and
infection by enteric pathogens other than RVA, when a multiple logistic regression model was
applied (Hosmer and Lemeshow test, p = 0.681).
Clinical features associated with RVA infection and hospitalization
With the exception of vomiting, that was significantly associated with RVA infection
(p<0.001), the percentage of children exhibiting AGE related symptoms (fever and duration
of diarrhea in days) and signs (lethargy, depressed fontanelle, sunken eyes and loss of skin
Table 2. (Continued)
Variable [0–12 [months [12–24 [months [24–59] months [0–59] months
RV(+) RV(-) RV(+) RV(-) RV(+) RV(-) RV(+) RV(-)
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
HAZ > -2SD (N = 225) 59 (85.5) 76 (67.3) 11 (73.3) 41 (55.4) 1 (100.0) 37 (61.7) 71 (83.5) 154 (62.3)
aFrom the 342 households, only those from Centro de Investigac¸ão em Sau´de de Angola (CISA) study area were included for analysis (N = 250).
b Water from the Central Water Treatment Plant (CWTP) included drinking water from taps in the yard, private tanks, public taps and piped water. Other
water sources, as the river, irrigation channel and borehole/tubewell were considered not being from the CWTP.
c Water treatment methods at home included the use of bleach or alum stone, boiling and filtration.
* p value (x2) = 0.006; OR = 0.348; 95%CI] 0.160–0.757[
** p value (x2) <0.001; OR = 0.327; 95%CI] 0.174;0.612[
https://doi.org/10.1371/journal.pone.0176046.t002
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elasticity) was similar in children with or without RVA infection (Table 3). Furthermore, from
data available on hospitalization regarding 302 children with AGE, it was observed that 81
(26.8%) were hospitalized, of which 24 (29.6%) were RVA positive cases (Table 3). Hospitaliza-
tion was non-significantly more common in RVA-positive cases than in RVA-negative cases
(32.4% versus 25.0%). Regarding the admission service, there was an excess of RVA positive
children at the emergency unit, which proved to be highly significant (p = 0.002) (Table 3).
Seasonality of RVA infection
During the study period, there was a substantial increase in diarrhea cases attended at the
BGH during the dry season, from May to October, with a peak in May 2013 (46 cases) (Fig 1).
RVA infection was detected throughout the study, with higher rates of RVA infection detected
in February (60.0%), March (40.0%), June (40.0%) and July (40.9%) 2013 (Fig 1).
Table 3. Clinical features and hospitalization of children with diarrhea attended at the Bengo General Hospital.
RV (+) RV (-) p-value
n (%) n (%)
Signs and symptoms Vomiting (N = 342) N = 86 N = 256
Yes (N = 175) 62 (72.1) 113 (44.1) <0.001*
No (N = 167) 24 (27.9) 143 (55.9)
Fever (N = 342) N = 86 N = 256
Yes (N = 255) 69 (80.2) 186 (72.7) 0.163
No (N = 87) 17 (19.8) 70 (27.3)
Duration of diarrhea in days (N = 333) N = 85 N = 248
1–3 days (N = 250) 68 (80.0) 182 (73.4) 0.432
4–5 days (N = 53) 10 (11.8) 43 (17.3)
 6 days (N = 30) 7 (8.2) 23 (9.3)
Lethargy (N = 325) N = 86 N = 239
Yes (N = 93) 29 (33.7) 64 (26.8) 0.222
No (N = 232) 57 (66.3) 175 (73.2)
Depressed fontanelle (N = 320) N = 86 N = 234
Yes (N = 48) 14 (16.3) 34 (14.5) 0.698
No (N = 272) 72 (83.7) 200 (85.5)
Sunken eyes (N = 329) N = 85 N = 244
Yes (N = 76) 22 (25.9) 54 (22.1) 0.480
No (N = 253) 63 (74.1) 190 (77.9)
Skin (lost of elasticity) (N = 318) N = 86 N = 232
Yes (N = 13) 5 (5.8) 8 (3.4) 0.349
No (N = 305) 81 (94.2) 224 (96.6)
Origin and referral of the patient Admission service (N = 342) N = 86 N = 256
Outpatient department (N = 164) 29 (33.7) 135 (52.7) 0.002**
Emergency unit (N = 178) 57 (66.3) 121 (47.3)
Hospitalization (N = 302) N = 74 N = 228
Yes (N = 81) 24 (32.4) 57 (25.0) 0.210
No (N = 221) 50 (67.6) 171 (75.0)
*OR = 3.3; 95%CI] 1.921–5.564[
**OR = 0.46; 95%CI] 0.274–0.759[
https://doi.org/10.1371/journal.pone.0176046.t003
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RVA genotypes: High prevalence of G1P[8] and G1P[6]
From the 86 RVA positive samples detected by rapid immunochromatographic assay, 76 (88.4%)
were analyzed by molecular biology methods (the remaining 10 samples had insufficient biologi-
cal material to proceed with the subsequent analysis). These RVA positive specimens (n = 76)
were then further characterized for the VP6, VP4 and VP7 genes by PCR protocols using specific
primers [31–34]. Of these, four samples proved to be negative by PCR. For the other 72 samples,
the G and P genotypes were determined and results are presented in Fig 2.
The most prevalent genotype combination was G1P[8] (47.2%, 34/72), followed by the
unusual G1P[6] (29.2%, 21/72) and G2P[4] (12.5%, 9/72). Only two G-types were found, G1
(83.3%, 60/72) and G2 (15.3%, 11/72), and for one sample it was not possible to determine the
G-type. Among the P-genotypes, P[8] was the most prevalent (47.2%, 34/72), followed by P[6]
(30.6%, 22/72) and P[4] (12.5%, 9/72). The determination of the P-type was not possible for 7
samples (9.7%, 7/72). When VP6 subgrouping was considered, it was observed that 84.7% (61/
72) of the specimens belong to SGII and only 15.3% (11/72) were assigned to SGI. The more fre-
quently detected genotypes G1P[8] and G1P[6] were all assigned to SGII, while G2P[4] to SGI.
Phylogenetic analysis of VP4 and VP7 genes
Randomly selected PCR amplicons from each identified genotype and from non-typable
strains were sent for sequencing. Phylogenetic trees were built with partial reference sequences
of VP4 and VP7 genes and are presented in Fig 3A and 3B. The RVA sequences obtained in
this study clustered together in well-defined monophyletic groups with reference sequences,
with significant bootstrap values (92%), defining very robust VP4 and VP7 genotypes.
Fig 1. Seasonality of rotavirus a antigen detection in stool samples of children with diarrhea attended at the Bengo
General Hospital.
https://doi.org/10.1371/journal.pone.0176046.g001
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The Angolan VP4 sequences (n = 17) were assigned to P[4] genotype lineage V (n = 2), P[6]
genotype lineage Ia (n = 12) and P[8] genotype lineage III (n = 3) (Fig 3A). The P[4] strains tightly
clustered with sequences of African origin, namely from Angola (KT225674, KT225677) and Bur-
kina Faso (JX154455). The P[6] sequences clustered with sequences from Angola (KT225696,
KT225681, KT225711) and other sub-Saharan African countries, such as São Tome´ and Prı´ncipe
(STP) (KF356342) and Burkina Faso (JN116516), as well as with other reference sequences from
Brazil (JQ693567) and the USA (JF460815). P[8] sequences, besides with Angolan sequences
(KT225720, KT225724, KT225723), and from other African countries, such as STP (KF356333),
Malawi (AJ302147) and South Africa (KF636182), clustered with internationally well character-
ized strains from USA (HM773747), Belgium (HQ392119) and Bangladesh (DQ146652). The P
[8] sequences from Bengo clustered all together in the same lineage (3), different from the line-
ages of the two vaccines Rotarix (lineage 1) and Rotateq (lineage 2).
The Angolan VP7 sequences (n = 14) were assigned to only two genotypes, G1 (lineage I)
(n = 11) and G2 (lineage IIa) (n = 3) (Fig 3B). The G1 (lineage I) monophyletic group included
the Bengo sequences under study and other sequences from Angola (KT225660, KT225654,
KT225650, KT225657, KT225658) and from other African countries, like STP (KF356355), the
Democratic Republic of the Congo (KC510182) and South Africa (KF636184). This lineage (I)
does not include the two vaccine strains Rotarix (assigned to lineage II) and Rotateq (assigned
to lineage III). The three sequences classified as G2 were clustered in lineage IIa with other
sequences from Angola (KT225664, KT225661) and Burkina Faso (JX154537).
Discussion
Although licensed since 2006, rotavirus group A (RVA) vaccines started to be introduced with
GAVI support in African countries only since the end of 2011, Sudan being the first designated
country. Presently, as many sub-Saharan African countries are still introducing the RVA vac-
cine in their Expanded Programme on Immunization (EPI), epidemiological studies on RVA
burden and disease are still highly important.
In Angola, a leading country in diarrheal diseases, the first studies on this issue were initi-
ated in 2012 in four provinces [22] but neither contemplating Bengo province, nor a year-
Fig 2. Distribution of G and P genotypes of rotavirus a strains in children with diarrhea attended at the
Bengo General Hospital.
https://doi.org/10.1371/journal.pone.0176046.g002
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round sampling. To overcome this, between September 2012 and December 2013, a cross-sec-
tional study was conducted at the Bengo General Hospital (BGH) in Caxito, Bengo province,
Angola. RVA detection rate (25.1%) was considered within the range of other African coun-
tries [16] although lower than the total detection rate reported for other provinces of the coun-
try (35%) [22]. The AdV detection rate was much lower (3.8%), but similar to the rates
registered in other sub-Saharan African countries such as Tanzania [38] and the Republic of
the Congo [39] before RVA vaccine introduction.
In addition to RVA infection rate (and genotype distribution), we have also investigated
several socio-demographic characteristics of the target population trying to get a better insight
of the general epidemiology of this virus within this population in Angola.
As shown in most of the African studies including neighboring countries such as Botswana
[40] or the Republic of the Congo [39] or considering RVA epidemiology in other provinces of
Angola [22], the group of children more significantly affected by RVA AGE was below 12
months of age. This shows a shift of RVA infection towards earlier age in most African settings
studied so far, the age factor being considered determinant for vaccination schedule set up,
further showing the importance of neonatal vaccine administration in African countries in
order to prevent RVA disease [41].
Considering earlier reports which associated maternal literacy and an increased level of
education with protection against child mortality and diarrheal diseases [42, 43], we looked
into these socio-demographic characteristics, but similarly to Mozambique [44], no correlation
was found. Although some studies [45] point towards a correlation between the level of
Fig 3. Phylogenetic analysis of the VP4 (A) and VP7 (B) genes from RVA identified strains. (A) Genotypes P[6]
(closed circles), P[4] (closed squares), and P[8] (closed diamonds) (B) G1 (closed circles) and G2 (closed squares)
detected in Bengo, Northwestern Angola. The analysis involved, respectively for VP4 and VP7, 53 and 46 nucleotide
sequences and a total of 468 and 627 positions in the final datasets. Phylogenetic analysis was performed using a
distance-based neighbour-joining method, based on the Kimura 2-parameter model, with 1,000 bootstrap resamplings
(percent bootstrap values of more than 70 are indicated at each node). The tree is drawn to scale, with branch lengths
proportional to the evolutionary distances.
https://doi.org/10.1371/journal.pone.0176046.g003
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maternal education and some markers of child health, a causal relationship is not unequivo-
cally established.
The high burden of diarrheal diseases, especially affecting developing countries, was previ-
ously associated with limited access to drinking water and poor sanitation conditions, factors
that facilitate transmission of enteric pathogens [46] thus of RVA. Considering the Global
Enteric Multi-Center Study (GEMS) from 2012, in sub-Saharan Africa, 83% of urban and 49%
of rural populations have access to improved water sources, while the numbers are much
lower when access to improved sanitation facilities is considered (43% of urban and 23% of
rural populations) [46]. Improving these conditions became a strong priority and one of the
Millennium Development Goals of the WHO. In this study, 28.7% (98/342) of the inquired
mothers/caretakers declared to use water from the local Central Water Treatment Plant
(CWTP) exactly as supplied, while 59.9% (205/342) applied a domestic treatment, including
the use of bleach or alum stone, boiling and/or filtration, to the water provided for the house-
hold, irrespective of the source (the CWTP or other sources. i.e., directly from rivers, irrigation
channel or boreholes). However, the procedure of home-treatment of drinking water is very
difficult to verify (almost impossible to check for the boiling time, if using the correct bleach
concentration or type of filters, how to combine with alum stone, etc.) and presumably not
always correctly implemented. That is one of the reasons why the results obtained should be
taken very cautiously. It is noteworthy that 11.4% (39/342) of the children drank untreated
water. As stated before, none of the categories considered seemed to be significantly associated
with RVA infection in this study. Comparing proportions of RVA-positive and -negative chil-
dren of different age groups, no significant association emerged concerning the drinking
water source and also the treatment method applied. The lowest RVA detection rate of 20.5%
(8/39) was obtained in the group using water originating from alternative sources to the
CWTP, with no treatment, and the highest RVA detection rate of 27.6% (27/98) in the group
using water from the CWTP with no additional home treatment. Although at first this could
mean that children drinking water from CWTP were the most exposed to RVA infection, our
statistical analysis does not seem to firmly support that statement.
Despite the absence of any significant differences between the rates of RVA infection by the
type of sanitation facilities reported (Table 2), on the overall and when considering each age
group, it was interesting to observe that RVA detection rate is the lowest in the absence of
latrines (20%, 14/70) and the highest with the use of public latrines (27.8%, 35/126), irrespec-
tive of the presence of running water. This could be explained by the fact that latrine sharing
creates unsanitary conditions (and keeping the community toilet clean could be difficult under
the circumstances), thus creating conditions for a more widespread fecal-oral transmission of
enteric pathogens and in this case RVA. To overcome this, proper cleaning and disinfection,
implementation of hygienic measures as well as healthy sanitation behavior should be pro-
moted and implemented at household level and particularly at improved public sanitation
facilities (use of latrines with running water).
Although no significant association of RVA infection and the drinking water source, water
treatment or furthermore hygiene practices related to sanitation facilities of the family
inquired was found, we would like to highlight the importance of implementing appropriate
and regular “home” treatment of the drinking water, adequate storage and pipeline distribu-
tion for the water of the CWTP. We cannot disregard the putative impact of the current poor
sanitation conditions on the transmission of other enteric pathogens (not addressed in this
study).
The interference of maternal antibodies in breast milk, one of the putative causes that has
been put forward to explain RVA vaccine lower efficacy in developing countries, was studied
in sub-Saharan settings before [44] and after the vaccine introduction [47]. Recent post-
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vaccination studies in Zambia and South Africa suggested that lower immunogenicity of
Rotarix vaccine could be explained partially by exposure to high antibody titres in breast milk
and early exposure to wild-type rotavirus infections [47, 48]. Some pre-vaccination studies
from developed [49] as well developing countries [50] indicated that breastfeeding protects
infants against AGE caused by RVA. However, our results confirmed the hypothesis presented
by a recent study from Mozambique [44] in which no significant protective effect against RVA
infection could be associated with breastfeeding.
Rotavirus infection and malnutrition are common in children in the developing countries,
thus we investigated the nutritional status of children enrolled. A recent study in Bangladesh
showed that a better nutritional status is positively associated with RVA diarrhea in the first
three years of life [51]. However, in earlier studies from Africa, wasting was associated with
more severe forms of diarrhea and RVA infection [52], showing that the impact of nutritional
status on susceptibility to RVA diarrhea is a controversial subject, far from being completely
understood. In our study, signs of malnutrition were quite evident, in a high proportion of the
children enrolled. Although underweight and wasted children seemed more prone for RVA
infection, no significant association was established. On the other hand, stunting (particularly
in children below 12 months of age) was significantly more common in children not infected
with RVA. Despite the differences observed, we cannot exclude the influence of other factors
affecting nutritional status such as maternal stunting and birth weight that were not consid-
ered in our study.
In terms of clinical features potentially associated with RVA infection, only vomiting was
highly significantly associated with RVA infection. This association was also shown before in
other sub-Saharan African countries [52]. As frequent as it may seem in RVA-infected chil-
dren, clinical management of vomiting requires a special attention, since prolonged vomiting
in these small, undernourished, children may rapidly deplete the body of water (dehydration),
profoundly impacting the electrolyte equilibrium.
Hospitalization for diarrheal diseases and specifically for RVA infection has been associated
with a significant burden to the health systems and households in developing countries [53].
In our study, we observed that the percentage of hospitalization in children with RVA infec-
tion (32.4%) was higher than in RVA negative children (25.0%), and that there was a highly
significant excess of RVA positive children at the emergency unit, when considering the
admission type for the AGE cases at the BGH. Before RVA vaccine introduction, studies to
evaluate its economic impact were undertaken. The great benefit of RVA vaccination, e.g. for
developing, GAVI-eligible countries, has been shown [54] namely in the reduction of the bur-
den of disease in already fragile healthcare facilities.
Although several studies from sub-Saharan African countries point for a higher prevalence
of RVA infection in the dry season [20, 39, 55], no seasonality of RVA infection was evident in
our year-round study. Nevertheless, an apparent increase in diarrhea cases admitted at the
BGH during the dry season seems plausible (Fig 1), showing the possibility of other enteric
agents being involved as etiologic agents.
Currently, a great regional and temporal variety of RVA strains have been reported world-
wide [21]. Their relative importance before and after RVA vaccine introduction, especially in
developing countries, where concerns aroused about strain replacement by emergence of
novel strains which could lower vaccine efficacy, has been acknowledged. Five viral strains
were reported as most prevalent globally before RVA vaccine introduction in the national
immunization programmes, the most prevalent being G1P[8], identified as dominant also in
the scope of this study (47.2%, 34/72). On the overall, this strain is considered as responsible
for more than 50% of RVA infections in children and is part of both licensed vaccines (Rotarix
RVA prevalence and genotype distribution in Bengo, Angola
PLOS ONE | https://doi.org/10.1371/journal.pone.0176046 April 19, 2017 14 / 19
and Rotateq), but considering AFROROTANET data a lower detection rate (14–31%) was
observed in African countries [16].
Another identified genotype, G1P[6], the second most detected in our study (29.2%, 21/72)
has been shown as an emerging strain in recent years. Considering the period 2007–2012, after
the RVA vaccines being licensed globally but before introduction in most of African countries,
P[6]-type were increasingly detected in Africa, with G1P[6] detection rate established as 6%
[21]. After RVA vaccines introduction in African countries, this strain became one of the six
most prevalent strains throughout the continent [56], fact that our results seem to corroborate.
Finally, G2P[4], a strain considered predominant as before as after RVA vaccine introduc-
tion, registered a detection rate of 12.5% (9/72) in our study. This detection rate is comparable
with data reported globally before vaccine introduction (10.6%) [15] but also afterwards (13%,
between 2007–2012) [21], as well as with reports from African countries during the period
2007–2013 (10.5%) [56].
The G and P-types identified in this study clustered together respectively with other G1 and
G2, and P[4], P[6] and P[8] strains, from sub-Saharan African countries and also international
references, sharing a high nucleotide identity with strains detected previously in other prov-
inces of Angola [22]. Albeit the long geographic distances involved, when comparing sampling
sites in the two studies, there is a remarkable genetic homogeneity within each genotype, both
for VP4 and for VP7 (Fig 3A and 3B). The limited number of genotypes found in this study
probably reflects a limited number of recent introductions in the study area of Bengo province
in Angola. The identified sequences were assigned to genotypes and furthermore to lineages
(e.g. GI-I and P[8]-III) although these lineages are different of the ones included in currently
used RVA vaccines (G1-II for Rotarix and G1-III for RotaTeq, P[8]-I for Rotarix and P[8] -II
for RotaTeq).
Although P[6] was initially considered of zoonotic origin [18] and assigned to SGI [18, 57],
the combination G1P[6] was shown to belong to SGII, as also shown before in the previous
Angolan study [22], and in the same subgroup as the well-studied G1P[8].
Finally, in Africa, P[6] RVA infection, described as emerging, has been associated with host
genetic factors (e.g. Lewis phenotype), apparently infecting more frequently Lewis-negative
children [58]. This Lewis phenotype was also shown to be more common in many African
populations than in Caucasian populations of Europe and North America, and thus this fact
could explain the increase of this strain detection rate in Africa. Further host genetics studies
could elucidate the P[6] association to Lewis-negative phenotype and get an insight on future
vaccine efficacy in this population, known the lower efficacy of RVA vaccines in low and mid-
dle-income African populations.
Conclusions
In this hospital-based study, aiming to provide baseline information before vaccine introduc-
tion in Angola, the detection rate of RVA infection and genotype distribution in the Bengo
province have been investigated. A high detection rate was registered (25.1%) and the most
prevalent genotypes were shown to be G1P[8] (47.2%), followed by G1P[6] (29.2%) and the
less detected G2P[4] (12.5%). The natural variability of RVA strains in Africa was demon-
strated by many studies including the present one, stressing the fact that epidemiological sur-
veillance prior and post RVA vaccine introduction would be crucial to detect potential
emergence of new genotypes. Apart from age and age distribution, there was no statistically
significant association between RVA infection and any other socio-demographic variable ana-
lyzed. Regarding clinical features associated with RVA infection, only vomiting proved to be
significantly associated with RVA infection. Although there was an increase in diarrhea cases
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registered at the BGH during the dry season, no seasonality of RVA infection was proved dur-
ing the study period.
Limitations
• Reduced amount of collected sample thus not allowing to genotype all RVA positives
detected by immunochromatographic rapid test.
• According to the inclusion criteria set up, children presenting with vomiting only were not
enrolled in this study, which may impact on disease burden, underestimating the RVA rate
of infection.
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Background: Giardia lamblia is a pathogenic intestinal protozoan with high prevalence in developing countries,
especially among children. Molecular characterization has revealed the existence of eight assemblages, with A
and B being more commonly described in human infections. Despite its importance, to our knowledge this is
the first published molecular analysis of G. lamblia assemblages in Angola.
Methods: The present study aimed to identify the assemblages of G. lamblia in children with acute diarrhoea present-
ing at the Bengo General Hospital, Angola. A stool sample was collected and microscopy and immunochromato-
graphic tests were used. DNA was extracted and assemblage determination was performed through amplification of
the gene fragment ssu-rRNA (175 bp) and β-giardin (511 bp) through polymerase chain reaction and DNA sequencing.
Results: Of the 16 stool samples screened, 12 were successfully sequenced. Eleven isolates were assigned to
assemblage B and one to assemblage A. Subassemblage determination was not possible for assemblage B,
while the single isolate assigned to assemblage A was identified as belonging to subassemblage A3.
Conclusion: This study provides information about G. lamblia assemblages in Bengo Province, Angola and may
contribute as a first step in understanding the molecular epidemiology of this protozoan in the country.
GenBank accession numbers for the ssur-RNA gene: MF479750, MF479751, MF479752, MF479753,
MF479754, MF479755, MF479756, MF479757, MF479758, MF479759, MF479760, MF479761.
GenBank accession numbers for the β-giardin gene: MF565378, MF565379, MF565380, MF565381.
Keywords: Angola, Children, Diarrhoea, Genotyping, Giardia lamblia, Hospital
Introduction
Giardia lamblia is a common intestinal parasite infecting a broad
range of vertebrate species, including humans.1 This parasite
has a global distribution and it is estimated that 280 million
people are infected worldwide,2,3 with 200 million people pre-
senting symptomatic giardiasis in the developing countries.2,4
Children living in developing countries with poor hygiene and
© The Author(s) 2018. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
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sanitation conditions5 are more vulnerable to the clinical conse-
quences of G. lamblia infection.6 The harmful effect of giardiasis
on growth and development in children has been observed in
several studies and the potential effects of chronic malnutrition
on cognition, intelligence and psychomotor development have
also been described.7,8 Several studies have shown that malnu-
trition in children can be an important consequence of Giardia
infection.9–12 However, there are few published studies in recent
years exploring the association of the assemblage of G. lamblia
with infant nutritional status.12,13
Currently G. lamblia is considered a species complex, compris-
ing eight assemblages (A–H).6 The majority of these assemblages
are host specific, but only assemblages A and B are known to
infect humans,14,15 with assemblage B being described as more
common.3 A recent study reported for the first time assemblage
E in humans in Australia.16 However, the number of molecular
epidemiological studies of giardiasis in humans is not enough to
determine geographic or socio-economic differences in the distri-
bution of assemblages A and B.6
The severity of the disease is determined by the interaction
among parasite’s virulence, host’s nutritional and immuno-
logical status, nature of the intestinal microflora and the pres-
ence or absence of other pathogenic intestinal agents.6
Although the different assemblages of G. lamblia may eventu-
ally produce different toxins or metabolic products that contrib-
ute to their pathogenicity17 or differences in antigenic variation
and host specificity,18–20 studies on the possible association
between the genetic groups of G. lamblia and their virulence
(defined by the probability of causing diarrhoea and other clin-
ical symptoms) continue to show inconsistent results.6,21,22
Although several studies have shown a correlation between G.
lamblia infections belonging to assemblage B with more severe
symptoms,23–26 others have correlated the most severe symp-
toms with assemblage A.20,22
An interesting observation raised by Almeida et al.21 was
that there seems to be a relationship between the molecular
marker used in the study and the assemblage believed to be
more aggressive. These investigators found that almost all
genotyping studies based on the ssu-rRNA and tpi genes support
the idea that assemblage A is associated with symptomatic dis-
ease, whereas studies based on the bg and gdh genes asso-
ciated the symptomatology with assemblage B.21
The occurrence and spread of giardiasis in human popula-
tions is an emerging public health problem around the world.
Molecular studies are essential to clarify the importance of local
Giardia assemblages.27
In Angola, there is limited information available concerning
infection with intestinal parasites and only in recent years
have some studies been published.28–31 Two of these studies
report G. lamblia as being the most prevalent intestinal proto-
zoan in children from the province of Bié and the city of
Lubango (Huíla province).28,31 We have no knowledge of pre-
vious studies on molecular characterization of G. lamblia car-
ried out in Angola.
The aim of the present study was to perform a genetic char-
acterization of G. lamblia, using polymerase chain reaction (PCR)
and DNA sequencing, in children with diarrhoea attending the
Bengo General Hospital.
Materials and methods
Population and study design
This study is part of a cross-sectional study conducted
between September 2012 and December 2013 at the Bengo
General Hospital, located in Caxito, the capital city of Bengo
Province, 60 km northeast of Luanda, Angola.32 The study
aimed to investigate the aetiology of diarrhoea in children
younger than 5 y attending the paediatric emergency service
or the hospital outpatient paediatric unit with diarrhoea
(three or more loose or liquid stools per day).32 Children
receiving antibiotics or antiparasitic drugs were excluded in
order to avoid false negatives. A survey including sociodemo-
graphic characterization, information on breastfeeding practices,
water source and sanitation conditions was applied by the clin-
ical staff. Symptomatology in the previous 10 days (diarrhoea,
vomiting, fever and bloody diarrhoea) was reported by care-
givers. Anthropometric measurements (weight and length/
height) were assessed to calculate anthropometric indices
expressed as a Z-score for each child.33
The study protocol was approved by the Ethics and Committee
of the Angolan Ministry of Health and the Ethics Committee of the
Instituto de Higiene e Medicina Tropical, Portugal.Written informed
consent and voluntary consent was obtained from parents or legal
guardians prior to the inclusion of each child.
Stool sample collection and initial diagnosis of
G. lamblia
A single stool sample per child was collected to a sterile con-
tainer provided by the clinic staff. Once delivered to the labora-
tory, stool samples were immediately processed for microscopic
identification of cysts and/or trophozoites of G. lamblia (direct
examination with saline and iodine and a concentration method
[ParasiTrap system, Biosepar, Mühldorf, Germany]) followed by
the detection of Giardia antigen through immunochromato-
graphic rapid tests (RIDAQUICK Cryptosporidium/Giardia Combi,
R-Biopharm, Darmstadt, Germany). Microscopy and immunochro-
matographic rapid tests were performed in 344 and 338 children,
respectively. Positive samples by at least one of the methods
applied were preserved at −20°C for DNA extraction (Figure 1).
DNA extraction
DNA was extracted from G. lamblia–positive stool samples preserved
at −20°C using a QIAamp DNA Stool Mini Kit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions, except for
the final step where 100 μl of the elution solution were used.
DNA amplification
The DNA of the extracted samples was amplified through PCR,
using primers targeting the small subunit ribosomal RNA (ssu-
rRNA)34,35 (Figure 1). The primers used were RH11: 5′-CAT CCG
GTC GAT CCT GCC-5′ and RH4: 5′-AGT CGA ACC CTG ATT CTC CGC
CCA GG-3′ for the first reaction and GiarF: 5′-GAC GCT CTC CCC
AAG GAC-3′ and GiarR: 5′-CTG CGT CAC GCT GCT CG-3′ for the
C. Gasparinho et al.
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Figure 1. Molecular characterization of Giardia lamblia detected by microscopy and/or rapid antigen test in stool samples from children with diarrhoea attending the Bengo General
Hospital, Angola.
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secondary PCR.34,35 All samples successfully amplified for ssu-
rRNA were posteriorly amplified for the β-giardin (bg) loci
(Figure 1). The primers used were G7: 5′-AAG CCC GAC GAC CTC
ACC CGC AGT GC-3′ and G759: 5′G AG GCC GCC CTG GAT CTT CGA
GAC GAC-3′ for the first reaction and G8: 5′-GAA CGA ACG AGA
TCG AGG TCC G-3′ and G9: 5′-CTC GAC GAG CTT CGT GTT-3′.36,37
Amplification reactions were performed using 2 μl of DNA
template in a final volume of 25 μl, using illustra PuReTaq
Ready-To-Go PCR beads (GE Healthcare, Little Chalfont, UK).
Both positive (DNA isolated from the Portland-1 strain; ATCC
30888D, ATCC-LGC Promochem, Manassas, VA, USA) and nega-
tive controls (no template added) were included in each series
of PCRs. PCR products were visualized on 2% agarose gels
stained with ethidium bromide.
DNA sequence analysis
For sequence analysis, PCR products of amplified samples were
purified using illustra GFX PCR DNA and the Gel Band Purification Kit
(GE HealthCare) according to the manufacturer’s instructions. DNA
sequencing reactions were carried out in both directions for ssu-
rRNA (175 bp) and β-giardin (511 bp) PCR-generated fragments.
Sequences obtained (75.0% [12/16] for ssu-rRNA and 80.0%
[4/5] for β-giardin) were aligned with previously published
sequences of G. lamblia isolates available in the GenBank data-
base (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using BLAST for
assemblage determination and Clustal Omega (http://www.ebi.
ac.uk/Tools/msa/clustalo/) for subassemblage determination.
Results
Microscopic identification and antigen detection of G. lamblia was
performed in a total of 338 children, of whom 73 (21.6%) were
positive: 40 (54.8%) were only detected through immunochroma-
tographic tests, 2 (2.7%) only by microscopy and 31 (41.2%)
through both methods (Figure 1). DNA extraction was performed
in 63 positive samples, of which 16 were amplified for the ssu-
rRNA gene fragment and 12 were successfully sequenced
(Figure 1). All analysed samples belonged to assemblage B (11/
12), except one that belonged to assemblage A (1/12) (GenBank
accession numbers: MF479750, MF479751, MF479752, MF479753,
MF479754, MF479755, MF479756, MF479757, MF479758,
MF479759, MF479760, MF479761) (Table 1). These samples were
also amplified for the bg gene fragment, for subassemblage
determination, but only four sequences had enough quality for
sequencing, three belonging to assemblage B and one to assem-
blage A (GenBank accession numbers: MF565378, MF565379,
MF565380, MF565381) (Table 1). It was not possible to determine
the subassemblages belonging to assemblage B due to the high
polymorphism observed in the chromatogram. However, the iso-
late belonging to assemblage A was found to belong to the A3
subassemblage (Table 1).
Discussion
To our knowledge this is the first study on the molecular charac-
terization of G. lamblia in Angola. Despite the small number of
the samples studied, in the present study assemblage B was
clearly predominant (93.8%), with only one sample assigned to
assemblage A. The prevalences of assemblages A and B are dif-
ferently distributed among and within countries, although there
is no solid evidence that explains this geographic variation
around the world.22 Studies conducted in Mexico, Brazil and
Colombia have identified high frequencies of assemblage A,
while studies in Nicaragua and Argentina have shown that
assemblage B predominates in these countries.38–40 In South
and Southeast Asia, including India, assemblage A seems to
predominate, just as in Europe.41–43 Reports from Africa have
also shown high prevalences of assemblage B in countries such
as Egypt (80%), Rwanda (85.9%) and Morocco (81.8%).12,44,45
It has been suggested that assemblage A is associated with
zoonotic transmission, since it is commonly found in a wide range
of animals, including in a large number of cattle.6,37,46 Assemblage
B was associated with a higher rate of cyst shedding compared
with assemblage A in a study conducted in Brazilian children,
which may contribute to a greater spread and consequently a
higher incidence of assemblage B.47 In this study, assemblage B
was more common in the studied children and this could indicate
that the major transmission route was more likely to occur
between humans. Indeed, in the studied population about 20% of
the households did not have a latrine, which may contribute to G.
lamblia faecal–oral transmission between humans.32 Furthermore,
there are no clear geographic differences or socio-economic fac-
tors responsible for the distribution of both assemblages.6,37,48
Assemblage B is considered genetically diverse and the iso-
lates present a high substitution rate that makes the real subas-
semblage patterns difficult to determine.49 The difficulty in
defining subassemblages in assemblage B is described in several
studies.3,39,50,51
This study has some limitations. This is a hospital-based
study that included children less than 5 years of age with diar-
rhoea, thus the results on the prevalence of G. lamblia and
respective assemblages cannot be generalized to the entire
population. To overcome this limitation, since infection by this
protozoan is mainly asymptomatic,52,53 a case–control design
would be interesting in order to compare the prevalence of
G. lamblia and its assemblages with other enteric pathogens in
participants with diarrheal and non-diarrheal stools. Moreover,
in diarrheal samples the non-resistant forms of this pathogen
(trophozoites) are predominant, which can impair the micro-
scopic diagnosis. The use of immunochromatographic tests
was able to prevent this problem. It was not possible to
assemblage some stool samples, probably due to freezing and
thawing of the samples since their initial collection, which may
contribute to DNA degradation. The limited number of samples
studied, with only one assemblage A being detected, precludes
investigating the differences between assemblage A and B in
relation to symptomatology, malnutrition and sociodemo-
graphic conditions.
Despite the limitations mentioned above, we believe that an
important contribution was made through the identification of
G. lamblia assemblages circulating in children attending the
Bengo General Hospital, Angola.
Future investigations are needed to clarify the current gen-
etic diversity and better understand the importance of local
G. lamblia assemblages. Studies with a larger number of sam-
ples, also including information about the seasonality of G.
C. Gasparinho et al.
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Table 1. Giardia lamblia assemblages identified in children with diarrhoea attending the Bengo General Hospital, Angola (N=12) and respective descriptions of sample collection
(month/year), gender (male/female), age in months, reported symptomatology (vomiting, fever and lethargy), type of enteric infection identified according to the enteric
pathogens detected (simple: the child was infected only by G. lamblia; multiple: the child was infected by G. lamblia and other enteric pathogens), laboratory results of
microscopy and rapid test detection methods performed.
Identification Sociodemographic
characterization
Symptomatology Enteric
infection
Diagnosis of Giardia lamblia
Number Collection date
(month, year)
Gender Age
(months)
Vomiting Fever Lethargy Type Microscopy Rapid test Molecular assemblages
ssu GenBank
accession
nos.
bg GenBank
accession
nos.
1 February 2013 Male 11.4 Yes Yes No Multiple Negative Positive B MF479750 n.a.
2 April 2013 Female 10.5 Yes Yes Yes Simple Negative Positive A MF479751 A3 MF565378
3 May 2013 Female 8.6 No Yes Yes Multiple Negative Positive B MF479752 B* MF565379
4 May 2013 Male 11.3 Yes Yes No Multiple Negative Positive B MF479753 B* MF565380
5 May 2013 Female 13.1 No Yes No Multiple Negative Positive B MF479754 n.a.
6 June 2013 Female 12.8 No Yes Yes Multiple Positive Positive B MF479755 n.a.
7 August 2013 Male 9.3 No Yes No Multiple Positive Positive B MF479756 n.a.
8 August 2013 Female 27.4 No No No Simple Positive Positive B MF479757 B* MF565381
9 August 2013 Female 14.2 No No No Multiple Positive Positive B MF479758 n.a.
10 August 2013 Male 27.3 Yes Yes No Multiple Positive Positive B MF479759 n.a.
11 October 2013 Female 30.9 No Yes Yes Simple Positive Positive B MF479760 n.a.
12 December 2013 Male 17.3 No Yes No Multiple Positive Positive B MF479761 n.a.
*Subassemblage determination not possible.
n.a.: not applicable.
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lamblia prevalence and the zoonotic potential of this proto-
zoan, would aid our understanding of the epidemiology of giar-
diasis in Angola, contributing to better definition of key
priorities in its control.
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Abstract 
Background:  Malnutrition and intestinal parasitic infections are a public health problem 
in children in Angola. A four-arm randomised parallel trial was longitudinally conducted 
to investigate if a single annual dose of albendazole (ALB) or a four-monthly test-and-
treat (FMTT) intestinal parasites approach at individual or household levels improve 
nutritional outcomes of children (2-5 years old) in Bengo, Angola. 
Methods and Findings: Children infected with at least one pathogenic intestinal parasite 
n=121) were enrolled and randomly assigned (1:1:1:1) to: annual single dose of ALB at 
individual level (Arm 1, n=29); annual single dose of ALB at household level (Arm 2, 
n=31); FMTT approach at individual level (Arm 3, n=31); and FMTT approach at 
household level (Arm 4, n=30). Growth was assessed by height, weight, height-for-age 
(HAZ), weight-for-height (WHZ), weight-for-age (WAZ), and mid-upper arm 
circumference Z-score (MUACZ) at baseline, 4, 8, 12, 16, 20, and 24 months. Intention-
to-treat analysis was done after a missing analysis. A non-parametric approach (nparLD), 
mixed effect models (LMM), and generalized estimating equations (GEEs) were used. At 
entry, children (26.6±4.86 months) were mainly infected by Giardia lamblia (57%) and 
Ascaris lumbricoides (26%). After two years, models provided no evidence or weak 
evidence of interventions on growth. Mean of HAZ, WAZ and MUACZ remained 
negative across arms, while WHZ registered positive means. Significant effects of 
intervention on height and WHZ was noted in GEE models. Children from A2, A4, and 
A3 were estimated to have 2.1 cm (SE=1.32), 1.4 cm (SE=1.44) and 0.3 cm (SE=1.26) 
more than those from A1. LMM provided similar estimates. The duration of the study 
and the sample size may have been insufficient to observe differences. 
Conclusions: Although none of strategies stood out significant effect on nutrition 
outcomes, findings highlight the burden of malnutrition in pre-school children. Future 
studies should consider multiple factors contributing to malnutrition (e.g., inadequate 
food, water, hygiene and sanitation, and health care services) in order to improve 
nutritional status of children. 
Trial registration: ISRCTN-72928001.  
Introduction 
Malnutrition is the underlying cause of 45% of deaths in children under five years 
[1]. Most of these preventable deaths occur due to poor living conditions, reduced access 
to adequate nutrition, water, sanitation, basic health services, and treatment of infectious 
diseases [1]. Globally, 151 million children are stunted and 50 5 million are diagnosed 
with wasting [1], with Africa ranking highest in prevalence of stunting (30.3%) [1]. 
Reducing by 40% the number of under-five stunted children between 2010 and 2025 is 
included in the second Sustainable Development Goal [1, 2]. 
Soil-transmitted Helminth (STH) infections, caused by Ascaris lumbricoides, Trichuris 
trichiura and the hookworms Necator americanus and Ancylostoma duodenale, have 
been associated to impaired growth, deficit cognitive development and reduced education 
attendance [3]. Generally, individuals with low-to-moderate infections are asymptomatic, 
whereas heavy infections are associated with morbidity [3]. The World Health 
Organization (WHO) recommends deworming, or preventive chemotherapy, with 
albendazole (ALB) or mebendazole of pre-school age children (PSAC) and school-age 
children (SAC) in  20.0%) to achieve a coverage of 
75% until 2020 [3]. 
Angola faced a 40-year period of war until 2002, with a massive destruction of 
infrastructures, forced migration, increased malnutrition, diseases and deaths [4]. Ten 
years later, in 2012, the government made a commitment to reducing stunting and wasting 
to less than 5% and underweight to less than 10% in children under-five years until 2021 
[5]. However, according to the Multiple Indicator Health Survey 2015-2016, a large 
proportion of children are still suffering from stunting (37.6%) and wasting (4.9%) [6]. 
In Bengo province, Dande municipality, malnutrition was previously reported as one of 
the major causes of deaths of under-five children between 2009 and 2012 [7]. In 2010, a 
community-based study registered a prevalence of STH in PSAC of 22.3%, as well in 
SAC (31.6%) and mothers (28.0%) [8]. Additionally, intestinal infections caused by 
protozoa such as Giardia lamblia (21.6%) were also diagnosed in a hospital-based study 
conducted in 2013 in Bengo [9]. To reduce morbidity from STH infections, the national 
strategy includes preventive chemotherapy with ALB in SAC, along with access to better 
hygiene and water conditions [10]. However, a single dose regimen of ALB has low 
efficacy against T. trichiura (cure rate of 28%) and longer-regimens would be needed to 
treat Strongyloides stercoralis and G. lamblia, previously associated with growth 
impairment [11-14].  
Although preventive chemotherapy has been shown to impact overall STH prevalence 
levels in a variety of countries, the health benefits and cost-effectiveness of deworming 
have been questioned by some. According to some systematic reviews, including the most 
recent Cochrane Systematic Reviews published in 2015, there are no benefits of 
deworming children living in endemic areas for STH at the community level (infected 
and non-infected), including growth and haemoglobin levels [15, 16]. Similarly, no 
significant effect of routine deworming was found on weight gain and on mortality of two 
million PSAC in India [17]. Conversely, analysis of more than 320.000 PSAC from 45 
countries found that those who were dewormed were less likely to be stunted and anaemic 
[18]. Results are controversial and it is clear that further research with new approaches 
are needed [19]. This longitudinal study was implemented to investigate if treatment of 
intestinal parasites (with or without previous diagnosis) in two levels (individual or 
household) impacts on nutritional status of children 2-5 years old, after a two-year follow-
up. Conducting at individual versus household level is important to understand if 
including all household members can benefit children growth by preventing transmission 
among family. Moreover, we considered the inclusion of children older than 24 months 
of age, not only because this is the age at which children become more frequently infected 
with intestinal parasites, but also to investigate the contribution of these different 
strategies in reducing chronic malnutrition beyond the well- of 
opportunity [20].  
Material and Methods 
Study design, setting and participants 
This four-arm randomised parallel trial was conducted in the Dande Health and 
Demographic Surveillance System (HDSS) study area, implemented by the Health 
Research Centre of Angola (CISA), which includes Caxito, Mabubas, Úcua, and a small 
part of Kikabo communes, located in Dande municipality, Bengo province, Angola [21]. 
Enrolment was conducted between December 2013 and December 2014 at three 
outpatient health units in Caxito: Hospital Geral do Bengo, Hospital Municipal do Dande, 
and Posto Médico o Bom Samaritano. 
At baseline, a questionnaire was applied in Portuguese to collect sociodemographic 
information, clinical condition and medication history. Anthropometric measurements of 
weight, height and mid-upper arm circumference (MUAC) were assessed. A single blood 
sample was collected for anaemia and malaria diagnosis, and a stool sample per child was 
requested for diagnosis of intestinal parasites.  
In a first phase, children were deemed eligible according to inclusion criteria: age between 
20-36 months at the recruitment (so during the follow-up period the age varied between 
24 and 59 months); residence in the HDSS area; and no history of antibiotic or 
antiparasitic drug (previous ten days). Then, if an infection with at least one pathogenic 
intestinal parasite was found, the child met all criteria to proceed in the study and was 
randomly allocated to one of four arms. Household members were also included in two 
of the four arms. At baseline, medication was provided according to the pathogenic agent 
identified before randomisation. Exclusion criteria was applied for children who did not 
appear to receive medication or whose parents did not consent their participation in the 
study. For household members, exclusion criteria included any person who did not live 
in the same house of the child, and those who refused to participate in the study.  
Ethics statement 
Medication for anaemia and infections caused by intestinal parasites and malaria was 
freely provided by clinical staff. Parents or caregivers were asked to sign two written 
consents (fingerprinted if illiterate) allowing the child to participate in the study: the first 
during recruitment and the second one for the follow-up period. Local authorizations and 
ethical approvals were obtained from the Bengo Provincial Health Authority, from the 
Ethics Committee of the Angolan Ministry, and from the IHMT Ethics Council, NOVA 
University of Lisbon, Portugal. Although the study protocol was submitted for ethical 
approvals before enrolment of the first participant, registration of the trial was performed 
retrospectively due to the lack of awareness of the mandatory prospective registration. 
Probably it would be easier and helpful if registration was also a requirement included in 
the national ethics committee. The trial was registered in ISRCTN registry, number 
ISRCTN72928001. 
Randomisation and masking 
Children were randomly assigned (1:1:1:1) by a nurse to one of the four arms: Arm 1 
(A1), to receive a single annual dose of ALB 400 mg at individual level; Arm 2 (A2), to 
receive a single annual dose of ALB 400 mg at household level; Arm 3 (A3), to test-and-
treat pathogenic intestinal parasites every four months at individual level; and Arm 4 
(A4), to test-and-treat pathogenic intestinal parasites every four months at household 
level. Participants and clinical trial staff were aware of the group to which children were 
assigned.  
Common procedures between arms 
Community follow-up (Fu) was performed at 4th (Fu1), 8th (Fu2), 12th (Fu3), 16th (Fu4), 
20th (Fu5) and 24th months (Fu6) after inclusion of each child to collect information on 
reported symptoms, anthropometric measurements, anaemia and malaria diagnosis.  
Symptoms 
Reported symptoms were related to the previous week and included fever, vomiting, 
blood in the stool and diarrhoea (defined as three or more loose or liquid stools per day);  
Anthropometric measurements 
Weight (using scale seca® 877), height (using seca®213, with precision of 0.1 cm), and 
MUAC measurements were assessed by trained health professionals. MUAC values were 
transformed to standardized Z-score (MUACZ) using WHO ANTHRO Software (version 
3.2.2) [22]. Additionally, weight and height measurements were converted to 
anthropometric indices in Z-scores, according to WHO Child Growth Standards: height-
for-age (HAZ), weight-for-height (WHZ) and weight-for-age (WAZ) to identify stunting, 
wasting and underweight, respectively. Children with Z- -1 were considered 
eutrophic. Malnutrition was classified as mild (- -score<-1), moderate (- -score<-
2), and severe (Z-score<-3). Children with symptoms of bilateral pitting oedema were 
classified as acute severely malnourished [23]  
 
Anaemia and malaria
A blood sample collected by finger prick was used to determine the haemoglobin (Hb) 
concentration using the HemoCue® Hb 301 System (HemoCue® AB, Angelhome, 
Sweden) and to classify anaemia as: no anaemia ( .0 g/dl), mild: (10.0-10.9 g/d), 
moderate (7.0-9.9 g/dl), and severe anaemia (<7.0 g/dl). Malaria diagnosis was performed 
by rapid immunochromatographic test (Standard Diagnostics Bioline Malaria Ag P.f/P.v, 
Standard Diagnostics Inc., Republic of Korea).  
Interventions  
Annual single dose of ALB  
Annual single dose of ALB (Fu1 and Fu4) was performed in A1 and A2, at individual 
and household levels, respectively, and without any previous knowledge of infection 
status. Participants older than 24 months received a single dose of ALB 400 mg, while 
those between 12 months and 24 months received a single dose of ALB 200 mg. 
At the end of the study, an additional stool sample was requested in participants of each 
arm (A1 and A2, at individual and household levels, respectively) for the diagnosis and 
treatment of intestinal parasite. We considered that it was ethically more appropriate and 
it would allow us to understand the pattern of infection among participants who received 
ALB during the follow-up. This did not influence the comparison of primary outcomes 
between the four arms since they were assessed before requiring the stool sample. 
Test-and-treat intestinal parasites approach  
Test-and-treat intestinal parasites approach (from Fu1 to Fu6) was performed in A3 and 
A4, at individual and household levels, respectively.  
A stool sample per child in A3 or per household member in A4 was requested for 
microscopic detection of intestinal parasites using direct saline and iodine mounts, 
formalin-ether sedimentation technique (Parasite Recovery System, PRSTM, Alphatec), 
modified Ziehl-Neelsen technique (for the identification of Cryptosporidium spp., 
Isospora belli and Cyclospora cayetanensis oocysts), and Kato-Katz smears (for the 
quantitative diagnosis of intestinal schistosomiasis and STHs within the 60 minutes of 
slide preparation Vertergaard Frandsen, Switzerland) [24]. If Entamoeba 
histolytica/dispar was identified through microscopy, a rapid test for the qualitative 
detection of Entamoeba histolytica was also performed (TECHLAB® E. HISTOLYTICA 
QUICK CHECKTM, code T30409). Microscopic analysis was carried out by two blinded 
microscopists, and by a third one for discordant results. Participants with positive results 
received medication by clinical staff, in Hospital Geral do Bengo, and according to a 
clinical protocol (Table 1).  
Table 1. Treatment of pathogenic intestinal parasites identified at the recruitment 
and during the follow-up in A3 and A4. 
Type of infection 
Intestinal parasites identified 
Medication regimens 
12 <age < 24 months  
A
L
B 
M
T
Z 
T
N
Z 
P
Z
Q 
Dosage Frequency 
A
L
B 
T
N
Z 
P
Z
Q 
Dosage Frequency 
Single infections 
Ascaris lumbricoides x    200 mg single dose x   400 mg single dose 
Ancylostoma sp. x    200 mg single dose x   400 mg single dose 
Entamoeba histolytica  x   35-50 mg/kg/dc 8/8h, 7d  x  50mg/kgb 3d 
Giardia lamblia  x   15mg/kg/d 8/8h, 5d  x  50mg/kgb single dose 
Hymenolepis nana    x 25mg/kg single dose   x 25mg/kg single dose 
Strongyloides stercoralis x    200 mg 12/12h, 7d x   400 mg 12/12h, 7d 
Trichuris trichiura x    200 mg 3d x   400 mg 3d 
Multiple infections 
G.lamblia +E.histolytica  x   35-50 mg/kg/dc 8/8h, 7d  x  50mg/kgb 3d 
G.lamblia +A.lumbricoides x    200 mg 5d x   400 mg 5d 
G.lamblia +T.trichiura x    200 mg 5d x   400 mg 5d 
G.lamblia +A.lumbricoides +T.trichiura x    200 mg 5d x   400 mg 5d 
G.lamblia +S.stercoralis x    200 mg 12/12h, 7d x   400 mg 12/12h, 7d 
G.lamblia +H.nana    x 25mg/kga single dose   x 25mg/kg single dose 
  x   15mg/kg/d 8/8h, 5d  x  50mg/kgb single dose 
A. lumbricoides +S. stercoralis x    200 mg 12/12, 7d x   400 mg 12/12, 7d 
T.trichiura +H.nana    x 25mg/kga single dose   x 25mg/kg single dose 
 x    200 mg 3d x   200 mg 3d 
ALB: Albendazole; MTZ: Metronidazole; TNZ: Tinidazole; PZQ: Praziquantel; d:day;
Praziquantel is administered alone in the first day 
b maximum dose is 2g.
c maximum dose is 750mg.
 An additional stool sample was requested ten days after completing the recommended 
treatment to ensure its effectiveness. Children younger than 12 months, pregnant women, 
and women breastfeeding did not receive any of the four interventions [25]. 
Outcomes 
The primary outcomes were height, weight, HAZ, WHZ, WAZ, and MUACZ, from 
baseline to 4, 8, 12, 16, 20, and 24 months of follow-up to assess growth. Secondary 
outcomes included the occurrence of infection by intestinal protozoa and helminths in all 
follow-up assessments in A3 and A4.  
Statistical analysis 
Sample size calculation for this longitudinal study was explored in GLIMMPSE software 
[26], based on a trend of HAZ across time and arms. A total of 152 participants with 
intestinal parasitic infections (38 per arm) were required to achieve a power of 80%, a 
type error 1 of 0.05, and applying the Hotelling-Lawley Trace test considering the 
posterior use of the parametric repeated measures in statistical analysis (S1 Appendix). 
Intention-to-treat (ITT) analysis is widely recommended to avoid bias associated with 
non-random loss, preserving the benefit of randomisation [27]. Thus, all randomised 
participants were included, after a missing values treatment [28]. Analyses to primary 
outcomes started describing the proportion of subjects with missing values by arms and 
choosing different methods to handle missing data. A special attention was given to height 
due to facility in terms of interpretation. In cases where the missing value was flanked by 
valid observations, interpolation was used to height, since there is a monotonic increasing 
in their values. For the remaining values, we performed multiple imputation using the 
Expectation Maximization, identifying the most plausible mechanism underlying our 
data. Missing Completely at Random (MCAR) was tested using Little´s test [29]. After 
an exploratory analysis and hypothesis tests, multivariate analysis was explored to 
determine nutritional changes induced by interventions throughout the follow-up 
assessments. Given the failure of the assumptions of the classic repeated measures, non-
parametric approaches were used for quantitative variables [30].  
Student t test was applied to compare the means of two independent groups, and ANOVA 
to compare the means of more than two groups. When requirements for the independent 
samples were not met (homogeneity of variances checked by Levene test and normality 
by Kolmogorov-Smirnov and Shapiro-Wilk tests), nonparametric Mann-Whitney-
Wilcoxon and Kruskall-Wallis were used instead. Paired t-test or Wilcoxon or Friedman 
tests were used to compare two or more moments. McNemar and Q-Cochran tests were 
applied for paired binary variables in two or more time points. 
Initially, nonparametric rank-based methods were explored in the nparLD (R program) 
[31] to address the key questions for each primary outcome: i) do the arms/treatments 
have the same effect?; ii) Is the time profile flat or there is a trend over the follow-up 
period?; iii) Are the effects of the treatments similar over time? This first rank-based 
approach is robust to outliers and present a competitive performance for small sample 
sizes [31]. However, other strategies are advantageous [28, 32]. Thus, linear mixed effect 
models (LMM) and generalized estimating equations (GEE) for longitudinal data were 
explored to reinforce our findings, using lme, nlme and geepack packages [28, 32]. 
Different correlation structures were considered in several LMM and GEE models. Plots 
were explored using gglopt2 package. Initial data analysis was done using IBM SPSS 
Software, version 24 (IBM Corp, Armonk, NY, USA), and advanced modelling using R 
Program. CONSORT 2010 guidelines were followed in this work (S1 Table). 
Results 
Between December 2013 and December 2014, 692 children were assessed for eligibility, 
of which 121 were included and randomly assigned to one of the four arms (Fig 1).  
Fig 1. Consort flow chart. 
Baseline characteristics 
The mean age of overall children was 26.6 ± 4.86 months and 50.4% of them were female. 
Overall, the proportion of mothers without education level 11/116 (9.5%) was higher 
compared with fathers 2/115 (1.7%), p=0.04. The distribution of children, considering 
their mothers and  age and education level, their household characteristics, and 
their access to water and sanitation conditions, was well balanced across arms. River was 
among the major water source used for drinking or bathing, and 19.7% of overall children 
did not have access to sanitation facilities at the household (Table 2).  
Table 2. Baseline sociodemographic characteristics by study arms. 
 Variable (n) Categoriesa A1 (n=29) A2 (n=31) A3 (n=31) A4 (n=30) 
C
hi
ld
 Sex ratio (n=121) Female : male 0.81 : 1.00 0.72 : 1.00 1.38 : 1.00 1.31 : 1.00 
Age (n=121) Mean ± SD, (months) 25.1 ± 4.57 27.7 ± 4.93 25.8 ± 4.90 27.6 ± 4.70 
Exclusively breastfed (n=114) Mean ± SD, (months) 4.6 ± 1.80  5.4 ± 1.82 4.3 ± 2.1 4.7 ± 2.3 
Complementary feeding (n=111) Mean ± SD, (months) 19.7 ± 3.9 19.6 ± 5.0 20.1 ± 4.1 21.0 ± 3.8 
M
ot
he
r 
Age (n=114) Mean ± SD, (years) 27.32 ± 6.44 28.97 ± 6.68 26.67 ± 5.05 30.42 ± 7.90 
Maternal education (n=116) No education 3 (10.3) 2 (6.9) 0 (0.0) 6 (20.7) 
 Primary 8 (27.6) 14 (48.3) 18 (62.1) 11 (37.9) 
 Secondary or higher 18 (62.1) 13 (44.8) 11 (37.9) 12 (41.4) 
Studying and working status (n=116) Do not study or work 5 (17.2) 7 (24.1) 8 (27.6) 5 (17.2) 
Only working 11 (37.9) 8 (27.6) 7 (24.1) 11 (37.9) 
Study and work 4 (13.8) 5 (17.2) 5 (17.2) 5 (17.2) 
Only studying 9 (31.0) 9 (31.0) 9 (31.0) 8 (27.6) 
Fa
th
er
 
Age (n=92) Mean ± SD, (years) 31.44 ± 7.93 35.07 ± 10.49 30.67 ± 4.90 36.84 ± 10.12 
Paternal education (n=115) No education 1 (3.4) 1 (3.6) 0 (0.0) 0 (0.0) 
 Primary 3 (10.3) 5 (17.9) 6 (20.7) 6 (20.7) 
 Secondary or higher 25 (86.2) 22 (78.6) 23 (79.3) 23 (79.3) 
Studying and working status (n=115) Do not study or work 0 (0.0) 0 (0.0) 1 (3.4) 1 (3.4) 
Only working 21 (72.4) 22 (78.6) 19 (65.5) 23 (793) 
Study and work 6 (20.7) 6 (21.4) 7 (24.1) 4 (13.8) 
Only studying 2 (6.9) 0 (0.0) 2 (6.9) 1 (3.4) 
H
ou
se
ho
ld
 
ch
ar
ac
te
ri
st
ic
s 
Members per household (N=117) Mean ± SD 6.29 ± 2.29 6.20 ± 2.30 5.45 ± 1.59 5.97 ± 2.06 
Place of residence (n=121) Urban 27 (93.1) 31 (100.0) 30 (96.8) 27 (90.0) 
Rooms (n=117)  23 (79.3) 17 (58.6) 25 (83.3) 22 (75.9) 
  >3 6 (20.7) 12 (41.4) 5 (16.7) 7 (24.1) 
Wall (n=117) Adobe 18 (62.1) 20 (69.0) 23 (76.7) 26 (89.7) 
  Bricks 11 (37.9) 9 (31.0) 7 (23.3) 3 (10.3) 
Floor (n=117) Earth/sand 5 (17.2) 4 (13.8) 3 (10.0) 3 (10.3) 
  Cement/ceramic 24 (82.8) 25 (86.2) 27 (90.0) 26 (89.7) 
Mobile phone (n=117)                                         Yes 27 (93.1) 28 (96.6) 30 (100.0) 25 (86.2) 
Television (n=117) Yes 25 (86.2) 26 (89.7) 26 (86.7) 26 (89.7)
Public electricity (n=117)       Yes 21 (72.4) 27 (93.1) 25 (83.3) 21 (72.4) 
Freezer (n=117)        Yes 22 (75.9) 22 (75.9) 23 (76.7) 21 (72.4) 
Cable TV (n=117) Yes 19 (65.5) 23 (79.3) 20 (66.7) 20 (69.0) 
Wheelbarrow(n=117)                Yes 14 (48.3) 18 (62.1) 16 (53.3) 15 (51.7) 
Radio (n=117) Yes 16 (55.2) 12 (41.4) 14 (46.7) 13 (44.8) 
Motorcycle(n=117)          Yes 9 (31.0) 9 (31.0) 15 (50.0) 9 (31.0) 
Generator (n=117) Yes 4 (13.8) 6 (20.7) 8 (26.7) 10 (34.5) 
Animals(n=117) Yes 6 (20.7) 3 (10.3) 7 (24.1) 7 (24.1) 
Refrigerator(n=117) Yes 5 (17.2) 4 (13.8) 6 (20.0) 6 (20.7) 
Car (n=117)  Yes 6 (20.7) 4 (13.8) 3 (10.0) 7 (24.1) 
Bicycle (n=117)        Yes 1 (3.4) 2 (6.9) 4 (13.3) 0 (0.0) 
W
at
er
 so
ur
ce
 a
nd
 sa
ni
ta
tio
n 
Drinking water sourceb (n=117)        Improved 21 (72.4) 22 (75.9) 19 (63.3) 21 (72.4) Unimproved 8 (27.6) 7 (24.1) 11 (36.7) 8 (27.6) 
Drinking water source (n=117)        River 8 (27.6) 5 (17.2) 9 (30.0) 7 (24.1) 
 Tap in the yard 5 (17.2) 12 (41.4) 7 (23.3) 8 (27.6) 
 Private tank 9 (31.0) 6 (20.7) 9 (30.0) 10 (34.5) 
 Othersc 7 (24.1) 6 (20.6) 5 (16.7) 4 (13.8) 
Bath water source (n=117)  Irrigation channel 9 (31.0) 4 (13.8) 9 (30.0) 6 (20.7) 
 River 7 (24.1) 6 (20.7) 9 (30.0) 8 (27.6) 
 Tap in the yard  3 (10.3) 7 (24.1) 4 (13.3) 7 (24.1) 
 Private tank 3 (10.3) 5 (17.2) 2 (6.7) 4 (13.8) 
 Othersd 7 (24.1) 7 (24.1) 6 (20.0) 4 (13.8) 
Latrine (n=117) No facility 7 (24.1) 3 (10.3) 7 (23.3) 6 (20.7) 
 Public 10 (34.5) 10 (34.5) 9 (30.0) 7 (24.1) 
 Private 12 (41.4) 16 (55.2) 14 (46.7) 16 (55.2) 
aFor categorical variables characteristics are expressed as n (%); 
b According to the WHO/UNICEF Joint Monitoring Programme for Water Supply, 
Sanitation and Hygiene (JMP) [32]. Improved water includes piped water into dwelling, 
tap in the yard, public tap water, tubewell, borehole, covered or uncovered tank, tanker 
truck; and unimproved water includes river, irrigation channel.  
c includes piped water, irrigation channel, borehole and tubewell.  
d includes piped water, borehole and tubewell. 
 
 
At baseline, overall children had mean values of height (84.63cm±5.0) weight 
(11.26kg±1.79), HAZ (-1.34±1.33); WHZ (-0.29±1.18); WAZ (-0.80±0.98) and MUACZ 
(-0.88±0.98). On average, anthropometric indices of children were negative in all arms, 
with exception of WHZ in A3, as shown in Table 3.  
Table 3. Baseline nutritional status, infection with intestinal parasites, symptoms 
reported, malaria, and anaemia in children by study arms. 
 Variable (n) Categoriesa A1 (n=29) A2 (n=31) A3 (n=31) A4 (n=30) 
N
ut
ri
tio
na
l s
ta
tu
s 
Height (n=121) Mean ±  SD 83.63 ± 5.32 85.49 ± 5.89 84.19 ± 5.68 85.15 ± 6.73 
Weightb (n=119) Mean ±  SD 10.70 ± 1.74 11.58 ± 1.77 11.40 ± 1.70 11.48 ± 1.87 
MUAC (n=121)  Mean ±  SD 13.83 ± 1.32 14.34 ± 1.12 14.33 ± 1.01 14.40 ± 0.94 
HAZ (n=121)  Mean ±  SD -1.26 ± 1.41 -1.35 ± 1.35 -1.30 ± 1.33 -1.43 ± 1.29 
WHZb (n=119) Mean ±  SD -0.65 ± 1.22 -0.25 ± 1.02 0.00 ± 1.36 -0.22 ± 0.98 
WAZb (n=119) Mean ±  SD -1.15 ± 1.19 -0.87 ± 1.07 -0.65 ± 1.15 -0.89 ± 1.04 
MUACZ (n=121) Mean ±  SD -1.19 ± 1.21  -0.85 ± 0.93  -0.73 ± 0.90 -0.75 ± 0.84 
Stunting (n=121) Eutrophic 12 (41.4) 11 (35.5) 11 (35.5) 10 (33.3) 
Mild 8 (27.6) 10 (32.3) 12 (38.7) 10 (33.3)
Moderate 5 (17.2) 6 (19.4) 6 (19.4) 8 (26.7)
 Severe  4 (13.8) 4 (12.9) 2 (6.5) 2 (6.7) 
Wasting (n=121) Eutrophic 17 (58.6) 23 (74.2) 24 (77.4) 22 (73.39 
 Mild 8 (27.6) 6 (19.4) 6 (19.4) 6 (20.0) 
 Moderate 3 (10.3) 1 (3.2) 1 (3.2) 1 (3.3) 
 Severe 1 (3.4) 1 (3.2) 0 (0.0) 1 (3.3) 
Underweight (n=119) Eutrophic 16 (55.2) 15 (50.0) 18 (58.1) 16 (55.2) 
 Mild 7 (24.1) 12 (40.0) 7 (22.6) 9 (31.0) 
  Moderate 4 (13.8) 2 (6.7) 6 (19.4) 3 (10.3) 
 Severe 2 (6.9) 1 (3.3) 0 (0.0) 1 (3.4) 
Pa
th
og
en
ic
 in
te
st
in
al
 p
ar
as
ite
s Type of infection (n=121) Monoparasitism 25 (86.2) 26 (83.9) 28 (90.3) 26 (86.7)   Polyparasitism 4 (13.8) 5 (16.1) 3 (9.7) 4 (13.3) 
Group of parasites (n=121) Protozoa (P) 18 (62.1) 17 (54.8) 19 (61.3) 13 (43.3) 
 Helminths (H) 8 (27.6) 12 (38.7) 11 (35.5) 14 (46.7) 
  P + H 3 (10.3) 2 (6.5) 1 (3.2) 3 (10.0) 
Giardia lamblia (n=121)        Positive 17 (58.6) 18 (58.1) 19 (61.3) 15 (50.0) 
Ascaris lumbricoides (n=121)                 Positive 3 (10.3) 8 (25.8) 8 (25.8) 12 (40.0) 
Strongyloides stercoralis (n=121) Positive 5 (17.2) 3 (9.7) 4 (12.9) 4 (13.3) 
Trichuris trichiura (n=121)  Positive 2 (6.9) 2 (6.5) 1 (3.2) 2 (6.7) 
Hymenolepis nana (n=121) Positive 1 (3.4) 3 (9.7) 3 (9.7) 0 (0.0) 
Cryptosporidium spp. (n=121)  Positive 3 (10.3) 1 (3.2) 1 (3.2) 2 (6.7) 
Entamoeba histolytica (n=121) Positive 2 (6.9) 1 (3.2) 0 (0.0) 0 (0.0) 
M
al
ar
ia
, H
b,
 
sy
m
pt
om
s
Malaria (P.falciparum) (n=121) Positive 4 (13.8) 3 (9.7) 2 (6.5) 2 (6.7) 
Haemoglobin (g/dl) (n=116) mean ± SD 10.3 ± 2.06  10.5 ± 1.65 11.0 ± 1.05 10.5 ± 1.81 
Anaemia (n=119) No 11 (40.7) 15 (48.4) 18 (58.1) 11 (36.7) 
 Mild 7 (25.9) 7 (22.6) 9 (29.0) 13 (43.3) 
 Moderate  7 (25.9) 7 (22.6) 4 (12.9) 4 (13.3) 
 Severe 2 (7.4) 2 (6.5) 0 (0.0) 2 (6.7) 
Diarrhoea (n=121) Yes 15 (51.7) 10 (32.3) 16 (51.6) 17 (56.7) 
Fever (n=121) Yes 24 (82.8) 25 (80.6) 22 (71.0) 26 (86.7) 
Vomiting (n=121) Yes 4 (13.8)  7 (22.6) 5 (16.1) 2 (6.7) 
a For categorical variables characteristics are expressed as n (%). 
b Did not include 2 children with bilateral oedema, one from A2 and another one from A4. 
Moderate-to-severe malnutrition was 31.0% in A1, 32.3% in A2, 25.9% in A3 and 33.4% 
in A4. However, a great proportion was also classified as having mild malnutrition 
(27.6% in A1, 32.3% in A2, 38.7% in A3 and 33.3% in A4). Monoparasitism was more 
common in all arms compared with multiple infections. Intestinal protozoa (single or 
multiple) were the most frequent among arms, with exception of A4 where helminthic 
infections were more frequent. Considering the pathogenic agent, Giardia lamblia was 
the most frequent in the four arms. Of the 31 Ascaris lumbricoides positive samples, Kato-
Katz was performed in 17 samples: 11 (64.7%) with light intensity and six (35.3%) with 
moderate-to-severe (data not shown). 
Overall, malaria was diagnosed in 11 children (9.1%) at baseline and more than 50% 
presented mild-to-severe anaemia. Almost half of the children had diarrhoea at baseline 
(Table 3). 
Loss to follow-up and missing values
Of the total, 12 (9.9%) children were permanently lost to the follow-up and did not 
perform the following assessment due to death (3), house not located (3), dropped-out 
(3), and emigration (3/12) (Fig 1). Temporary withdrawal occurred in children from all 
arms, mainly due to the absence of participants from their homes on the day the evaluation 
was scheduled (S2 Appendix). S2 Table presents complete primary outcomes and missing 
values. A total of 96 (79.3%) children conclude the study with complete data, whereas 25 
(20.7%) had at least one missing value during the two years of the follow-up. No 
differences were found among arms (p=0.534).  
Effect of interventions on nutritional outcomes 
The primary analysis was ITT and involved all patients randomly assigned. Firstly, using 
parametric and non-parametric tests, the primary outcomes in each follow-up were not 
significantly different among arms.  
From a descriptive point of view (S3 Table), on average, children from A1 (younger) had 
lower stature and weight at entry and persisted, however, no significant differences were 
found comparing the four arms. Considering mean values of HAZ, WHZ and WAZ, no 
differences were detected among arms in any follow-up assessment. Mean values of HAZ 
remained negative and far from zero in all six moments, highlighted in S3 Table (ranging 
from -1.42±1.19 to -0.99±0.98). Negative values persisted for WAZ (-1.00±1.03 to -
0.57±0.85), and MUACZ (-0.95±0.85 to -0.59±0.82), whereas positive mean values were 
registered considering WHZ (ranging from -0.51±1.06 to 0.14±0.97) (S3 Table).  
During the follow-up period, moderate-to-severe stunting in children varied between 
19.4% and 36.7%, while mild-to-severe stunting ranged from 44.8% to 72.4% (values 
presented in bold in S4 Table). Until the end of the study, a significant decrease was 
observed in mild-to-severe stunting (mainly in A1 by 27.6%, A2 by 19.3% and A4 by 
20.0%), but not in moderate-to-severe stunting (although in A2 the reduction from 35.5% 
to 19.4% was close to be significant). Analysing the progress of stunting separated by 
sex, no differences were observed among arms and between the first and the sixth follow-
ups (S5 Table). Moreover, no differences between the initial and final prevalence of 
wasting and underweight were registered within arms (S4 Table). 
Regarding the three key questions (i, ii, and iii), analysing simultaneously the effects of 
arm (treatment), time (follow-up) and interaction arm*time on anthropometric outcomes, 
results of nparLD LMM and GEE models are shown in Table 4.  
Table 4. ANOVA tables for primary outcomes, using a nonparametric analysis of 
longitudinal data (nparLD) and LMM and GEE models. 
Outcome NparLD LMM GEE 
ANOVA modified Wald ANOVA ANOVA 
Effect Statistic df p-value Statistic df p-value Statistic df1 df2 p-value Statistica df p-value 
Height               
Arm 0.94 2.930 0.42 3.03 3 0.39 1.0 3 117 0.48 10.0 3 0.02* 
Time 1210.04 1.903 <0.001* 1860.84 5 <0.001* 6997.0 1 601 <0.001* 427.0 1 <0.001* 
Arm*Time 0.79 5.483 0.57 11.86 15 0.69 0.0 3 601 0.72 0.0 3 1.00 
Weight               
Arm 0.63 2.939 0.59 1.82 3 0.61 1.0 3 117 0.62 7.5 3 0.06 
Time 474.71 3.279 <0.001* 1053.28 5 <0.001* 2025.0 1 601 <0.001* 216.8 1 <0.001* 
Arm*Time 0.82 8.979 0.60 15.83 15 0.39 0.0 3 601 0.69 0.1 3 0.99 
HAZ               
Arm 0.06 2.986 0.98 0.19 3 0.98 0.1 3 117 0.96 2.13 3 0.55 
Time 29.30 3.256 <0.001* 64.53 5 <0.001* 54.2 1 601 <0.001* 5.23 1 0.02* 
Arm*Time 0.73 8.670 0.68 11.43 15 0.72 0.4 3 601 0.78 0.13 3 0.99 
WAZ               
Arm 0.12 2.986 0.95 0.40 3 0.94 0.3 3 117 0.84 5.08 3 0.17 
Time 6.06 4.292 <0.001* 23.73 5 <0.001* 1.9 1 601 0.17 0.21 1 0.65 
Arm*Time 0.77 10.112 0.66 15.92 15 0.39 0.3 3 601 0.83 0.04 3 1.00 
WHZ               
Arm 0.29 2.955 0.83 0.95 3 0.81 0.5 3 117 0.68 8.10 3 0.04* 
Time 10.15 4.534 <0.001* 46.32 5 <0.001* 15.6 1 601 <0.001* 4.08 1 0.04* 
Arm*Time 0.48 11.766 0.93 9.63 15 0.84 0.06 3 601 0.98 0.04 3 1.00 
MUACZ              
Arm 0.35 2.947 0.79 1.00 3 0.80 0.5 3 117 0.66 7.52 3 0.06 
Time 4.35 4.549 0.001* 19.15 5 0.002* 6.8 1 601 0.009* 1.86 1 0.17 
Arm*Time 0.40 12.047 0.96 6.80 15 0.96 1.0 3 601 0.39 0.77 3 0.86 
a -for-age Z-score; WAZ: weight-for-age Z-score; WHZ: Weight-for-height Z-score; MUACZ: Mid-Upper 
Arm Circumference Z-score; *p<0.05 
Considering nparLD, no significant effects were obtained in any of the interventions 
(effect of arm), nor by arm*time interaction. However, temporal changes (effect of time) 
occurred in all nutritional outcomes (p<0.05) (Table 4). 
Exploring the same questions using models GEE and LMM models, the same patterns 
were observed (Table 4). Nevertheless, there was a significant effect of arm intervention 
on height (p=0.02) and WHZ (p=0.04), and very close to be significant on weight and 
MUACZ. Considering A1 as a reference, parameter estimations associated to GEE and 
LMM models are presented in Table 5.  
Table 5. Parameter estimation for primary outcomes using GEE and LMM models 
Variable Parameter LMM GEE E SE Df Statistic p-value E SE Statistic p-value 
Height (Intercept) 84.1 1.08 601 78.1 <0.001* 84.3 0.92 8324.2 <0.001* 
A1A2 2.1 1.50 117 1.4 0.16 2.1 1.32 2.6 0.11 
A1A3 0.3 1.50 117 0.2 0.85 0.3 1.26 0.1 0.80 
A1A4 1.5 1.51 117 1.0 0.33 1.4 1.44 1.0 0.32 
Time 2.5 0.06 601 40.9 <0.001* 2.5 0.24 106.67 <0.001* 
A1A2:Time 0.0 0.09 601 0.0 0.97 0.0 0.34 0.0 0.95 
A1A3:Time 0.1 0.09 601 0.7 0.48 0.1 0.33 0.0 0.85 
A1A4:Time 0.0 0.09 601 -0.4 0.69 0.0 0.38 0.0 0.98 
Weight 
(Intercept) 11.4 0.35 601 32.1 <0.001* 11.4 0.32 1301.5 <0.001* 
A1A2 0.6 0.49 117 1.1 0.26 0.6 0.44 1.8 0.18 
A1A3 0.2 0.49 117 0.5 0.62 0.3 0.41 0.4 0.51 
A1A4 0.4 0.50 117 0.8 0.45 0.4 0.46 0.8 0.36 
Time 0.6 0.03 601 21.3 <0.001* 0.6 0.09 45.1 <0.001* 
A1A2:Time 0.0 0.04 601 0.2 0.87 0.0 0.12 0.0 0.98 
A1A3:Time 0.0 0.04 601 0.9 0.38 0.0 0.11 0.1 0.81 
A1A4:Time 0.0 0.04 601 1.0 0.34 0.0 0.13 0.0 0.85 
HAZ 
(Intercept) -1.38 0.210 601 -6.6 <0.001* -1.39 0.201 47.7 <0.001* 
A1A2 0.04 0.292 117 0.1 0.90 0.04 0.278 0.0 0.90 
A1A3 0.00 0.292 117 0.0 0.99 0.01 0.271 0.0 0.98 
A1A4 -0.09 0.295 117 -0.3 0.77 -0.09 0.280 0.1 0.76 
Time 0.04 0.015 601 2.8 0.01* 0.04 0.051 0.6 0.42 
A1A2:Time 0.02 0.021 601 1.0 0.31 0.03 0.069 0.1 0.72 
A1A3:Time 0.02 0.021 601 0.7 0.46 0.02 0.068 0.1 0.83 
A1A4:Time 0.01 0.021 601 0.6 0.56 0.02 0.071 0.1 0.83 
WHZ 
(Intercept) -0.08 0.179 601 -0.4 0.67 -0.08 0.181 0.2 0.65 
A1A2 0.06 0.248 117 0.2 0.81 0.08 0.250 0.1 0.75 
A1A3 0.25 0.248 117 1.0 0.32 0.26 0.226 1.3 0.25 
A1A4 0.11 0.250 117 0.4 0.67 0.13 0.240 0.3 0.58 
Time -0.04 0.022 601 -2.0 0.04* -0.04 0.046 0.7 0.41 
A1A2:Time 0.00 0.030 601 -0.1 0.91 -0.01 0.062 0.0 0.87 
A1A3:Time 0.00 0.030 601 0.1 0.94 -0.00 0.058 0.0 0.98 
A1A4:Time 0.01 0.030 601 0.3 0.78 0.00 0.062 0.0 1.00 
WAZ 
(Intercept) -0.79 0.175 601 -4.5 <0.001* -0.80 0.178 20.2 <0.001* 
A1A2 0.04 0.243 117 0.2 0.86 0.06 0.244 0.1 0.79 
A1A3 0.18 0.243 117 0.7 0.47 0.19 0.228 0.7 0.40 
A1A4 0.01 0.245 117 0.0 0.97 0.04 0.236 0.0 0.88 
Time -0.02 0.016 601 -1.4 0.16 -0.02 0.046 0.1 0.73 
A1A2:Time 0.02 0.022 601 0.7 0.47 0.01 0.061 0.0 0.88 
A1A3:Time 0.01 0.022 601 0.5 0.65 0.01 0.058 0.0 0.93 
A1A4:Time 0.02 0.022 601 0.9 0.38 0.01 0.060 0.0 0.86 
MUACZ 
(Intercept) -0.92 0.153 601 -6.0 <0.001* -0.92 0.168 30.1 <0.001* 
A1A2 0.24 0.213 117 1.1 0.27 0.24 0.236 1.0 0.31 
A1A3 0.35 0.213 117 1.7 0.10 0.35 0.120 3.1 0.08 
A1A4 0.36 0.215 117 1.7 0.09 0.36 0.215 2.8 0.09 
Time 0.00 0.021 601 0.2 0.86 0.01 0.042 0.0 0.91 
A1A2:Time -0.03 0.029 601 -1.1 0.27 -0.03 0.058 0.3 0.57 
A1A3:Time -0.04 0.029 601 -1.5 0.13 -0.04 0.051 0.7 0.41 
A1A4:Time -0.04 0.029 601 -1.5 0.13 -0.04 0.054 0.7 0.44 
 
Reference class = A1; E=Estimate; SE=Standard error; *p<0.05 
 
The results were very similar, even for different correlation structures, enhancing 
significant temporal changes in height and weight, regardless the method performed. 
According to GEE analysis, based on population-average, children from A2 are estimated 
to have 2.1 cm (SE=1.32) more than children from A1, while those from A4 and A3 are 
estimated to have 1.4 cm (SE=1.44) and 0.3 (SE=1.26) more than children from A1, 
respectively, Table 5. These estimates were identical to parameter estimation obtained in 
LMM model. In terms of height, an increase of 2.5 cm is expected per four-months. The 
significance of parameter associated to time in HAZ and WHZ outcomes were different 
in two type of models. Fig 2 shows the estimates of the Relative Treatment Effects (RTE) 
of each arm over time obtained by the rank-based approach for some of the primary 
outcomes (for overall and by sex). 
Fig 2. Estimates of the relative effects of arm over time for primary outcomes to 
overall and by gender. 
An increase in the effect seems clear for height over time. An almost overlap of lines is 
visible for HAZ over time, supporting the non-significant finding from GEE models. 
Indeed, plots from nparLD approach also show a change in the trajectories of HAZ and 
WHZ, at least in Fu5 and Fu6 and by gender (Fig 2). 
In terms of WAZ and WHZ, from Fu4 to Fu6, a decrease was observed, particularly in 
A2. By sex, also without significance differences, A2 presented worse results in females, 
namely for WAZ and WHZ.  
 
 
Effect of test-and-treat intestinal parasites approach on 
secondary outcomes 
There were no significant differences of intestinal infection frequencies between A3 and 
A4 during follow-up (S1 Fig). From Fu1 to Fu6, there was a significant reduction of 
intestinal parasitic infection in A4 (p=0.039), but not in A3 (p=0.727). Giardia lamblia 
was the most frequent parasite identified in each follow-up (S1 Fig). Similarly, the 
reduction of infection from Fu1 to Fu6 was higher in A4 (from 37.5% to 16.7%, p=0.07) 
than A3 (from 34.6% to 30.4%, p=0.727) (Fig 3). Conversely, A. lumbricoides infection 
was higher in A4 than A3, except in Fu6, although without significant differences: Fu1 
(3.8 vs 4.2%), Fu2 (4.5% vs 12.5%), Fu3 (4.0% vs 23.1%), Fu4 (4.2% vs 16.7%), Fu5 
(13.6% vs 20.0%), and Fu6 (8.7 vs 8.3%).  
Fig 3. Stool sample collection and treatment of pathogenic intestinal parasites in A3 
and A4 during follow-up. Protozoa, helminths or protozoa + helminths (P+H) include 
single and multiple infections.  
Giardia lamblia and A.lumbricoides infections also include single and multiple 
infections. At the end of the study, we verified lower infection frequencies of G. lamblia 
in A4 (16.7%), compared with A3 (30.4%), A1 (34.8%), and A2 (40%), whereas 
infections caused by A. lumbricoides remained similar in all arms (near 9% for A1 and 
A2, 10% in A3, and 8% in A4) (Fig 4). 
Fig 4. Percentage (%) of monoparasitism and polyparasitism at Fu0 and Fu6, 
highlighting Giardia lamblia and Ascaris lumbricoides infections. 
 
 
Discussion 
We investigated the impact of four interventions (annual albendazole at individual level; 
annual albendazole at household level; four-monthly test-and-treat intestinal parasites at 
individual level; and four-monthly test-and-treat intestinal parasites at household level on 
nutritional outcomes of children.  
Malnutrition is a public health problem in Bengo 
At baseline, a very high proportion of stunting was found among overall children (30.6%), 
(ranging from 25.9% to 33.9% among arms), similar to the estimates for Africa (30.3%)  
[1], but lower than the national (37.6%) and Bengo (39.7%) prevalence levels previously 
reported [6]. This was probably because the majority of participants was from urban areas, 
known to have lower prevalence of stunting compared with rural areas [6]. The 
percentage of wasting in overall children was 7.4%, very close to the Africa region 
estimates (7.1%), but higher when compared to MICS prevalence levels (4.7% for Bengo 
and 4.9% for the country-level) [1, 6]. This was possibly because children were recruited 
in health units seeking for healthcare services.  
At baseline, overall mean HAZ (-1.34±1.33) was similar to the pattern described in a 
previous research including children from 57 countries (-1.43±1.70) and also without sex 
differences [33]. Growth faltering has been reported in low- and middle-income countries 
where children are already born with mean values of HAZ below the WHO reference and 
continue to decrease substantially until two years of age, after which it increase slightly 
until five years [20]. Considering children between two and five years, sub-Saharan 
Africa (where Angola is also included) is the region with the shortest children, after South 
Asia, while the tallest are in Europe and Central Asia with almost 1.5 Z-score higher [20].  
Interventions and primary outcomes
After two years, this longitudinal study suggested that screening and treating intestinal 
parasites did not result in better growth outcomes of children compared with yearly 
albendazole, with exception of height and WHZ using GEE model at 5% level. Significant 
temporal changes were obtained in arms for all primary outcomes, regardless of the 
statistical analysis performed (nparLD and LMM models). The effect of time was not 
significant in GEE models for WAZ and MUACZ. 
LMM and GEE models estimate an expected four-monthly increase of 0.04 in HAZ 
-up growth reported for African children 
older than 24 months (0.005 z-score per month) [20]. Furthermore, the aforementioned 
study [20] reported a decrease of WAZ between -0.01 and -0.02 per month after 12 
-0.005 WAZ per 
month). From Fu1 to Fu3, boys had lower mean of WHZ than girls, but at Fu4 there was 
an inversion of sex distribution, which was previously described for children between 44 
and 59 months [33].  
Although there was no evidence of significant effect on nutritional outcomes by any of 
the treatment strategies, an important reduction of mild malnutrition occurred in children 
from A1, A2 and A4. This is important since all levels of malnutrition, including mild 
malnutrition, have been previously associated with significantly higher mortality [34].  
Although Angola has been at peace since 2002, malnutrition remains a public health 
problem. Children with mild malnutrition living in precarious environmental conditions 
with reduced access to improved hygiene and sanitation conditions and healthcare 
services can be at risk of increasing the severity of malnutrition.  
 
Intestinal parasites and secondary outcomes
In Bengo, G. lamblia infection was previously reported in PSAC with diarrhoea (21.6%) 
[9]. In this study, it was the most frequent parasite diagnosed at baseline (57.0%), with 
the greatest proportion among children without diarrhoea, similar to precedent findings 
[35, 36]. There is evidence that subclinical infection of G. lamblia is negatively associated 
with growth in low resource settings, highlighting the importance of diagnosing and 
treating G. lamblia to control the spread of infection, and, consequently, its impact on 
nutritional status [13]. In A3 and A4, where screening was performed four-monthly, G. 
lamblia was the most frequent parasite identified in each follow-up. However, a greater 
reduction of G. lamblia occurred in A4, enhancing the importance of transmission among 
individuals living in the same household, as previously reported in Malaysia [37]. 
A higher rate of infection with A. lumbricoides was found compared with a previous 
community-study performed in Bengo (25.6 vs 15.3%) [8]. However, STH infections 
were mostly of light intensity and evidence suggests that those who are lightly infected 
or not infected do not benefit from deworming [3]. This could explain the lower impact 
of treatment on growth on this trial. S. stercoralis was the second most frequent helminth 
at baseline, highlighting the importance of this neglected STH.  
Limitations  
First, implementing a longitudinal study in a poor setting is challenging, and not 
surprisingly our sample was slightly smaller than the sample size calculated. One of the 
reasons was the higher percentage of children not delivering the stool sample at the 
recruitment, as well as those children who met the inclusion criteria but did not appear. 
Logistically it was not possible to extend the recruitment for longer periods. Second, 
diagnosis of intestinal parasites was performed using a single stool sample in each follow-
up, which could have contributed to underestimate the infections. However, collecting 
three samples instead of one would be logistically more difficult for caregivers, and would 
increase the lost to follow-up. To overcome this limitation, different laboratory 
techniques were performed. Third, there is no guarantee that participants did not take any 
other medication. Some treatments in A3 and A4 included more than one dosage/days, 
and we cannot guarantee that caregivers have complied with the prescription. Self-
reported data from questionnaires are also prone to social desirability response bias (a 
limitation difficult to overcome in any study). Fourth, adherence to interventions 
throughout the study was higher in ALB-arms compared with test-and-treat arms, which 
could have contributed to bias. To overcome this limitation, an intention-to-treat analysis 
was performed according to CONSORT guidelines  S1 Table [27]. The greatest 
difficulty was centred on the delivery of samples, especially when household family 
members were also included. Follow-up visits can interfere with the dynamics of each 
household member, their leisure time, work schedule and responsibilities to the 
community. Besides, the access to some houses was difficult given the poor condition of 
roads. Thus, it is extremely important to be aware of the social context of the study. 
Lastly, given its design, the study cannot be generalized to the entire population.  
Strengths  
This trial includes seven repeated measurements from the same participant (including 
baseline), which is a key strength of studies with this design. A study with repeated 
measurements allows to chart the profile of the same individual across time, an advantage 
compared with cross-sectional study where different subjects are commonly observed at 
different times [30]. It is true that missing values can represent a huge challenge in a 
longitudinal study. However, different methods were applied for imputation and given 
the fact that data from the same children was collected repeatedly, it decreased the risk of 
incorrect anthropometric data since height does not decrease and subjects can serve has 
their own controls. Moreover, a study with repeated measurements increases statistical 
power for detecting changes across time, and smaller sample sizes are needed compared 
with cross-sectional studies [38]. The main findings of this study were obtained by three 
different statistical approaches for longitudinal data, one of them (nparLD) described in 
the literature as robust to outliers and suitable for small sample sizes [31]. 
Conclusions 
In conclusion, no significant effects were found for different interventions on nutritional 
outcomes of children. Previous studies addressing parasitic infections and malnutrition in 
Angola, were mainly cross-sectional and without any type of longitudinal intervention. 
This trial contributes with new research approaches by including both intestinal protozoa 
and helminths when thinking on therapeutic interventions to improve the growth of 
PSAC. Screening and treating parasitic infections is more difficult and expensive than 
preventive chemotherapy, especially in these settings. From an epidemiological 
perspective, it is crucial to know the causal agent of an infection, in order to plan 
preventive measures, and to provide the access to antimicrobial treatment, especially 
when children are repeatedly exposed to a wide variety of pathogens. Besides, additional 
research is needed to address the benefits of these interventions on nutrition outcomes of 
children, ideally in a more heavily infected setting and including a higher number of 
participants. Malnutrition can result from multiple factors and, thus, its reduction seems 
to require multidisciplinary approaches including maternal and child interventions, safe 
water and sanitation, access to health care services, food production, availability and 
distribution, some of them not addressed in this study. 
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S1 Appendix. Sample size calculation 
The sample size calculation was performed using GLIMMPSE software (URL: 
http://glimmpse.samplesizeshop.org/#/).This is an open source tool that researchers can 
use for computing the sample size or power of longitudinal studies with repeated 
measurements [1-3].  HAZ was considered the main response variable in our study, which 
is a continuous variable measured 7 times (in Z-scores): baseline, Fu1, Fu2, Fu3, Fu4, 
Fu5 and Fu6. 
Step by step 
The easy way to start is choosing the Guided Study Design Method, which is designed 
for applied researchers as physicians, nurses and other researchers. To calculate the 
sample size, the following criteria were defined and introduced in the software: 
1. Power value – Usually a power value of 0.8 or 0.9 is desired. Considering the 
costs, human resources, logistic and time, in our study we chose 0.8 for 
calculation. 
2. Model – On the repeated measurements we wrote time in dimension text box to 
indicate that we will take repeated measurements across time. HAZ is going to be 
assessed 7 times (including baseline and six community follow-ups) with equal 
spacing between them. The two main predictors defined were treatment and level. 
For treatment predictor we insert two categories: Treatment without previous 
diagnosis and Treatment after diagnosis. For level predictor, the categories are: 
individual and household. After that, a ratio 1:1:1:1 was chosen to obtain equal 
group sizes for arms. 
3. Hypothesis – selecting the primary hypothesis, a statistical test and a type 1 error 
rate: In this study we aimed to evaluate the trend of the height-for-age Z score 
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reduction across time and within-participants-factors (treatment) using the 
Hotelling-Lawley Trace test, and a type error 1 of 0.05. 
4. Mean values – In this step the researcher has to define which is the expected mean 
value for the response variable in each treatment group and at each follow-up. We 
assumed that the average at baseline was the same for all the study groups (A1, 
A2, A3 and A4), and for this reason we input 0 for the expected baseline reduction 
value. We expect that each month the HAZ will reduce 0.01, 0.02, 0.04 and 0.06 
per month after individual treatment without previous diagnosis (A1), household 
treatment without previous diagnosis (A2), individual treatment after diagnosis 
(A3), and household treatment after diagnosis (A4), respectively. 
5. Standard deviations and correlations – We considered a standard deviation (SD) 
of 1.1 Z-scores. For correlations between two consecutive measurements we 
assumed 0.95 with a decay rate of 1% for the remaining. 
6. Results – The total sample size of children who are infected at least with one 
pathogenic intestinal parasite (protozoa and/or helminths) was computed to be 152 
(38 participants per group). 
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S2 Appendix. Losses to follow-up 
Overall 12 (9.9%) were permanently lost to the follow-up (7 boys and 5 girls), and did 
not perform the following assessment, mainly due to death (3/12), house not located 
(3/12), dropped-out (3/12), and emigration (3/12). All deaths occurred in female children, 
with 32, 29 and 49 months old, and the cause of death was known for only one child 
belonging to Arm 3 (malaria). Temporary withdrawal occurred in children from all arms: 
In Arm 1: 
 96.6% (28/29) of children received a single dose of ALB at Fu1; 
 85.7% (24/28) of children received a single dose of ALB at Fu4 (4 children were 
absent from their residence); 
 Of the total included, 82.8% (24/29) received complete intervention in both Fu1 
and Fu4. 
In Arm 2: 
 90.3% (28/31) of children and 83.3% (125/150) of household members received 
a single dose of ALB at Fu1; Coverage of ALB by household was ≥ 80% in 25 
cases. 
 93.1% (27/29) of children and 80.9% (123/152) of household members received 
a single dose of ALB at Fu4; Coverage of ALB by household was ≥ 80% in 23 
cases.  
 71.0% (22/31) of children received ALB in both Fu1 and Fu4 with a household 
coverage ≥80%. 
In Arm 3: 
 The percentage of children delivering a stool sample and receiving appropriate 
treatment by follow-up was: 77.4% (24/31) in Fu1; 67.7% (21/31) in Fu2; 74.2% 
(23/31) in Fu3; 74.2% (23/31) in Fu4; 64.5% (20/31) in Fu5, and 71.0% (22/31) 
in Fu6.  
 However, only 48.4% (15/31) of children delivered a stool sample and received 
appropriate treatment in all follow-ups. 
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In Arm 4: 
 The percentage of children delivering a stool sample and receiving appropriate 
treatment by follow-up was: 73.3% (22/30) in Fu1; 80.0% (24/30) in Fu2; 83.3% 
(25/30) in Fu3; 76.7% (23/30) in Fu4; 83.3% (25/30) in Fu5; and 73.3% (22/30) 
in Fu6. 
 The percentage of household members delivering the requested stool sample 
during the follow-up period ranged between 63.0% (92/146) and 74.6% (94/126). 
 At the household level, only nine children (30%) and at least 50% of their 
household members were able to deliver a stool sample and receive appropriate 
treatment in the six follow-ups. 
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S1 Table. Consort 2010 checklist 
 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 4, 5 
2b Specific objectives or hypotheses 5, 6 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 6 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons N/A 
Participants 4a Eligibility criteria for participants 6, 7 
4b Settings and locations where the data were collected 5, 6 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
7, 8, 9, 10 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
11 
6b Any changes to trial outcomes after the trial commenced, with reasons N/A 
Sample size 7a How sample size was determined 11 and 
Supplementary 
material 
7b When applicable, explanation of any interim analyses and stopping guidelines N/A 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 7 
8b Type of randomisation; details of any restriction (such as blocking and block size) 7,8 
 Allocation 9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers),  
CONSORT 2010 checklist  Page 2 
concealment 
mechanism 
describing any steps taken to conceal the sequence until interventions were assigned 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
7 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
N/A 
11b If relevant, description of the similarity of interventions 8, 9 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 11, 12 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses  
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
12 and Fig 1 
13b For each group, losses and exclusions after randomisation, together with reasons 15,16 and  
Fig 1 
Recruitment 14a Dates defining the periods of recruitment and follow-up 6, 12 
14b Why the trial ended or was stopped N/A 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 2 and 3 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
Fig 2 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
17, 18 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended Supplementary 
material 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
Supplementary 
material 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) N/A 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 23, 24 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 24 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 23, 24, 25 
Other information  
Registration 23 Registration number and name of trial registry 3 
CONSORT 2010 checklist  Page 3 
Protocol 24 Where the full trial protocol can be accessed, if available http://www.isrctn.com/
ISRCTN72928001 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Submission 
system 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
S2 Table. Primary outcomes missing data by study arm 
 
Follow-up (2 years) 
Arm 1 
(n=29) 
Arm 2 
(n=31) 
Arm 3 
(n=31) 
Arm 4 
(n=30) 
Total 
(n=121) 
n (%) n (%) n (%) n (%) n (%) 
No missing values 24 (82.8) 23 (74.2) 23 (74.2) 26 (86.7) 96 (79.3) 
1 missing values 2 (6.9) 4 (12.9) 3 (9.7) 1 (3.3) 10 (8.3) 
2 missing values  1 (3.4) 2 (6.5) 1 (3.2) 2 (6.7) 6 (5.0) 
3 missing values 1 (3.4) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.8) 
6 missing values 1(3.4) 2 (6.5) 4 (12.9) 1 (3.3) 8 (6.6) 
Note: the percentage of primary outcome missings (height, weight, MUAC, and the anthropometric indices of 
HAZ, WHZ and WAZ) did not differ among the four arms (p=0.534). Little´s test (Chi-Square = 39.952, DF =39, 
Sig= 0.428) suggested a mechanism MCAR, in terms of missing data 
 
 
S3 Table. Mean primary outcomes during follow-up by arms and overall 
Outcome 
Follow-up 
A1 (n=29) A2 (n=31) A3 (n=31) A4 (n=30) p-value 
mean ± SD mean ± SD mean ± SD mean ± SD 
Height 
Fu1 86.61 ± 5.27 88.70 ± 5.84 86.92 ± 5.29 88.02 ± 6.68 0.469 
Fu2 89.38 ± 5.43 91.45 ± 5.82 89.90 ± 4.96 90.67 ± 6.65 0.528 
Fu3 91.95 ± 5.60 94.22 ± 5.50 92.40 ± 5.21 93.39 ± 6.62 0.420 
Fu4 94.48 ± 5.85 96.71 ± 5.35 95.18 ± 4.86 96.01 ± 6.57 0.432* 
Fu5 96.83 ± 5.78 99.23 ± 5.37 97.47 ± 5.01 98.30 ± 6.82 0.408 
Fu6 99.29 ± 5.90 101.35 ± 5.33 99.91 ± 5.09 100.51 ± 6.46 0.548 
Dif fu6-fu1# 12.69 ± 2.01  12.65 ± 1.83 12.99 ± 1.72 12.49 ± 1.65 0.745 
Weight 
Fu1 11.83 ± 1.72 12.39 ± 1.86 12.08 ± 1.48 12.25 ± 1.91 0.572* 
Fu2 12.49 ± 1.86 13.12 ± 1.83 12.88 ± 1.55 13.06 ± 1.94 0.615* 
Fu3 13.20 ± 1.78 13.82 ± 1.84 13.56 ± 1.70 13.66 ± 2.03 0.644* 
Fu4 13.85 ± 1.91 14.45 ± 1.84 14.25 ± 1.65 14.37 ± 2.01 0.580* 
Fu5 14.44 ± 2.13 14.87 ± 1.82 14.75 ± 1.67 14.79 ± 2.20 0.798* 
Fu6 14.67 ± 2.27 15.32 ± 1.92 15.13 ± 1.77 15.36 ± 2.29 0.618* 
Dif fu6-fu1# 2.83 ± 0.95 2.93 ± 0.89 3.05 ± 0.76 3.11 ± 0.73 0.579 
HAZ 
Fu1 -1.33 ± 1.18 -1.29 ± 1.21 -1.33 ± 1.16 -1.42 ± 1.19 0.981 
Fu2 -1.31 ± 1.19 -1.23 ± 1.24 -1.25 ± 1.04 -1.38 ± 1.19 0.962 
Fu3 -1.28 ± 1.21 -1.13 ± 1.06 -1.24 ± 1.08 -1.30 ± 1.15 0.941 
Fu4 -1.24 ± 1.22 -1.08 ± 1.00 -1.12 ± 0.99 -1.21 ± 1.12 0.937 
Fu5 -1.19 ± 1.14 -0.99 ± 1.02 -1.11 ± 1.00 -1.19 ± 1.15 0.874 
Fu6 -1.12 ± 1.14 -0.99 ± 0.98 -1.05 ± 1.02 -1.15 ± 1.07 0.924 
Dif fu6-fu1# 0.21 ± 0.50 0.30 ± 0.51 0.28 ± 0.38 0.26 ± 0.36 0.849 
WHZ 
Fu1 -0.20 ± 1.09 -0.16 ± 1.14 0.03 ± 0.75 -0.10 ± 0.89 0.793 
Fu2 -0.21 ± 1.04 -0.08 ± 0.96 0.10 ± 0.88 0.05 ± 1.01 0.608 
Fu3 -0.12 ± 0.96 -0.07 ± 1.03 0.14 ± 0.97 -0.04 ± 0.98 0.754 
Fu4 -0.11 ± 0.90 -0.07 ± 1.00 0.11 ± 0.94 0.01 ± 1.05 0.829 
Fu5 -0.15 ± 0.94 -0.27 ± 0.76 0.03 ± 0.86 -0.19 ± 0.91 0.579 
Fu6 -0.51 ± 1.06 -0.39 ± 0.83 -0.20 ± 0.83 -0.23 ± 0.98 0.542 
Dif fu6-fu1# -0.31 ± 0.79 -0.22 ± 0.86 -0.23 ± 0.58 -0.13 ± 0.55 0.824 
WAZ 
Fu1 -0.86 ± 1.06 -0.81 ± 1.10 -0.69 ± 0.88 -0.84 ± 0.92 0.909 
Fu2 -0.87 ± 1.06 -0.75 ± 0.96 -0.62 ± 0.86 -0.73 ± 0.92 0.792 
Fu3 -0.80 ± 0.97 -0.69 ± 0.90 -0.60 ± 0.91 -0.76 ± 0.93 0.839 
Fu4 -0.79 ± 0.95 -0.68 ± 0.89 -0.57 ± 0.85 -0.70 ± 0.87 0.815 
Fu5 -0.80 ± 1.03 -0.77 ± 0.84 -0.64 ± 0.78 -0.82 ± 0.88 0.845 
Fu6 -1.00 ± 1.03 -0.84 ± 0.86 -0.76 ± 0.79 -0.84 ± 0.93 0.752 
Dif fu6-fu1# -0.15 ± -0.55 -0.03 ± 0.64 -0.07 ± 0.44 0.01 ± 0.31 0.655 
MUACZ 
Fu1 -0.92 ± 1.11 -0.76 ± 1.10 -0.62 ± 0.65 -0.59 ± 0.82 0.508 
Fu2 -0.91 ± 0.81 -0.71 ± 0.94 -0.60 ± 0.61 -0.71 ± 0.83 0.518 
Fu3 -0.95 ± 0.85 -0.78 ± 0.92 -0.81 ± 0.74 -0.66 ± 0.73 0.591 
Fu4 -0.85 ± 0.81 -0.72 ± 1.02 -0.67 ± 0.59 -0.64 ± 0.67 0.733 
Fu5 -0.87 ± 0.92 -0.80 ± 0.88 -0.64 ± 0.72 -0.71 ± 0.78 0.736 
Fu6 -0.93 ± 0.90 -0.91 ± 0.75 -0.88 ± 0.68 -0.85 ± 0.68 0.977 
Dif fu6-fu1# -0.01 ±0.75 -0.15 ± 0.89 -0.26 ± 0.67 -0.26 ± 0.52 0.496 
From a descriptive point of view, children in A2 were, on average, slightly taller (and older) at entry and 
persisted with higher mean heights throughout the study. Children in A1 were, on overage, slightly thinner 
(and younger) at entry and persisted with lower mean weights throughout the study compared to the 
remaining groups.  
Comparing the mean HAZ, WHZ and WAZ from Fu1 to Fu6, no differences were detected among arms. 
The mean HAZ was slightly higher in A1 compared to the remaining arms. However, after two years of 
follow-up, slight improvements in mean HAZ were registered mainly in A2, followed by A3, A4 and A1, 
although mean values remained negative and far from zero in all six moments (ranging from -1.42±1.19 
and -0.99±0.98). Considering WHZ, mean values during follow-up were higher compared with HAZ 
(ranging from -0.51±1.06 and 0.14±0.97), with slight improvements until Fu4, followed by a decreased 
close to those values observed at the baseline. Mean values of WAZ ranged from -1.00±1.03 to -0.57±0.85 
and remained negative and without significant differences throughout the study. Mean values of MUACZ 
remained negative across follow-up period, ranging from -0.59 ± 0.82 to -0.95 ± 0.85. *Kruskal-Wallis; 
#difference between initial follow-up (Fu1) and final follow-up (Fu6). 
S4 Table. Percentage of stunting, wasting and underweight in children during 
follow-up and by arms 
Variables Follow-up 
A1  A2  A3  A4  p-value 
(n=29) (n=31) (n=31) (n=30) 
n (%) n (%) n (%) n (%) 
S
tu
n
ti
n
g
 
Moderate-to-severe 
(HAZ < -2) 
Fu1 7 (24.1) 11 (35.5) 8 (25.8) 11 (36.7) 0.630 
Fu2 7 (24.1) 10 (32.3) 7 (22.6) 10 (33.3) 0.727 
Fu3 8 (27.6) 6 (19.4) 9 (29.0) 11 (36.7) 0.526 
Fu4 7 (24.1) 7 (22.6) 7 (22.6) 10 (33.3) 0.741 
Fu5 7 (24.1) 6 (19.4) 8 (25.8) 9 (30.0) 0.807 
Fu6 6 (20.7) 6 (19.4) 7 (22.6) 8 (26.7) 0.914 
P-value (Fu6 vs Fu1)§ 1.000 0.063 1.000 0.375   
Dif (%) Fu6 – Fu1#  -3.4 -16.1 -3.2 -10.0  
Mild-to-severe  
(HAZ < -1) 
Fu1 21 (72.4) 21 (67.7) 21 (67.7) 20 (66.7) 0.966 
Fu2 15 (51.7) 20 (64.5) 21 (67.7) 20 (66.7) 0.570 
Fu3 15 (51.7) 17 (54.8) 20 (64.5) 18 (60.0) 0.762 
Fu4 15 (51.7) 16 (51.6) 19 (61.3) 16 (53.3) 0.865 
Fu5 15 (51.7) 17 (54.8) 17 (54.8) 14 (46.7) 0.918 
Fu6 13 (44.8) 15 (48.4) 17 (54.8) 14 (46.7) 0.891 
P-value (Fu6 vs Fu1)§ 0.008* 0.031* 0.125 0.031*  
Dif (%) Fu6 – Fu1# -27.6 -19.3 -12.9 -20.0   
W
a
st
in
g
 
Moderate-to-severe 
(WHZ < -2) 
Fu1 1 (3.4) 2 (6.5) 0 (0.0) 1 (3.3) 0.652¶ 
Fu2 1 (3.4) 0 (0.0) 0 (0.0) 0 (0.0) 0.240¶ 
Fu3 1 (3.4) 1 (3.2) 1 (3.2) 2 (6.7) 0.874¶ 
Fu4 1 (3.4) 1 (3.2) 1 (3.2) 1 (3.3) 1.000¶ 
Fu5 2 (6.9) 2 (6.5) 0 (0.0) 0 (0.0) 0.257 
Fu6 2 (6.9) 0 (0.0) 0 (0.0) 2 (6.7) 0.213 
P-value (Fu6 vs Fu1)§ 1.000   1.000  
Dif (%) Fu6 – Fu1# 3.5 -6.5 0.0 3.4  
Mild-to-severe  
(WHZ < -1) 
Fu1 8 (27.6) 7 (22.6) 1 (3.2) 4 (13.3) 0.038¶ 
Fu2 7 (24.1) 3 (9.7) 3 (9.7) 5 (16.7) 0.359¶ 
Fu3 7 (24.1) 4 (12.9) 2  (6.5) 4 (13.3) 0.282¶ 
Fu4 5 (17.2) 4 (12.9) 3 (9.7) 6 (20.0) 0.668¶ 
Fu5 6 (20.7) 4 (12.9) 2 (6.5) 8 (26.7) 0.157¶ 
Fu6 11 (37.9) 7 (22.6) 3 (9.7) 6 (20.0) 0.079¶ 
P-value (Fu6 vs Fu1)§ 0.250 1.000 0.500 0.500  
Dif (%) Fu6 – Fu1# 10.3 0.0 6.5 6.7  
U
n
d
er
w
ei
g
h
t 
Moderate-to-severe 
(WAZ < -2) 
Fu1 4 (13.8) 4 (12.9) 1 (3.2) 3 (10.0) 0.474 
Fu2 4 (13.8) 3 (9.7) 2 (6.5) 3 (10.0) 0.786 
Fu3 4 (13.8) 1 (3.2) 2 (6.5) 3 (10.0) 0.415 
Fu4 2 (6.9) 3 (9.7) 0 (0.0) 3 (10.0) 0.315 
Fu5 3 (10.3) 2 (6.5) 0 (0.0) 2 (6.7) 0.344 
Fu6 5 (17.2) 2 (6.5) 1 (3.2) 3 (10.0) 0.256 
P-value (Fu6 vs Fu1)§ 1.000 1.000 1.000 1.000  
Dif (%) Fu6 – Fu1# 3.4 -6.4 0.0 0.0  
Mild-to-severe  
(WAZ < -1) 
Fu1 10 (34.5) 13 (41.9) 11 (35.5) 14 (46.7) 0.757 
Fu2 10 (34.5) 12 (38.7) 10 (32.3) 10 (33.3) 0.962 
Fu3 11 (37.9) 12 (38.7) 11 (35.5) 11 (36.7) 1.000 
Fu4 11 (37.9) 10 (32.3) 10 (32.3) 11 (36.7) 0.951 
Fu5 11 (37.9) 15 (48.4) 11 (35.5) 13 (43.3) 0.736 
Fu6 14 (48.3) 14 (45.2) 12 (38.7) 13 (43.3) 0.903 
P-value (Fu6 vs Fu1)§ 0.125 1.000 1.000 1.000  
Dif (%) Fu6 – Fu1# 13.8 3.3 3.2 -3.4  
§McNemar´s test; ¶Fisher´s exact-test; #Difference in percentage between initial (Fu1) and final follow-up (Fu6); 
*p<0.05 
 
S5 Table. Percentage of stunting during follow-up and by gender.  
Gender Variable 
 
Follow-up A1 
(n=29) 
A2 
(n=31) 
A3 
(n=31) 
A4 
(n=30) 
p-
value 
 n (%) n (%) n (%) n (%) 
Female 
(N=61) 
Moderate-to-
severe stunting 
(HAZ < -2) 
Fu1 3 (23.1) 6 (46.2) 4 (22.2) 5 (29.4) 0.540 
Fu2 3 (23.1) 6 (46.2) 3 (16.7) 3 (17.6) 0.266 
Fu3 4 (30.8) 3 (23.1) 4 (22.2) 4 (23.5) 0.954 
Fu4 3 (23.1) 4 (30.8) 2 (11.1) 3 (17.6) 0.597 
Fu5 3 (23.1) 3 (23.1) 3 (16.7) 3 (17.6) 0.947 
Fu6 2 (15.4) 3 (23.1) 3 (16.7) 2 (11.8) 0.934 
P-value*  
(Fu1 vs Fu6) 
1.000 0.250 1.000 0.250  
Mild-to-severe 
stunting 
(HAZ < -1) 
Fu1 10 (76.9) 9 (69.2) 12 (66.7) 11 (64.7) 0.929 
Fu2 8 (61.5) 9 (69.2) 11 (61.1) 11 (64.7) 0.983 
Fu3 9 (69.2) 8 (61.5) 11 (61.1) 9 (52.9) 0.847 
Fu4 9 (69.2) 9 (69.2) 11 (61.1) 7 (41.2) 0.357 
Fu5 9 (69.2) 9 (69.2) 10 (55.6) 7 (41.2) 0.359 
Fu6 7 (53.8) 8 (61.5) 10 (55.6) 6 (35.3) 0.532 
P-value*  
(Fu1 vs Fu6) 
0.250 1.000 0.500 0.063  
Male 
(N=60) 
Moderate-to-
severe stunting 
(HAZ < -2) 
Fu1 4 (25.0) 5 (27.8) 4 (30.8) 6 (46.2) 0.283 
Fu2 4 (25.0) 4 (22.2) 4 (30.8) 7 (53.8) 0.160 
Fu3 4 (25.0) 3 (16.7) 5 (38.5) 7 (53.8) 0.160 
Fu4 4 (25.0) 3 (16.7) 5 (38.5) 7 (53.8) 0.160 
Fu5 4 (25.0) 3 (16.7) 5 (38.5) 6 (46.2) 0.299 
Fu6 4 (25.0) 3 (16.7) 4 (30.8) 6 (46.2) 0.359 
P-value*  
(Fu1 vs Fu6) 
1.000 0.500 1.000 1.000  
Mild-to-severe 
stunting 
(HAZ < -1) 
Fu1 11 (68.8) 12 (66.7) 9 (69.2) 9 (69-2) 1.000 
Fu2 7 (43.8) 11 (61.1) 10 (76.9) 9 (69.2) 0.315 
Fu3 6 (37.5) 9 (50.0) 9 (69.2) 9 (69.2) 0.261 
Fu4 6 (37.5) 7 (38.9) 8 (61.5) 9 (69.2) 0.219 
Fu5 6 (37.5) 8 (44.4) 7 (53.8) 7 (53.8) 0.757 
Fu6 6 (37.5) 7 (38.9) 7 (53.8) 8 (61.5) 0.515 
P-value*  
(Fu1 vs Fu6) 
0.063 0.063 0.500 1.000  
* McNemar´s test 
 
  
 
 
 
 
 
 
 
 
S1 Fig. Infection with pathogenic intestinal parasites in children during follow-up: 
A3 and A4 
 
 
87 
 
 
 
 
3. DISCUSSION AND CONCLUSIONS 

DISCUSSION AND CONCLUSIONS
89 
 
 
Similar to other low- and middle-income countries, in Angola, malnutrition and 
diarrhoeal disease are among the major causes of deaths in children under-five years of 
age (1-3). Data related to malnutrition prevalences from the Multiple Indicators Survey 
in 2015-2016 indicates that 37.6% of children are suffering from stunting, 4.9% from 
wasting, and 19.0% from underweight (4). As previously mentioned in the introduction 
section of this thesis, the national nutrition goal is to reduce stunting to less than 5%, 
wasting to less than 5% and underweight to less than 10% by 2021 (2). Current studies 
focusing on malnutrition and enteric infections in the paediatric population of Angola are 
still scarce (5-12). 
In this thesis two studies were performed: one hospital-based cross-sectional study aiming 
to identify the aetiological agents of diarrhoea in 344 children under-five years attending 
the Bengo General Hospital between September 2012 and December 2013, including the 
molecular characterization of rotavirus circulating genotypes and Giardia lamblia 
assemblages and subassemblages; and a four-arm randomised parallel trial during two 
years to investigate if treatment of intestinal parasites (with or without previous diagnosis) 
in two different levels (individual or household) impacts on nutritional status of 121 
children between 2 and 5 years old. Main findings of both studies are summarized in 
Annexe IV. 
High levels of malnutrition were found among children included in both studies (cross-
sectional and longitudinal): moderate-to-severe stunting (32.4% and 30.6%), wasting 
(31.5% and 7.5%) and underweight (34.5% and 16.0%). However, a great proportion of 
children were suffering from mild malnutrition in both studies: mild stunting (22.2% and 
33.1%), mild wasting (19.5% and 33.1%) and mild underweight (26.6% and 29.4%), 
showing the importance of intervening in a timely manner in this group of children to 
prevent worsening of the nutritional status. The discrepancies between two studies are 
expected, since the first one included under-five children with diarrhoea (of which more 
than 80% were under 24 months of age); and the second study included older children 
(aged 20-36 at the recruitment to be followed-up between their second and fifth year of 
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life) infected with at least one pathogenic intestinal parasite, regardless presenting 
diarrhoea or not. 
Considering the living conditions, the results were also similar between the cross-
sectional and the longitudinal studies: near 20% of children did not have access to a latrine 
(in both studies); the drinking water sources more frequently used were the river (27.0% 
in the first study and 24.8% in the second study), the tap in the yard (24.4% and 27.4%), 
the private tank (24.4% and 29.1%) and the public tap water (13.3% and 7.7%); and 
among those treating water before consuming (60.2% and 42.7%), bleach (82.1% and 
88.0%) and boiling were the most frequent methods applied. These results show that a 
large proportion of children does not have access to safe water, hygiene and sanitation 
conditions. Indeed, the majority of Angolans, even in peri-urban areas, are still depending 
on informal mechanisms for water supply, most of them of poor quality and, thus, 
representing a significant risk for the health (13).  
In the cross-sectional study, it was found that 66.0% of children were infected with at 
least one pathogenic enteric agent. Most cases of diarrhoea were due to Cryptosporidium 
(30.0%), rotavirus (25.1%) and Giardia lamblia (21.6%). Other enteric pathogens were 
also identified, such as diarrheagenic Escherichia coli (6.3%), Ascaris lumbricoides 
(4.1%), adenovirus (3.8%), Strongyloides stercoralis (3.5%), astrovirus (2.6%), 
Hymenolepis nana (1.7%), Entamoeba histolytica/díspar (0.9%), Taenia spp. (0.6%), 
Trichuris trichiura (0.3%), and Entamoeba histolytica (0.3%). Twenty-five percent of 
children had multiple infections. These results are important to national health policies, 
since the identification of the agent causing diarrhoea is essential to define better 
strategies related to the primary and secondary health sectors (e.g., vaccination and 
treatment regimens, respectively). 
In this context, before the introduction of rotarix vaccine in the national immunization 
plan, the Angolan Ministry of Health sponsored a research study to provide baseline 
information on the molecular profile of rotavirus (5). It was a cross-sectional study 
addressing viral agents (first rotavirus, and then norovirus and astrovirus) carried out in 
health units, mainly located in urban areas of four provinces: Huambo (June 2012), Zaire 
(July-August 2012), Luanda (September-October 2013) and Cabinda (September-
October 2013). Infection rates varied between the provinces: Zaire (56.0%), Huambo 
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(37.4%), Luanda (22.7%) and Cabinda (14.6%), and a globally common G1P[8] was 
found (50.0%), along with the uncommon strain G1P[6] (29.3%) and G2P[4] (5.2%) (5).  
The study conducted in Bengo, also before the vaccine introduction, contributed with new 
information since there was no previous data on the burden of rotavirus for this province, 
nor during a year-period in the country. It was found that 25.1% of children were infected, 
and similar to the previous study, G1P[8] was the most frequent genotype (47.2%), 
followed by G1P[6] (29.2%) and G2P[4] (12.5%). A systematic review investigating the 
prevalence of RVA genotypes circulating in Africa between 2006 and 2016 found that 
G1P[8] was also the most encountered combination (22.6%), followed by G2P[4] (8.3%), 
G9P[8] (7.0%) and G2P[6] (5.0%) (14), though difference in circulating strains were 
found across years, within regions and countries (14).  
Associations between rotavirus infection and other sociodemographic variables were also 
explored in the cross-sectional study. Rotavirus infection rate was more frequent in 
children less than 12 months, presenting vomiting, and attending the emergency service 
unit. No significant association was found between rotavirus infection and the type of 
water source or sanitation conditions, probably due to the fact that rotavirus is ubiquitous, 
and it is not confined only in settings with poor hygiene and sanitation conditions (15). 
Thus, since rotavirus is highly contagious (faecal oral and person-to-person transmission, 
as well through fomites in the environment), and without an effective treatment such as 
antibiotics, severe cases can rapidly deteriorate the nutritional status of children, leading 
to severe dehydration and death (16). This enhances the importance of rotavirus vaccine 
introduction in the country in order to prevent morbidity and mortality, especially in 
infants, along with other strategies, such as access to adequate WASH and early 
rehydration therapy (1, 15). Thus, the introduction of the vaccine in Angola was 
recognized as a priority, and it was formalized in April 2014 with Rotarix vaccine to be 
administered at two and four months of age. This marked two distinct eras: pre- and post-
introduction of the vaccine.  
According to WHO Surveillance Standards of Vaccine-Preventable Diseases, during the 
pre-era, countries must generate information to facilitate and support the introduction of 
rotavirus vaccine, related to the epidemiology and burden of associated hospitalizations, 
clinical presentations and outcomes of the disease, seasonality, and the prevalence of 
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circulating strains (17). The collection of data in at least one sentinel site per country, 
among children under-five, and preferably by including 250-500 cases during two full 
years prior to vaccine introduction, is also recommended (17). Thus, considering these 
guidelines, it is undeniable the contribution of the study conducted in Hospital Geral do 
Bengo, although not performing collection data during the full two year-period. Findings 
from this research were formally communicated to the Ministry of Health, and 
disseminated through publication in international journals, presentations in national and 
international conferences, television, radio and national health newspaper.  
Since the rotarix introduction in Angola, according to the update estimates reported by 
WHO (21 September 2018), coverage has been increasing over the years, achieving in 
2017 a rate of 82% in the first dose administered and 68% in the second dose (18). As 
emphasized in October 2018, during the Meeting of the Strategic Advisory Group of 
Experts on Immunization - SAGE (October, 2018), it is essential to perform surveillance 
and obtain data at national and subnational levels after the vaccine introduction (19). 
Rotavirus vaccination has showed to substantially reduce global deaths of children 
younger than five years, which is a target included in the Sustainable Development Goals 
(20). Therefore, it is expected that the introduction of rotarix vaccine will be likely to 
contribute to the reduction of infant and under-five mortality rates in Angola, which in 
turn can lead to better health and socioeconomic outcomes of the country (20). However, 
gains must be monitored and maintained. A recent systematic review with post-licensure 
57% in countries with low, medium, and high child mortality, respectively (152). 
diarrhoea-associated deaths among infants in a rural community of Malawi (34%), 
showing the important impact of rotavirus vaccine programs (21). In the European & 
Developing Countries Clinical Trials Partnership (EDCTP) stakeholder meeting on 
diarrhoeal diseases (July, 2016), rotavirus prevention was not identified as a high priority 
area for short-term research since the vaccine is providing good results, but it was 
enhanced that vaccine effectiveness needs continued monitoring to certificate that vaccine 
covers the diversity of strains in SSA (22). Until this moment, no research studies were 
published addressing the impact and effectiveness of rotavirus vaccine in reducing 
diarrhoea-associated mortality in Angolan infants. Research studies conducted during the 
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pre-era vaccination will be crucial as baseline information to compare with pos-era 
vaccination studies.  
The first study of this thesis added relevant information on the burden of enteric disease, 
addressing not only viruses, but also parasitic and bacteria infections in under-five 
children. Regarding bacterial agents, Escherichia coli was confirmed to be pathogenic in 
19 of 97 isolates: 12.4% EAEC and 7.2% ETEC. A multisite birth cohort study (MAL-
ED), conducted between 2009 and 2012 in eight sites in South America, Africa, and Asia 
have identified Campylobacter spp. as the enteric agent with the highest attributable 
burden of diarrhoea during the first two years, as well as Shigella, though only during the 
second year (23). After applying molecular procedures in the same samples, Shigella spp., 
Escherichia coli, Campylobacter spp. and typical enteropathogenic Escherichia coli 
continued to be among the top ten pathogens accounted for attributable diarrhoea (24).  
Conversely, Campylobacter jejuni, Shigella spp and Salmonella spp. were not isolated in 
this study. In poor-resource settings performing conventional microbiologic techniques 
can be challenging due to the constant problems related to the electrical power, which can 
interfere with the laboratory procedures (25, 26). Thus, our bacterial results should be 
interpreted with caution, and future studies are needed to better address the prevalence of 
these infections among preschool children in Angola. Indeed, there are cultural habits in 
the country that can influence the faecal-oral transmission of pathogens. For instance, 
similar to other low and middle-income countries, the informal street food vending is 
common in Angola, and is usually conducted outside the regulation of national laws. 
There is evidence that the preparation of street foods with inadequate hygienic conditions, 
the time that the food remains at ambient temperature, and serving with bare hands 
contribute to the transmission of pathogens of public health importance, mainly 
Campylobacter jejuni, Salmonella spp. and Shigella spp. However, due to the relatively 
inexpensive prices, food street attracts mainly, but not only, individuals with lower 
purchasing power (27, 28).  
The lack of hygiene conditions is an important factor also among intestinal parasites 
transmission. For instance, in the MICS survey 2015-2016, 11% of caregivers reported 
giving other food or liquid than breastmilk in the first three days of the child´s life (4). 
Considering that a great proportion of caregivers reported drinking water from river or 
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from the tap in the yard without any previous treatment, children can became easily 
infected even in the first months of their lives, as shown in the study addressing the 
aetiological agents of diarrhoea. In the same study, helminthic infections were more 
common in children older than 12 months. At this age, children start walking barefoot, 
playing in contaminated soils and putting their hands in the mouths. Thus, these 
environmental conditions where children spend their time can increase the risk for 
infections. Furthermore, the high temperature of this region can also influence the 
dehydration of children who spend considerable time away from home without 
supervision of caregivers (29).  
In the cross-sectional study, Cryptosporidium spp. was the most common pathogenic 
identified, especially during infancy. More recently, a study conducted in Cubal, 
Benguela province, have also reported Cryptosporidium spp. infection after molecular 
analysis of stool samples of school-aged children (2.9%) (10). Results from Bengo study 
are in accordance to findings from MAL-ED study, where Cryptosporidium spp. was the 
second leading agent, after rotavirus, causing the highest burden of diarrhoea in children 
less than 12 months (23). Moreover, this protozoan has been also associated in developing 
countries with a greater than two-fold increase in mortality in children aged 12-23 months 
with moderate-to-severe diarrhoea (30). 
These findings highlight the importance of Cryptosporidium infection, and considering 
the results from Bengo province, more attention should be given to the burden of the 
disease among infants. Oocysts of Cryptosporidium are stable and persistent in the 
environment, and can be found in contaminated water sources (31-33). In this study, no 
significant association was found between the type of water source used and this 
infection. As previously reported, the use of unsafe water for drinking is common, and 
when treated, bleach was the most common treatment method applied. We did not collect 
data to understand if the treatment method was correctly applied. However, when talking 
to the caregivers it was possible to perceive that a great proportion did not applied it 
correctly (e.g. inadequate number of bleach drops in relation to the amount of water to be 
treated, or boiling during few minutes, less than the necessary). Despite this, it is known 
that water disinfection with chlorine is not effective against Cryptosporidium spp., an 
important waterborne protozoan parasite (34), and boiling was a method applied by small 
proportion of caregivers, which enhances the need for safe drinking water source (35). 
95 
 
DISCUSSION AND CONCLUSIONS 
Regardless of the method of water treatment, it was possible to understand that providing 
information on the adequate treatment of drinking water is essential. Findings from a 
recent systematic review also did not report a significant association between poor 
drinking water quality and Cryptosporidium spp. infection in low- and middle income 
countries (33). In our cross-sectional study no association was found between 
Cryptosporidium spp. infection and sanitation conditions. However, according to the 
systematic review previously referred, lack of appropriate sanitation/ open defecation 
(OR: 1.82; 95%CI: 1.19-2.8), animal contact (OR: 1.98, 95%CI: 1.11-3.54), diarrhoea in 
the household (OR:1.98, 95%CI: 1.13-3.49), and overcrowded living conditions 
(OR:1.37, 95%CI: 1.07-1.75) were also important risk factors for the infection (33).  
Our cross-sectional study found a higher proportion of wasting in children infected with 
Cryptosporidium spp. compared to those not infected (34.1 versus 25.8%), only 
significant in the univariate analysis. Infection with Cryptosporidium spp. has been 
previously associated with malnutrition, stunted growth and cognitive impairment (31). 
A longitudinal birth cohort study conducted in Bangladesh found that 77.0% of children 
experienced at least one infection with Cryptosporidium spp. in the first two years of life 
(36), and that extreme poverty was associated with higher rates of infection, leading to a 
greater than two-fold increased risk of severe stunting at age two, compared to those not 
infected (36).  
Regarding treatment strategies, nitazoxanide is the only available drug for treatment in 
children older than 12 months, and it was previously reported an efficacy ranging from 
56% to 96% in healthy individuals (32). However, it is less effective in 
immunocompromised individuals, such as those HIV positive and/or malnourished (32, 
37-40). Thus, Cryptosporidium spp. infection is a great challenge, especially in settings 
with poor sanitation and in HIV-positive individuals (32, 36, 38, 41). The need for more 
effective drugs was defined as a high priority level in the EDCTP meeting on diarrhoeal 
diseases in 2016, and it was also suggested conducting a clinical trial to investigate the 
effect of the drug on stunting (22). Until better treatment strategies are found, a great 
investment should be done to increase the access to safe drinking water and adequate 
sanitation conditions (33). 
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The cross-sectional study included in this thesis found a large proportion of children with 
diarrhoea infected with Giardia lamblia (21.6%). Other studies conducted in Angola also 
reported high infection rates, but in school-age children, in the provinces of Bié (18.0%) 
Huila (20.1%) and Benguela (37.9%) (7, 8, 10). Additionally, findings from Bengo study 
have also provided a molecular characterization of Giardia lamblia, showing a 
predominance of assemblage B among children with acute diarrhoea (11/12, 91.7%), 
while assemblage A was identified in only one child (1/12, 8.3%). Despite the few 
samples used, this was the first report providing information on the molecular profile of 
this intestinal protozoan. More recently, a higher frequency of Giardia assemblage B 
(18/28, 64.3%) compared with assemblage A (10/28, 35.7%) was also reported in Cubal, 
Benguela (10). In Rwanda, a study conducted in a rural community (84.4%) and health 
units (15.6%) showed that, off all intestinal parasites, Giardia lamblia was the most 
frequent in under-five children, with a prevalence of 19.8% considering microscopic 
diagnosis, and 60.1% after molecular analysis with PCR (42).  
In our longitudinal study, a great proportion of Giardia lamblia was found in 
asymptomatic children compared with children with diarrhoea, at baseline. From a public 
health perspective this is an important issue, since asymptomatic children can shed cysts, 
and thence contribute for the transmission of disease. This highlights the need to address 
giardiasis among children, in parallel with soil-transmitted helminth infections. However, 
only STHs are targeted in the regular preventive chemotherapy (deworming) 
recommended by WHO (43).  
According to the most recent Cochrane systematic review, in communities where 
intestinal helminths are endemic, the effect of a single dose deworming drug probably 
has little or no effect on average weight gain (moderate quality evidence), on average 
haemoglobin (moderate quality evidence), and on cognition (low quality evidence) of 
children (44). Similarly, according to another systematic review, including 52 studies 
from low- and middle-income countries, the effect of mass deworming for STHs was also 
reported to have little effect on growth and other health outcomes of children between 6 
months and 16 years (45). A cluster-randomised trial including one million pre-school 
children in north India has also shown little or no effect of regular deworming on mortality 
(46). Conversely, in a research study using data from 45 Demographic and Health 
Surveys, it was recently reported that deworming was consistently associated with 
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stunting and anaemia reduction in SSA and, thus, supporting the benefits of deworming 
among preschool age children (47). Results are controversial and the benefits of 
deworming on nutritional status of children are still under discussion (48).  
To our knowledge, the four-arm randomised controlled trial included in this thesis was 
the first longitudinal study performed in Angola to investigate the effect of different 
treatment strategies (annual albendazole versus screening and treating intestinal parasites) 
at two levels (individual and household) on nutritional status of children aged 2-5 years. 
Some results of this study were summarized in the fourth paper, but additional data can 
be explored in the future. 
Briefly, 121 children infected with at least one pathogenic intestinal parasite were 
included for two years of community follow-up. A sociodemographic survey applied in 
this study also provided new information regarding the household environment. For 
instance, household material construction had mainly adobe walls (74.4%), cement or 
ceramic floor (87.2%) and iron sheets roof (95.7%), as illustrated in Annexe V   Photos 
from fieldwork. The majority of assets had at least a mobilephone (94.0%), television 
(88.0%), public electricity (80.3%). Freezers (75.2%) were more commonly used than 
generators (23.9%) or refrigerators (17.9%). After an exploratory analysis, we have found 
that the proportion of stunting was higher in houses with adobe walls compared with those 
made of bricks, and in houses with earth or sand floors compared with cement floor, 
enhancing the contribution of poor living conditions in the health of children. 
Findings from the longitudinal study suggest that screening and treating intestinal 
parasites did not result in better growth outcomes compared to annual albendazole, 
regardless it was performed at individual or household level. According to previous 
research, the benefits of deworming is likely greatest among children with severe 
intensity of infection (43). However, at baseline of our longitudinal study children were 
lightly infected with STH, which could have also contributed to these results. Besides, 
deworming does not interrupt the cycle of transmission, and without changing the 
evolving environmental conditions, they remain vulnerable to reinfections (49).  
Besides, there are other nutrition-factors that were not addressed in this thesis but could 
have contributed for this result: the diet quality (which can be influenced by factors 
related to the consumer, such as time, knowledge, purchasing power, and preferences) 
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and the food environment (related to food production, crop yields, price, quality and 
physical access) (50, 51). In Angola, all these factors were recently recognized as 
determinants for better nutritional outcomes during the first International Conference on 
Food and Nutrition Security that took place in Luanda, the capital province. Promoting 
agricultural production, ensuring food storage and transport, transformation and retailing 
is essential. Agriculture sector is now a priority area for action in Angola given its 
expected impact on employment growth, household income and, consequently, in 
reducing poverty (52).  
To assess the evolution of nutritional status, in our longitudinal study anthropometric 
indices were calculated at baseline and every four months until the end of the study. At 
baseline, the overall mean observed for anthropometric indices were: HAZ -1.34±1.33; 
WHZ -0.29±1.18; and WAZ -0.80±0.98. After two years, the mean Z-scores values 
remained negative for all anthropometric indices: HAZ -1.08±1.04, WHZ -0.33±0.92, and 
WAZ -0.86±0.90. Similar to our baseline results, mean Z-scores of children under-five 
years included in the MICS 2015-2016 were: HAZ -1.5; WHZ 0.1; and WAZ -1.0 (4), 
showing this is an important issue to be addressed not only in Bengo province, but also 
at national level. Moreover, compared to other regions of the world, SSA is the region 
with the shortest children, after South Asia, while the tallest are in Europe and Central 
Asia, almost to 1.5 Z-scores higher than the obtained for SSA region, for children between 
two and five years (53). 
An important factor that can influence child malnutrition is related to maternal health, 
also not addressed in this thesis. Growth faltering has been reported mainly in low- and 
middle-income countries, where children are already born with mean values below the 
WHO reference and continue to decrease substantially until two years of age, enhancing 
the importance of interventions targeting the first 1,000 days of life (including pregnancy 
and the first two years of the child´s life), also known as window of opportunity for 
preventing undernutrition (53).  
Although there was no evidence of significant effect on nutritional outcomes by any of 
the treatment strategies performed in the longitudinal study, we have found an important 
reduction of mild malnutrition, even beyond the window of opportunity. It is true that 
severe malnutrition poses an increased risk of death in children (54, 55). However, 
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children with mild malnutrition are vulnerable to variations of their nutritional condition. 
Although Angola has been at peace for more than a decade, there are regions where 
children are vulnerable to poverty, which can contribute to worsen their nutritional status. 
Thus, greater attention should be given to this neglected degree of malnutrition.  
Regarding the interventions provided in arms 3 (screening and treating at individual level) 
and 4 (screening and treating at household level), it was possible to observe, from the 
initial to the final follow-up, a significant reduction of Giardia lamblia infection among 
children from arm 4, but not among children of arm 3, enhancing the importance of 
transmission among individuals living in the same household. Given the great dimension 
of data collected in the longitudinal study, pathogenic intestinal parasites identified 
among the household members are not presented in this work, but it is our intention to 
address this subject in the near future. 
Implementing a longitudinal study in a poor setting is challenging, and not surprisingly, 
our sample size was slightly smaller than the theoretical sample calculated. This was due 
to a high proportion of children not delivering the stool sample at the recruitment 
(compared to what we have expected), as well as those children that met the inclusion 
criteria but did not appear for treatment before allocation. In this longitudinal study, we 
not only included 121 children, but also household members: for example, in Arm 2 the 
single dose of albendazole was also given to 125 household members in the first follow-
up (83.3% of the total, 125/150), and 123 in the fourth follow-up (80.9% of the total, 
123/152). Moreover, in Arm 4, a stool sample was requested to each one of the members 
living in the same household in all follow-ups. Logistically this becomes much more 
demanding because families are monitored over time and the success of interventions 
requires not only access to the child, but also the collaboration of all household members. 
It is important to keep in mind that a follow-up visit interferes with the dynamics of each 
member of the family, their leisure time, work schedule and their responsibilities to the 
community (56). For these and other reasons, it is extremely important to be aware of the 
social context of the study and the importance of promoting good communication and 
flexibility in order to enhance the participation of all members of each household 
included. In this study, we included only participants with residence in the Dande HDSS 
study area, since a geographical coordinate is generated for each household. However, 
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even with this great support, during community- follow-up, sometimes it was difficult to 
access the houses of the participants for different reasons: poor condition of roads11, some 
streets have no name, and reference available to vague outstanding points (e.g. near the 
old tree, by the river, next to the house of the hamlet coordinator). Some of these 
difficulties were addressed by including the support of local collaborators. Even so, 79% 
of children were successfully followed-up in the community for the six assessments 
scheduled during the study. 
In terms of public health, these findings suggest that to improve children nutritional 
status, deworming alone or other treatment strategies might not be sufficient, and 
probably longer interventions would be necessary to decrease height deficits in children. 
This was the first longitudinal trial contributing with new research approaches by 
emphasizing the importance of including intestinal protozoa, in addition to helminthiasis, 
when thinking on therapeutic interventions to improve the growth of preschool children. 
Moreover, growth patterns using repeated measurements in six time points were assessed 
during the follow-up. The interventions were carried-out considering individual and 
household level, which should be also addressed in future studies given the dynamics of 
transmission of most pathogenic agents.  
3.1 Limitations and strengths 
Limitations of the studies conducted were already mentioned in detail in each one of the 
papers presented in the results section of this thesis. The first thing that is important to 
eneralized to the entire population given its 
design concept. The second aspect is related to the inclusion criteria. For instance, in the 
cross-sectional study, only children with diarrhoea were included. However, 
asymptomatic children can also serve as reservoirs of infections, ensuring transmission 
to other individuals at community level, and they were not included in the cross-sectional 
study given the fact that we aimed to address the aetiology of diarrhoea. In the case of 
rotavirus, probably the infection rate was underestimated since we have not included 
                                                 
11 See Annexe V  Photos from field work 
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children presenting only vomiting, and it is known that rotaviruses are shed for several 
days in very high concentrations in the stools and vomitus of infected individuals (15).  
There are also laboratory diagnosis limitations important to mention here. In the cross-
sectional study, only one stool sample per child was requested, which could have 
underestimate the rate of infection given the intermittent shedding of some intestinal 
parasites (57). Similarly, in the longitudinal study we have also requested only one stool 
sample per follow-up assessment. Requiring three instead one sample in each moment 
would be logistically more difficult for caregivers, and thus, could contribute to increase 
losses to follow-up. Moreover, since we were dependent on the delivery of the stool 
sample, we cannot guarantee that it was done right after of defecation, and this could have 
influenced microscopic diagnosis of pathogenic agents such as hookworm (eggs degrade 
rapidly) and Giardia lamblia (in diarrhoeal stools, trophozoites disappear rapidly) (57, 
58). Microscopic detection of Strongyloides stercoralis could have been underestimated 
given the low sensitivity of techniques performed (59). Regarding molecular procedures 
applied in the cross-sectional study: for characterization of rotavirus genotypes, we found 
some barriers related to the reduced amount of diarrhoeal samples; and for molecular 
characterization of Giardia lamblia, only in few samples DNA was successfully 
sequenced, which could have been due to DNA degradation.  
Another limitation is related to medication regimens in the longitudinal study. According 
to the study treatment protocol, some treatments included more than one dosage/days of 
treatment, and we cannot guarantee that caregivers have complied with the prescription 
at home. Self-reported data from questionnaires are also prone to social desirability 
response bias (a limitation difficult to overcome in any study).  
The strengths of our cross-sectional study include the identification of the main causes of 
diarrhoea in children under-five living in Bengo, as well as associated risk factors, during 
a year-period. This is important, so interventions can be conceptualized based on realistic 
information and targeting the age groups of children at higher risk of enteric infections. 
The identification of rotavirus strains was very important since it was performed before 
the vaccine introduction and it will be essential for comparison in future studies.  
Considering the longitudinal study, this trial included seven repeated measurements from 
the same participant (including baseline), which is a key strength of studies with this type 
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of design. A study with repeated measurements allows to chart the profile of the same 
individual across time, which is an advantage compared with cross-sectional study, where 
different subjects are commonly observed at different times (60). Adherence to 
interventions differed across arms of the study and this may have contributed to bias. This 
limitation is more concerned in a complete analysis.  However, to overcome this 
limitation, we performed an intention-to-treat analysis, according to CONSORT 
guidelines, after a missing data analysis (61). Missing values can represent a huge 
challenge in longitudinal studies (62). In this study, different methods were applied, such 
as: interpolation for height values and multiple imputation using the Expectation 
Maximization for other measurements (62). On the other hand, data collected from a 
longitudinal study is more reliably that would be data from cross-sectional study, given 
the fact that the same children were followed repeatedly, and it decreased the risk of 
collecting incorrect anthropometric data because the height does not decrease and 
subjects can serve as their own controls (60). Moreover, since we have focused on the 
effect of treatment strategies on nutritional status of each one of the participants included 
over time, smaller sample sizes are needed compared with cross-sectional designs (60). 
3.2 Conclusions 
After suffering a long-term period of civil war, Angola has made a huge progress in the 
socioeconomic and health indicators, but there are still improvements to be made. In 
Bengo province, children are exposed to a wide variety of enteric pathogenic agents in 
the first years of life. Findings from studies conducted under this thesis confirmed that 
children under 12 months are at higher risk of rotavirus and Cryptosporidium spp. 
infections, which have been identified as one of the major causes of moderate-to-severe 
diarrhoea contributing to malnutrition and death in developing countries. In addition, 
older children are also at risk of acquiring other infections caused by soil-transmitted 
helminths, which can affect the nutritional status of children. In terms of primary 
prevention, a major achievement was the introduction of the rotavirus vaccine in the 
national immunization plan in 2014. In the future, efforts must be made to assess the 
effectiveness of the rotarix vaccine in the country. For the control of soil-transmitted 
helminths, deworming is a public health intervention recommended by WHO, also 
adopted in Angola. At the moment, the benefits of deworming on the nutritional status of 
children are under discussion in the international research community. The two-year 
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longitudinal study performed in this thesis did not find differences between giving 
albendazole once a year or diagnosing and treating intestinal parasites, both at individual 
and household levels, in the nutritional status of children 2-5 years. Additional research 
is needed to address the benefits of deworming in the nutritional status of children in more 
heavily infected children, and investigate the dynamics of infection between the different 
pathogenic agents.  
In both studies performed in this thesis, more than 30% of children were suffering from 
stunting. After, in 2016, national data registered 38% of stunting in Angola and 40% in 
Bengo province (MICS 2015-2016). The national goal of reducing stunting to less than 
5% by 2021 seems very ambitious and unachievable. However, efforts must not stop 
during the sustainable development era. Decision-makers must be aware of 
socioeconomic consequences of malnutrition not only in the present, as well in the future 
generation, for a stronger political commitment. Social and financial investments are 
essential to improve people's living conditions, especially in rural areas, where they face 
a higher risk of poverty. Malnutrition and inadequate development of children are a result 
of multiple factors. Therefore, a multidisciplinary approach within different 
governmental sectors is required to improve access to safe water, adequate sanitation and 
hygiene conditions, and access to health care services. In addition, education and 
agriculture are also key sectors, in order to increase food production and availability. 
Thus, each child should be able to access foods with nutritional value and according to 
his/her health status and age. 
 
3.3 Recommendations  
Scientific research is essential for policy decision-making, however, it is still scarce in 
Angola. A greater recognition of the importance of research in decision-making is 
necessary, and, on the other hand, it is essential that research studies manage to focus on 
the major health problems, giving particular atte  
Improving laboratorial capacity for diarrhoeal diseases is needed for a better and more 
timely treatment and also for more rigorous epidemiological studies (22, 25). Since 
Angola is now in the pos-era of the vaccine introduction, rotavirus surveillance is 
important to support national vaccination strategies (17, 19). In this context, it is 
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recommended to monitor the impact of rotavirus vaccination on disease reduction 
(requires laboratory capacity of health units to perform routine diagnosis through enzyme 
immunoassays for antigen detection) and monitor the changes in the circulating strains 
(using more complex techniques such as reverse transcription polymerase chain reaction) 
(15). After interacting with laboratory technicians from Bengo, it was possible to verify 
that stool sample were collected only for the microscopic detection of intestinal parasites, 
through direct examination. However, improvements must be made not only in the 
preparation of the stool sample, but also in the ability to identify intestinal protozoa and 
helminths. Intestinal protozoa such as Giardia lamblia are completely neglected and, 
thus, undiagnosed. Strengthening human resources capacity and training is essential for 
identifying the aetiological agents of infection. This is important to provide adequate 
treatment and avoids the prescription of antibiotics in cases where it is not indicated (25). 
In our study, we included mainly children from urban areas. However, given disparities 
within regions, special attention should be given to children living in rural areas, where 
poverty limits the access to adequate food, adequate health care services, safe drinking 
water source, and sanitation conditions. Actions to promote early breastfeeding should be 
adopted and its importance transmitted to caregivers in both hospital and community 
settings. Nutrition education at community level should also be performed so caregivers 
are able to identify, among the available food, those more adequate for the child´s age. 
Moreover, it is also important to inform the population on how to correctly treat the water 
before drinking. In this context, in the final 2014, a cluster randomised trial was started 
in the Health Research Center of Angola (CISA), Bengo province, to compare the efficacy 
of two community-based interventions (nutritional education vs wash, sanitation and 
hygiene practices, both with additional treatment strategies of infectious diseases 
including malaria, schistosomiasis and soil-transmitted helminths) in the reduction of 
anaemia in preschool children (63). The results obtained from this study (not published 
yet) can lead to important contributions in this field. In settings such as Bengo province, 
the radio and the church are one of the most important means for the dissemination of 
information and, therefore, should be used more routinely to educate the population.  
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Annexe I  List of the 17 Sustainable Development Goals 
 
The Sustainable Development Agenda includes 17 Goals (Figure 20) and 169 targets to 
be achieved by 2030. 
 
 
 
Figure 20. Sustainable Development Goals  
Adapted from: (1) 
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Annexe II  Goal 2 - Zero Hunger: targets and indicators 
 
Table 17. Goal 2. End hunger, achieve food security and improved nutrition and promote 
sustainable agriculture 
Targets Indicators 
2.1 By 2030, end hunger and ensure access 
by all people, in particular the poor and 
people in vulnerable situations, 
including infants, to safe, nutritious and 
sufficient food all year round  
2.1.1 Prevalence of undernourishment  
2.1.2 Prevalence of moderate or severe food 
insecurity in the population, based on 
the Food Insecurity Experience Scale 
(FIES) 
2.2 By 2030, end all forms of malnutrition, 
including achieving, by 2025, the 
internationally agreed targets on 
stunting 12  and wasting 13  in children 
under-5 years of age (WHA65.6), and 
address the nutritional needs of 
adolescent girls, pregnant and lactating 
women and older persons 
2.2.1 Prevalence of stunting (height for age <-
2 standard deviation from the median of 
the World Health Organization (WHO) 
Child Growth Standards) among 
children under-5 years of age 
2.2.2 Prevalence of malnutrition (weight for 
height Z-score >+2 or Z-score <-2 ) 
among children under-5 years of age, by 
type (wasting and overweight)  
2.3 By 2030, double the agricultural 
productivity and incomes of small-scale 
food producers, in particular women, 
indigenous peoples, family farmers, 
pastoralists and fishers, including 
through secure and equal access to land, 
other productive resources and inputs, 
knowledge, financial services, markets 
and opportunities for value addition and 
non-farm employment  
2.3.1 Volume of production per labour unit by 
classes of farming/pastoral/forestry 
enterprise size  
2.3.2 Average income of small-scale food 
producers, by sex and indigenous status  
2.4 By 2030, ensure sustainable food 
production systems and implement 
resilient agricultural practices that 
increase productivity and production, 
that help maintain ecosystems, that 
strengthen capacity for adaptation to 
climate change, extreme weather, 
drought, flooding and other disasters and 
that progressively improve land and soil 
quality  
2.4.1 Proportion of agricultural area under 
productive and sustainable agriculture  
2.5 By 2020, maintain the genetic diversity 
of seeds, cultivated plants and farmed 
2.5.1 Number of plant and animal genetic 
resources for food and agriculture 
                                                 
12 A 40% reduction in the number of children under-five years of age who are stunted. 
13 Reduce and maintain childhood wasting to less than 5% 
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Targets Indicators 
and domesticated animals and their 
related wild species, including through 
soundly managed and diversified seed 
and plant banks at the national, regional 
and international levels, and promote 
access to and fair and equitable sharing 
of benefits arising from the utilization of 
genetic resources and associated 
traditional knowledge, as internationally 
agreed 
secured in either medium or long-term 
conservation facilities  
2.5.2 Proportion of local breeds classified as 
being at risk, not-at-risk or at unknown 
level of risk of extinction  
2.A Increase investment, including through 
enhanced international cooperation, in 
rural infrastructure, agricultural research 
and extension services, technology 
development and plant and livestock 
gene banks in order to enhance 
agricultural productive capacity in 
developing countries, in particular least 
developed countries  
2.A.1 The agriculture orientation index for 
government expenditures 
2.A.2 Total official flows (official 
development assistance plus other 
official flows) to the agriculture sector  
2.B Correct and prevent trade restrictions 
and distortions in world agricultural 
markets, including through the parallel 
elimination of all forms of agricultural 
export subsidies and all export measures 
with equivalent effect, in accordance 
with the mandate of the Doha 
Development Round 
2.B.1 Producer Support Estimate 
2.B.2 Agricultural export subsidies  
2.C Adopt measures to ensure the proper 
functioning of food commodity markets 
and their derivatives and facilitate timely 
access to market information, including 
on food reserves, in order to help limit 
extreme food price volatility  
2.C.1 
 
 
 
Indicator of food price anomalies 
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Annexe III  Assessing weight and length/height in children 
 
The basic anthropometry measurements include weight, length or height (depending on 
the child´s age).  
Weight 
Children should be weighed naked (especially babies) or, when socially inacceptable, 
with as less clothing as possible. If infants, if a diaper is worn, its weight is subtracted 
from the observed weight. It is recommended to use an electronic scale with a precision 
of 0.1kg (100g). 
If the child is less than two years old or is unable to stand, it is better to use a scale that 
allows tared weighing (reset to zero with a person still on the scale). Thus, while 
remaining on the scale, the person holds the child and the scale gives the child´s weight 
(Figure 21-A). If the child is two years of age or more, the child can be weighed alone if 
she or he is capable of standing (Figure 21-B) 
 
Figure 21. Weighing a child 
(A)  Weighing a child under two years of age (or incapable to stand); (B)  Weighing a child with two or 
more years old. Adapted from (2) 
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Length and height 
Ideally, length/height measurements should be assessed after weighing because the child 
is already with the clothes off, especially shoes, socks and hair ornaments. In children 
under two years of age the length is measured using a infantometer in the recumbent 
position (lying down), Figure 22. In older children (two or more years), the height is 
measured standing using a stadiometer, Figure 23.  
In both cases, technicians must ensure that children do not have shoes, socks or hair 
ornaments during measurements, and the head should be positioned according to the 
Frankfurt position so that an imaginary vertical line from the ear canal to the lower border 
of the eye socket is perpendicular to the board. In general, standing height is about 0.7 
cm less than recumbent length (3). Whether measuring length or height, caregiver 
collaboration is important to keep the child calm and in the right position.  
 
 
Figure 22. Measuring length of children less than two years 
Source: (4) 
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Figure 23. Measuring height of children with two years or more. 
Source: (4) 
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Annexe IV  Summary of the thesis results 
 
The main findings of this thesis are presented in Table 18.  
 
Table 18. Main findings of the thesis 
Paper Title Main findings 
I Etiology of 
diarrhoea in 
children 
younger than 5 
years attending 
the Bengo 
General 
Hospital in 
Angola 
Sociodemographic characterization 
 344 children included between September 2012 and December 2013 
 mean age of children 15.5 months ± 12.4 SD 
 River (27.0%) was the most frequent drinking water source 
 No latrine existence in 20.3% of household 
Malnutrition 
 Wasting: mild (19.5%), moderate (11.1%), and severe (20.4%)  
 Stunting: mild (22.2%), moderate (15.9%), and severe (16.5%)  
 Underweight: mild (26.6%), moderate (19.5%), and severe (15.0%) 
Diagnosis of enteric infections 
 An enteric pathogenic agent was identified in 66.6% of samples 
 Cryptosporidium spp. (30.0%), rotavirus (25.1%), Giardia lamblia 
(21.6%), diarrheagenic Escherichia coli (6.3%), Ascaris lumbricoides 
(4.1%), adenovírus (3.8%), Strongyloides stercoralis (3.5%), astrovirus 
(2.6%), Hymenolepis nana (1.7%), Entamoeba histolytica/díspar 
(0.9%), Taenia spp. (0.6%), Trichuris trichiura (0.3%), and Entamoeba 
histolytica (0.3%) 
Virus: 
 Rotavirus the most frequent viral agent. 
 Rotavirus independently associated with age (<12 months, OR:5.0, 
95% CI 2.7-9.3), type of admission (outpatients, OR:0.5, 95% CI: 2.7-
9.3) and vomiting (yes, OR: 2.7, 95% CI: 1.5-4.8). Association with 
wasting only in the univariate analysis. 
Parasites: 
 Intestinal protozoa were more frequent than helminths  
 Cryptosporidium spp. independently associated with age (<12 months, 
OR: 3.5) 
 Helminths more common in older children (12-59 months, p=0.02) 
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 Strongyloides stercoralis independently associated with maternal 
education (with education, OR: 0.2, 95% CI: 0.1-0.7) 
 All 6 children infected with Hymenolepis nana were stunted  
 No significant differences were found between protozoa and 
malnutrition 
 
Bacteria: 
 Suspicious colonies of Escherichia coli were isolated in 140 and 19 
were confirmed to be pathogenic: EAEC (4.0%) and ETEC (2.3%) 
 Shigella spp., Salmonella spp., and Campylobacter jejuni were not 
isolated  
Water and sanitation  
 No significant association was found between any of the pathogenic 
agents and water sources, water treatment or latrine usage. 
 
II Characterizati
on of rotavirus 
infection in 
children with 
acute 
gastroenteritis 
in Bengo 
province, 
Nortwestern 
Angola, prior 
to vaccine 
introduction 
 Characterization 
 Between September 2012 and December 2013, 342 stool samples were 
tested for rotavirus by immunochromatographic rapid test, and 86 
(25.1%) were positive 
 Of the total positive samples, 72 (83.7%) were genotyped 
 
Genotypes: 
 G1P[8] 47.2%  
 G1P[6] 29.2% 
 G2P[4] 2.5% 
 Two G-types were found: G1 (83.3%) and G2 (15.3%). It was not 
possible to determine G-type for one sample. 
 Three P-types: P[8]: 47.2%; P[6]: 30.6%; and P[4]:12.5%. It was not 
possible to determine P-type for seven samples. 
 SGI: 15.3%, and SGII: 84.7% 
 
Risk factors: 
 The mean age of children was significantly lower for children with 
rotavirus compared to those not infected (9.2±5.00 vs 17.6±13.40 
months) 
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 Rotavirus infections was significantly more frequent in children who 
were being breastfed (exclusive or continued) compared to those who 
had already been weaned or had never been breastfed (34.2% vs 3.9%)  
 No association was found between rotavirus infection and maternal 
education, drinking water source and treatment method applied, 
sanitation facilities, underweight, fever, signs of dehydration, 
hospitalization, duration of diarrhoea, and seasonality.  
 
III Molecular 
characterizatio
n of Giardia 
lamblia in 
children less 
than 5 years of 
age with 
diarrhoea 
attending the 
Bengo General 
Hospital, 
Angola. 
Characterization 
 Between September 2012 and December 2013, the diagnosis of Giardia 
lamblia was performed in 344 stool samples, through microcopy and 
antigen rapid test, and 73 (21.6%) were positive for at least one of the 
methods. 
 
Molecular charaterization 
 DNA extraction was performed in 63 (86.3%) 
 16 were amplified for the ssu-rRna, and 11 successfully sequenced 
 Samples belonging to assemblage B (11/12)  91.7% 
 Samples belonging to assemblage A (1/12)  8.3% 
 It was not possible to determine the subassemblages belonging to 
assemblage B due to high polymorphism observed 
 Isolate belonging to assemblage A was found to belong to the A3 
subassemblage 
 
IV Two-year 
impact of 
annual 
albendazole 
versus four-
monthly test-
and-treat 
approach of 
intestinal 
parasites on 
children 
nutritional 
Characterization 
 Between December 2013 and December 2014, 692 children were 
recruited, and 121 children were included and randomly assigned to: 
 Arm 1 (A1)  29 (ALB, individual level)  
 Arm 2 (A2)  31 (ALB, household level) 
 Arm 3 (A3)  31 (diagnosis + treatment, individual level) 
 Arm 4 (A4)  30 (diagnosis + treatment, household level) 
Baseline  
 sociodemographic, anthropometric and clinical characteristics were 
similar across arms. Of the total (N=121): 
 95.0% were from urban areas  
 29.1% with unimproved drinking water source 
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status in 
Bengo, Angola: 
a four-arm 
randomised 
parallel trial 
 19.7% without a latrine 
 Mean member per household 5.97 ± 2.08 SD 
 74.4% with less than 3 rooms per household 
 74.4% living in houses made of adobe 
Malnutrition 
 Stunting: mild (33.1%), moderate (20.7%), and severe (9.9%) 
 Wasting: mild (21.5%), moderate (5.0%), and severe (2.5%) 
 Underweight: mild (29.4%), moderate (12.6%), and severe 
(3.4%) 
 Mean HAZ (-1.34±1.33) 
 Mean WHZ (-0.29±1.18)  
 Mean WAZ (-0.80±0.98) 
 More stunting in children living in houses with adobe walls 
compared with those made of bricks (39.1% vs 10.0%, 
p=0.003, OR=4.2). 
 More stunting in children living in houses with earth or sand 
floors than those with ceramic floors (60% vs 27.5%, p=0.017; 
OR=1.2). 
 
Intestinal parasites 
 Giardia lamblia (57.0%), Ascaris lumbricoides (25.6%), 
Strongyloides stercoralis (13.2), Trichuris trichiura (5.8%), 
Hymenolepis nana (5.8%), Cryptosporidium spp. (5.8%), 
Entamoeba histolytica (2.5%) 
 diarrhoea (47.9%), fever (80.2%), vomiting (14.9%);  
 mean haemoglobin: 10.6 ± 1.67 g/Dl 
 Malaria (P.falciparum  rapid test) 
 
Follow-up 
 12 permanently lost to follow-up  
 Temporary withdrawal occurred in all arms 
 
Follow-up: Interventions - Arm 1 
 28 (96.6%) children received a single dose of ALB at Fu1; 
 24 (85.7%) children received a single dose of ALB at Fu4 
 24 (82.8%) received complete intervention in both Fu1 and Fu4 
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Follow-up: Interventions - Arm 2 
 28 (90.3%) children and 126 household members received ALB in 
Fu1  
 27 (87.1%) children and 152 household members received the 
allocated treatment in Fu4  
 In sum, the intervention was completely received by 22 children 
(71%) in both time points, with a household coverage 80%. 
 
Follow-up: Interventions - Arm 3 
 the number of those delivering a stool sample and receiving 
appropriate treatment was 24 (77.4%) in Fu1, 21 (67.7%) in Fu2, 23 
(74.2%) in both Fu3 and Fu4, 20 (64.5%) in Fu5, and 22 (71.0%) in 
Fu6.  
 Only 15 (48.4%) children completed intervention by delivering a 
stool sample in all follow-ups and receiving appropriate treatment. 
 
Follow-up: Interventions - Arm 4 
 the number of children delivering a stool sample and receiving 
treatment was 22 (73.3%) in Fu1, 24 (80.0%) in Fu2, 25 (83.3%) in 
Fu3, 23 (76.7%) in Fu4, 25 (83.3%) in Fu5, and 22 (73.3%) in Fu6.  
 The percentage of household members delivering the requested stool 
sample during the follow-up period ranged between 63.0% (92/146) 
and 74.6% (94/126). 
 At the household level, only nine children (30%) and at least 50% of 
their household members were able to deliver a stool sample and 
receive appropriate treatment in the six follow-ups. 
Non-parametric approach for longitudinal data (nparLD): 
 no significant effects were obtained in any of the interventions 
(effect of arm), nor by arm*time interaction, table 3. However, 
temporal changes occurred in all nutritional outcomes (p<0.05) 
Modeling for longitudinal data:  
 The results from GEE and LMM models were very similar, even for 
different correlation structures, enhancing significant temporal 
changes in primary outcomes 
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For secondary outcomes: 
 no significant differences in the rates of infection between A3 and 
A4 
 Giardia lamblia was the most frequent parasite identified in each 
time 
 From Fu1 to Fu6, there was a significant reduction of parasitic 
infection in A4 (p=0.039), but not A3 (p=0.727). 
 At the end, the reduction of Giardia lamblia infection was higher in 
A4 (from 37.5% to 16.7%, p=0.07) than A3 (from 34.6% to 30.4%, 
p=0.727). 
 After requiring a stool sample to all children in the last Fu, infections 
rates for G. lamblia were lower in A4 (16.7%), followed by A3 
(30.4%), A1 (34.8%), and A2 (40%); but for A. lumbricoides they 
remained similar in all arms (near 9% for A1 and A2, 10% in A3, 
and 8% in A4). 
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Annexe V  Fieldwork photos 
 
 
Figure 24. Outpatient health unit of Hospital Geral do Bengo, Bengo province, Angola 
 
 
Figure 25. Hospital Municipal do Dande, Bengo province, Angola 
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Figure 26. Posto Médico o Bom Samaritano, província do Bengo, Angola 
 
 
 
Figure 27. Data collection  
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Figure 28. Using the global positioning system (GPS) for houses location 
 
 
Figure 29. On the way for a community follow-up assessment 
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Figure 30. On the way for a community follow-up assessment 
 
 
Figure 31. Entering a house for community follow-up assessment 
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Figure 32. Community follow-up assessment  
 
 
Figure 33. Assessing haemoglobin concentration  
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Figure 34. Assessing a child´s height during a community follow-up assessment 
 
 
 
Figure 35.  Difficulties in accessing houses during community follow-up 
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Figure 36. Household construction materials in the Dande HDSS area 
A - Block walls and roof tile; B- Adobe walls and iron sheet roof; C- Wattle and daub walls and iron sheet 
roof; D - Straw walls and roof 
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Figure 37. Common water sources for drinking, and/or bathing, and/or other activities  
A-Irrigation channel; B- Public tap water; C- river; D - tank 
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Figure 38. Laboratory at the Health Research Centre of Angola (CISA), Bengo, Angola  
 
 
Figure 39. CISA´s multidisciplinary field team 
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